Western University

Scholarship@Western
Electronic Thesis and Dissertation Repository
5-17-2012 12:00 AM

Heme Binding and Transfer in the Isd Heme Scavenging Pathway
of Staphylococcus aureus
Michael T. Tiedemann, The University of Western Ontario
Supervisor: Dr. Martin J. Stillman, The University of Western Ontario
A thesis submitted in partial fulfillment of the requirements for the Doctor of Philosophy degree
in Chemistry
© Michael T. Tiedemann 2012

Follow this and additional works at: https://ir.lib.uwo.ca/etd
Part of the Other Chemistry Commons

Recommended Citation
Tiedemann, Michael T., "Heme Binding and Transfer in the Isd Heme Scavenging Pathway of
Staphylococcus aureus" (2012). Electronic Thesis and Dissertation Repository. 545.
https://ir.lib.uwo.ca/etd/545

This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca.

Heme Binding and Transfer in the Isd Heme Scavenging
Pathway of Staphylococcus aureus
(Spine title: Heme Binding and Transfer in Staphyloccus aureus)
(Thesis format: Integrated-Article)

By

Michael Thomas Tiedemann

Graduate Program in Chemistry

Submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy

The School of Graduate and Postdoctoral Studies
The University of Western Ontario
London, Ontario, Canada
April, 2012

© Michael Thomas Tiedemann 2012

The School of Graduate and Postdoctoral Studies
The University of Western Ontario

CERTIFICATE OF EXAMINATION
Supervisor

Examiners

Dr. John F. Corrigan
Dr. Martin Stillman
Dr. Len G. Luyt

Dr. Gilles A. Lajoie

Dr. Rebecca A. Jockusch

The thesis by

Michael Thomas Tiedemann
entitled:

Heme Binding and Transfer in the Isd Heme Scavenging Pathway of
Staphylococcus aureus
is accepted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy

Date
Chair of the Thesis Examination Board

ii

ABSTRACT
The antibiotic resistant bacterium Staphylococcus aureus is a significant problem in hospitals
and communities worldwide. Survival of the bacterium in the host is reliant on iron scavenging.
Staphylococcus aureus has adopted specialized mechanisms for scavenging iron from the host.
The cell wall and membrane-associated iron regulated surface determinant (Isd) proteins allow
Staphylococcus aureus to scavenge iron from the heme in hemoglobin. There are nine Isd
proteins (IsdH, IsdB, IsdA, IsdC, IsdE, IsdD, IsdF, IsdG and IsdI) located at different depths in
the cell wall and membrane. Magnetic circular dichroism (MCD) spectroscopy and electrospray
ionization mass spectrometry (ESI-MS) have been used to determine the direction, mechanistic
details and heme binding ligands of the Isd heme transfer system. Ferric heme extracted from
metHb by IsdB and has been demonstrated to transfer in a unidirectional fashion with the heme
transferring along the pathway in the sequence (proximal amino acid) IsdB-N2 (Tyr)  IsdA-N
(Tyr)  IsdC-N (Tyr)  IsdE (His) or, alternatively, when initiating from IsdH-N3 (Tyr) the
transfer sequence is  IsdA-N (Tyr)  IsdC-N (Tyr)  IsdE (His). Heme transfer through the
cell wall must occur through IsdC indicating that IsdC acts as the central conduit of the Isd
system. MCD and ESI-MS data show that disruption of unidirectional heme transfer occurs with
heme analogs and protein mutational studies. Finally, kinetic analysis provides rate constants for
the major unidirectional reaction steps.

Keywords: Staphylcoccus aureus, iron-regulated surface determinant, heme transfer pathway,
heme binding proteins, heme transfer kinetics, heme analogs, protein mutants, MCD
spectroscopy, ESI-mass spectrometry.
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Chapter 1.

Introduction

1.1 Staphylococcus aureus
Staphylococcus aureus (S. aureus), also known as "golden staph" due to its colour when
grown on a laboratory plate, Figure 1-1, is an invasive Gram-positive coccoid bacterium that
innocuously colonizes the anterior nares of approximately 30% of the human population [1, 2].

Figure 1-1
Staphylococcus aureus, "golden staph", left side and E.coli on right for
comparison, grown on a trypticase soy agar plate. Reprinted with permission from [3].
Copyright 2007 American Society of Clinical Pathology.
In hospitals, S. aureus is one of the most commonly acquired bacterial infections. About 20% of
nosocomial bloodstream infections are caused by S. aureus making it a leading cause of
nosocomial infections [4]. S. aureus causes more severe infections when it gains access to
deeper tissues and the bloodstream after penetrating the skin surface or mucosal barriers.
Breaching this initial state of colonization, S. aureus causes a range of potentially lethal diseases
such as pneumonia, meningitis, toxic shock syndrome (TSS), endocarditis, septicemia and death
[5, 6]. The disease severity and outcome is dependent on the infection site and immune status of
the host.
To complicate this crippling bacterial infection, the emergence of resistant S. aureus has taken
place over several decades. The first reported cases of penicillin resistant S. aureus was reported
around 1944 [7, 8]. More potent antibiotic-resistant S. aureus started emerging more recently.
Methicillin was first released in North America in 1961 to combat drug resistant bacterial strains
and reports of methicillin-resistant S. aureus (MRSA) have appeared as early as 1968 [9].
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Vancomycin is often referred to as a last resort drug but resistance was first reported in 2002
[10].

Now, vancomycin-resistant S. aureus (VRSA) infection cases are observed more

frequently in health care facilities [5, 11]. Strict control over the use of vancomycin and other
MRSA effective antibiotics has now been implemented, only being used in severe cases where
other less-toxic antibiotics are ineffective. Furthermore, MRSA, initially limited to hospitals, has
since spread to the community [12]. This clinical challenge is compounded each year in the
United States since MRSA strains alone cause an estimated 94,360 invasive infections, resulting
in ~19,000 deaths [13], which is more deaths than HIV [14]. In Canada, the death toll is lower
compared to the United States, ~2000 deaths in 2006 [15]. However, MRSA still represents a
significant financial burden with annual costs for treatment and control in Canadian hospitals
estimated to be ~$130 million [16]. These facts highlight the need for further study of the
bacteria and search for novel targets and identification of new antimicrobials to treat this
infectious threat [17, 18].
The invasive and pathogenic success of S. aureus is due to the bacteria's ability to survive
within many different hostile host environments and systems. The S. aureus bacterial surface is
coated by a capsule and the thick cell wall is laden with other protective components to impede
immune recognition [19]. Numerous surface adhesions allow S. aureus to adhere to almost any
surface in the human body extending the bacteria's efficiency in infecting almost any system of
the human body [20, 21]. S. aureus secretes numerous proteases, lytic toxins and lipases that
exacerbate tissue and immune damage in order to avoid the host's immune system [22].
However, in order to facilitate such an anti-immune response and flourish in a host system, a
steady supply of nutrients must be garnered from host tissues for growth. S. aureus achieves this
through tissue damage and high affinity uptake systems. Iron is likely one of the most important
limiting nutrients and as a result, S. aureus expends significant resources to acquire iron.

1.2 Iron in the human host
Iron is the fourth most abundant metal in the earth's crust and is an essential component of
nearly every living biological system [23] due to the ability to undergo changes in oxidation state
(Fe3+ (ferric) and Fe2+ (ferrous)), hence, iron is an important biological catalyst [24]. Iron plays a
major role in vital processes such as energy production, detoxification, nucleotide biosynthesis
and oxygen transport and storage [25, 26].

Free iron is insoluble at physiological pH
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[Ksp(Fe(III))=10-39 M] [27] and can cause oxidative damage via the Fenton reaction ( Fe2+ +
H2O2

Fe3+ + OH- + OH.) in vertebrate tissues where H2O2 is a byproduct of the body's

protective reaction to free reactive oxygen species. In order to prevent host damage free iron is
quickly removed or sequestered into high-affinity iron-binding proteins such as transferrin,
lacotoferrin and the iron storage protein ferritin, or by incorporation into a protoporphyrin ring as
heme in hemoproteins [23, 25].

The human body contains ~4g of iron and free iron

concentrations are maintained at orders of magnitude below (approximately 10-18 M [28]) those
required to support bacterial growth, making it difficult for bacteria to obtain iron [29, 30]. Due
to host sequestration of free iron, free iron is not typically available and as a result invasive
organisms have developed high affinity systems to acquire and store iron [31].
Table 1-1 shows the major iron sources in the human body. Interestingly, the most abundant
potential iron source for bacteria is heme-b (Fe-PPIX). Approximately 75% of the intracellular
iron pools are heme-iron, predominantly found in the oxygen transporter, hemoglobin (Hb) and
myoglobin including other heme-iron enzymes [30].

Heme is a prosthetic group in many

proteins and enzymes where it plays key and significant roles in many fundamental biological
processes including O2 storage and transport (myoglobin and hemoglobin), respiration and
electron transfer (cytochromes), activation of the O-O bond (P450 enzymes and peroxidase), and
signal transduction and gas sensing (CooA, nitric oxide synthase (NOS)) [25].
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Table 1-1
List of the major iron containing molecules in humans and their percentage
of the total iron pool [27]
Iron containing molecules

% of total human iron pool

Heme (hemoglobin)

~70%

Heme (myoglobin)

~5%

Ferritin

~25%

Transferrin

<1%

Heme enzymes

<1%

Other heme/iron containing

<1%

molecules

This lipophilic molecule with low molecular weight (616.48 Da), Figure 1-2, can easily
percolate into membranes and thus impair lipid bilayers and organelles.

Damage results in

destabilization of the cytoskeleton of cells and furthermore, heme catalyzes the formation of
reactive oxygen species [25]. Therefore, like free iron, free heme is poorly tolerated by cells and
heme is rapidly bound by molecules such as hemopexin, albumin and hemoglobin. Ultimately,
both heme-hemopexin and albumin are recycled in the liver [32].

Figure 1-2
Structure of ferrous (Fe(II)) heme-b. Free heme is sequestered in the human
body and bound by axial amino acid ligands from proteins typically forming octahedral like
complexes.
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1.3 Iron uptake in Gram-positive bacteria
The body's response to sequester and reduce extracellular iron levels and free heme may be a
potentially effective strategy however, pathogenic bacteria have evolved specialized mechanisms
for acquiring iron from the host. Numerous iron acquisition systems target a number of iron
containing molecules. Iron uptake in Gram-positive bacteria is not as well understood as their
Gram-negative counterparts despite the fact that many of these systems comprise of fewer
components. This is mainly due to a larger research focus on Gram-negative bacteria in the past
[25].

Figure 1-3
Cartoon schematic showing the difference Gram-negative (left) and Grampositive (right) bacteria. All similar structures are similarly coloured. Gram-negative bacteria
typically secrete iron-chelator molecules (red) and due to the extra cell wall, receive complexes
in outer membrane receptors (yellow) using energy derived from the TonB-ExbB-ExbD complex
(purple). Gram-positive bacteria receive iron-chelator molecules at the cytoplasmic membrane.
Other protein receptors (brown), which are not exclusive to only one system, are bound to the
cell wall typically through anchors to either the outer membrane or the cell wall. Both bacteria
contain permeases (blue), which facilitate membrane transport and are driven by ATP produced
from ATPase (orange).
Figure 1-3 shows the main differences between Gram-positive and Gram-negative bacteria.
Gram-positive bacteria have a thicker cell wall, typically 15-80 nm thick [33] which is
composed of murein sacculus, attached polysaccardides, teichoic acid and cell wall proteins [34].
Gram-positive bacteria characteristically have more complex cell wall structures and due to the
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lack of an outer cell membrane the cell-wall proteins are typically tethered which anchors them
into the cell wall instead of having free transport components like in Gram-negative bacteria
[35]. The Ton system that is found in Gram-negative bacteria is not found in Gram-positive
bacteria [25]. However, surprising similarities have been found between Gram-positive bacteria
where many of them contain ATP binding cassette (ABC)-transporters, powered by ATP that
facilitate heme transfer across the cell wall [25]. Interestingly, a ferric hydroxamate uptake
(Fhu) system was discovered in S. aureus with similarities to the E. coli system which shows the
promiscuity of these iron systems in bacteria [36, 37].

1.4 Staphylococcus aureus iron uptake systems
1.4.1 Siderophores in Staphylococcus aureus
S. aureus responds to the iron-restricted environment of the host with an array of iron-uptake
and acquisition systems.

It has been shown that S. aureus is able to grow using heme,

hemoglobin, hemoglobin-haptoglobin, transferrin, ferric iron or ferrous iron as the sole iron
source [38-40]. An example of iron uptake is through the use of siderophores, low molecular
weight iron binding molecules (usually 400-1000 Da) that are secreted by bacteria into their
extra-cellular environments. Typically, siderophores have a high affinity for iron and are found
in numerous bacterial systems. Siderophores secreted by bacteria are able to remove iron from
transferrin and S. aureus is no exception with two structurally characterized polycarboxylatetype siderophores, Staphyloferrin A and Staphyloferrin B, Figure 1-4, have been shown to be
produced by S. aureus [41, 42]. Siderophores are transported through the cell wall in a cartoon
schematic found in Figure 1-5. Siderophores are bound by substrate binding proteins which are
anchored to the cell wall (brown) at the cell wall to cytoplasm interface where HtsA binds
Staphyloferrin A and SirB binds Staphyloferrin B. The heterodimeric permeases (HtsBC and
SirBC (blue)) allow release and passage of siderophores through the cell membrane and into the
cytoplasm. The permeases receive ATP from FhuC (orange), a functional ATPase for both
importers.
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Figure 1-4

Structure of A) Staphyloferrin A and B) Staphyloferrin B [41, 42]

Figure 1-5
Left) Staphyloferrin A transport and Right) Staphyloferrin B transport in
Staphyloccus aureus. These systems comprise of 3 main components which facilitate
siderophore-iron complexes through the cell wall: Siderophore binding protein (HtsA or SirB),
permease (HtsBC or SirBC) and ATP generator (FhuC) [41, 42].

1.4.2 Isd heme transport system in Staphylococcus aureus
Since the majority of iron is sequestered and bound as heme-iron, S. aureus has also evolved
mechanisms to exploit and scavenge heme as an iron source.

The iron-regulated surface

determinant (isd) gene cluster was first identified in 2002 [40, 43, 44], and then in 2003,
Mazmanian et al. [38] reported that when grown in iron-limiting medium, S. aureus expresses
genes that are involved in iron acquisition. Mazmanian et al. were the first to propose that the
Isd series of protein comprise of a heme transfer pathway across the cell wall and through the
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cell membrane. The Isd system is so named because it is based on the iron regulation of all
genes in the cluster, and the observation that four of the protein products of the system (IsdA,
IsdB, IsdC and IsdH) are cell wall anchored.

The genetic Isd system is encoded by five

transcriptional units (isdA, isdB, isdCDEFsrtBisdG, isdH and isdI) [45, 46]. These genes encode
cell wall anchored proteins (IsdA, IsdB, IsdC and IsdH), a membrane transporter (IsdDEF), a
sortase (SrtB), and two cytoplasmic proteins (IsdG and IsdI).

Overall, the Isd system is

composed of and consists of nine iron-regulated proteins named IsdA, IsdB, IsdC, and IsdH,
which are cell-wall anchored surface proteins; IsdDEF, which together constitute a membranelocalized ABC transporter; and finally, IsdG and IsdI, which encode heme-degrading enzymes in
the cytoplasm [47, 48]. This system has been proposed [40, 43, 44] and shown [38] to pass heme
through the gram-positive cell wall and cell membrane into the cytoplasm where heme is
deconstructed and free iron is released. These nine proteins mediate the delivery of heme from
the host’s plasma into the S. aureus cytoplasm [49]. Surface proteins are often covalently
anchored to the cell wall by the action of sortase enzymes due to the fact that Gram-positive
bacteria lack an outer membrane. Sortase enzymes cleave a specific amino acid sequence at the
end of the C terminal protein to attach the surface proteins to the cell wall. IsdC is achored by
sortase B (SrtB) while the rest of the surface receptors are anchored by sortase A (SrtA) [38].
Studies have shown that IsdB and IsdH are exposed to the surface environment of the cell, while
IsdA is only partially exposed. IsdC is buried within the cell wall and since it is attached with a
sortase B anchor rather than the rest of the proteins, it is speculated that IsdC is attached to a
unique portion of the cell wall compared with other protein components of the Isd system [38,
45, 46]. Interestingly, genetic inactivation of IsdA, IsdF or either SrtA or SrtB led to a decreased
association of heme with S. aureus cells [38]. Other studies have shown similar results where
inactivating IsdA, IsdG or IsdI impaired growth in iron-chelated minimal media with heme as the
sole iron source [50, 51]. Furthermore, inactivation of IsdH and IsdB also led to decreased
growth on hemoglobin as a sole iron source [52].
In S. aureus, all the cell wall anchored Isd proteins, IsdA, IsdB, IsdC and IsdH each contain
one to three copies of a conserved near transporter (NEAT) domain. The NEAT domain is found
in most pathogenic bacteria. The domain has been found to be related to iron transport. NEAT
domains are composed of about 125 amino acids and are mostly composed of beta sheets [53].
A cartoon schematic representation of the cell wall anchored Isd proteins, Figure 1-6, shows the
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NEAT domain structure of the proteins as well as the C-terminal tags which anchor the proteins
to the cell wall. IsdA and IsdC each contain one NEAT domain which has been shown to bind
heme [50, 54, 55]. IsdB contains two NEAT domains of which only IsdB-NEAT domain 2 binds
heme. IsdH contains three NEAT domains of which only IsdH-NEAT domain 3 binds heme.

Figure 1-6
Schematic showing the cell wall anchored Isd proteins. Heme binding NEAT
domains are colored red.
Early research on the Isd system from S. aureus focused on characterization of the heme
binding characteristics of the Isd proteins and mechanism of heme transfer and extraction from
iron sources.

A schematic of known information when starting this thesis is summarized in

Figure 1-7. Early mechanistic research had found that heme acquisition proteins, IsdB and IsdH
captured heme from Hb released from erythrocytes by hemolysins [52, 56].

IsdH binds

haptoglobin (a serum glycoprotein that protects the host from free hemoglobin) and the
haptoglobin-hemoglobin complex [39, 57]. IsdA is proposed to function as a heme scavenging
protein and a “heme reservoir” for IsdH and IsdB [55, 58]. IsdC, which is located in the cell
wall, acts as the central conduit of heme transfer in the Isd system [50, 59, 60]. The membrane
bound complex IsdDEF complex pumps heme across the membrane [49]. Heme is finally
deconstructed by IsdG monooxygenase or its paralog, IsdI [48, 49]. The proteins IsdA, IsdB,
IsdC and IsdH each contain at least one NEAT domain that adopts a beta sandwich structure to
bind one ferric heme into a groove with heme-iron coordination via Tyr. IsdA can bind ferrous
heme through a histidine binding motif while IsdC is not able to bind ferrous heme [50, 55, 58,
59, 61-63]. IsdE, a lipoprotein, which does not contain any NEAT domains, binds heme into a
shallow groove between two lobes of the protein using His to coordinate to the ferric heme-iron.
Ferrous heme is bound by histidine and methionine amino acid binding ligands [64, 65]. Current
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studies on the Isd system in S. aureus are focusing on the structural aspects of the heme and
heme analog binding [49, 54], mechanistic details in terms of heme transfer/binding [56, 66, 67],
and the heme degradation reaction [68, 69]. Some studies have started to look at different metalsubstituted porphryins and their binding to the Isd system [49, 54, 69-71].

Figure 1-7
Proposed model for the Isd heme scavenging pathway in Staphyloccocus
aureus. This scheme was adapted from the proposal by Mazmanian et al. [38]. Shown are the
structures of the NEAT domains for IsdA and IsdC, and IsdE (using the deposited pdb files [2itf,
2o6p, 2q8q]). It is proposed that IsdH-N1 binds the haptoglobin-hemoglobin complex, and
IsdH-N3 binds heme. IsdB-N1 binds hemoglobin, while IsdB-N2 binds heme. IsdC is believed
to be a central conduit to the heme transfer mechanism and only binds heme in the NEAT
domain. IsdE does not contain a NEAT domain since it is a lipoprotein involved in heme
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passage through the ABC transporter comprised of IsdEF. IsdG and IsdI are responsible for
degradation and release of free useable iron into the bacterial cell. Adapted from [72].
Copyright 2008 Portland Press Limited.

1.5 Scope of thesis
Heme uptake mechanisms of bacterial pathogens present an ideal path for targeted drug
delivery because they accumulate heme via active transport and are maximally expressed in ironlimiting conditions in the host, which happens during infection [24]. However, mechanistic
detail about heme and heme analog transfer through this pathway has not been studied.
Furthermore, the heme binding characterization of the remaining Isd proteins, IsdB and IsdH has
also not been explored as in depth as the other NEAT containing Isd proteins, IsdA and IsdC.
The research in this thesis focuses on the characterization and mechanistic detail of heme and
heme analog binding and transfer in the Isd system of Staphylococcus aureus.
This thesis consists of 9 chapters. The first chapters give an overview of Staphyloccocus
aureus and the importance of iron to bacteria. Chapter 1 provides an introduction into the heme
transfer Isd system in S. aureus with a summary of research on the system that was performed
when starting this thesis. Chapter 2 explores the recombinant protein synthesis method used to
produce the Isd proteins used in this thesis as well as an explanation of the techniques used
which include UV-visible absorption spectroscopy, magnetic circular dichroism spectroscopy
and electrospray-ionization mass spectrometry. An introduction to heme spectroscopy and heme
proteins is also provided.
Chapter 3 consists of the first and complete experimental mapping of heme transfer in vitro
of the Isd system. Protein-protein interactions are speculated to control the specific heme
transfer reactions found. Chapter 4 explores the heme binding motif of the unexplored IsdBNEAT domain 2 and IsdH-NEAT domain 3. The results found in this chapter lead to speculation
that the heme binding motif plays a characteristic role in the selectivity of heme transfer found in
the Isd system.
Chapter 5 explores the importance of the heme binding ligands of IsdE with regards to the
selective transfer found in the Isd system. Importantly, the strong unidirectional nature of the
system is controlled by the amino acids ligands in IsdE and without them, heme transfer does not
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involve specific protein-protein interactions but is transformed into a associative/dissociative
mechanism.
Chapter 6 describes the difference in rates of heme transfer found within the Isd system of S.
aureus. This chapter also explores the importance of performing heme transfer kinetics using
ESI-MS techniques with heme binding multi-protein systems where characterization by
absorption spectroscopy is difficult and ambiguous due to the similar spectral properties of heme
binding proteins.
Chapter 7 explores the start of the Isd pathway looking at interactions with IsdB with bovine
hemoglobin as a model for human hemoglobin extraction. The importance of oxidation state as
well as protein-protein interactions is explored.
Chapter 8 looks at heme analog transfer through the core three Isd proteins, IsdA, IsdC and
IsdE. The correlation between central metal and ring structure is explored with insight into
potentially interrupting and disrupting the Isd system in order to potentially kill the bacteria by
blocking important resource pathways.
Chapter 9 draws together the results from each chapter and discusses them with respect to the
structural properties, heme binding properties, heme transfer properties and mechanistic detail of
the Isd proteins.
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Chapter 2.

Materials

and

Methods:

Preparation,

Purification and Characterization of Isd Proteins from S.
aureus1
2.1 Introduction
Modern studies rely heavily on recombinant protein expression systems, where the protein of
interest is grown and isolated from a non-natural source. For the Isd system, the protein of
interest is grown and purified from a recombinant system using Escherichia coli (E. coli). The
Isd protein gene was integrated into an expression plasmid that had been inserted into a host
organism. Hence, the plasmid was induced to produce significant quantities of the protein.
There are several advantages when compared to isolation from natural sources, including
enhanced isolation techniques, purity, yield and efficiency.

This is important since

Staphylococcus aureus is a dangerous pathogenic bacteria and the Isd genes are only expressed
during non-optimal, iron-limiting environments.
In this chapter, the recombinant protein preparation techniques are described for the
production of the Isd proteins. A multitude of instrumental techniques was used to study the Isd
heme transfer system including UV-visible absorption spectroscopy, magnetic circular dichroism
(MCD) spectroscopy and electrospray ionization mass spectrometry (ESI-MS).

A brief

description of the instrumental techniques used to characterize the Isd proteins and their heme
binding properties is also provided.

2.2 Chemical Inventory
Table 2-1: List of materials used
Chemical / Reagent
Acetonitrile
Agar-Agar
Ammonium Hydroxide
Ampicillin
L-Arabinose
2-Butanone
Carbon Monoxide gas
Co(III)-Protoporphyrin IX
1

Supplier
Caledon
Fisher Scientific
EMD
Bioshop
Fisher Scientific
Alfa Aesar
Praxair
Frontier Scientific

A portion of this work has been published:
Tiedemann M. T., Stillman M. J., J. Porphyrins Phthalocyanines, 2011, 15, 1134-1149.
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Deionized (dI) water >16 MΩ•cm
N,N-Dimethylformamide
Dimethylsulfoixde
Ferrous Chloride
Formic Acid
Formic Acid (Ammonium Salt)
Hemin
His-Trap HP 1mL Column
Hydrochloric Acid
Imidazole
Luria Bertani Broth Mix
Mn(III)- Protoporphyrin IX
Myoglobin
Nitric Acid
Potassium Ferricyanide
Protoporphyrin IX
Protoporphyrin IX-Dimethylester
Pyridine
Sodium Chloride
Sodium Cyanide
Sodium Dithionite
Sodium Phosphate
Thrombin

Branstead Nanopure Infinity
Caledon
Caledon
Sigma
Caledon
J. T. Baker
Fluka
GE Healthcare
Caledon
Fisher Scientific
Difco
Frontier Scientific
Sigma
Fisher Scientific
Fisher Scientific
Frontier Scientific
Frontier Scientific
Caledon
Caledon
Fisher Scientific
Fisher Scientific
Caledon
GE Heathcare

2.3 Isd Proteins
The recombinant Isd proteins were kindly engineered in the laboratory of David Heinrichs at
The University of Western Ontario (London, Ontario). DNA encoding residues 62-184 of IsdA
(the NEAT domain of IsdA or IsdA-N), residues 144-462 of IsdB (IsdB-N1N2), residues 144269 of IsdB (IsdB-N1), residues 337-462 of IsdB (IsdB-N2), residues 28-150 of IsdC (IsdC-N),
residues 539-658 of IsdH (IsdH-N3) and residues 32-292 of IsdE were PCR amplified from S.
aureus RN6390 chromosome and cloned into pET28(+) in such a way as to incorporate Nterminal 6X-His tags. DNA encoded His-tagged protein was digested out of pET28a(+) and
cloned into pBAD30 [1], for ampicillin resistance, before being introduced into E.coli RP523, a
hemB mutant, which cannot produce heme [2].
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2.4 Protein Growth and Purification
2.4.1 Protein Expression and Growth
All solutions were prepared with deionized water with a resistivity greater than 16 MΩ•cm
with a Nanopure Inifinity water system (Barnstead, Illinois, USA). All solutions were either
made with autoclaved water (eg. growth cultures, heme, ampicillin, L-arabinose solutions) at 121
o

C for 20 minutes with a Sterilmax Table Top Sterilizer (Thermo Scientific, Iowa, USA).
Figure 2-1 shows the detailed outline of the protocol used to synthesize and isolate Isd

proteins. Production of each Isd protein follows the same protocol. Transformed cells stored in
glycerol stocks in a -80 oC freezer were plated onto agar plates containing 10 mg/L ampicillin
and 20 mg/L heme. The cells were allowed to grow at 37 oC overnight. Cells were then
transferred to liquid cultures (2x50 mL LB-Luria) containing 10 mg/L ampicillin and 10 mg/L
heme. Twenty hours after incubation (37 oC), the cells were collected by centrifugation, 5 000
rpm for 15 min at 4 oC with an Avanti J-series centrifuge (Beckman-Coulter, Canada) and a
JLA-25.50 rotor. Cells were then resuspended in minimal LB-Luria media and added to liquid
cultures (3x1 L LB-Luria) containing 10 mg/L ampicillin and 10 mg/L heme with an absorbance
of the cell culture at 0.1 at 600 nm; the starting absorbance for optimal growth. After 20 hours
(37 oC) cells were then collected by centrifugation, 5 000 rpm for 15 min at 4 oC with an Avanti
J-series centrifuge and a JLA-16.250 rotor. Heme was washed away by gently swirling the cells
in 10 mM PBS Buffer, pH 7.4. Cells were then resuspended in minimal LB-luria media and
added to liquid cultures (3x2 L LB-Luria) containing 10 mg/L ampicillin and 0.2% L-arabinose
at 30 oC to induce protein expression. 20 hours after induction, the cells were harvested by
centrifugation at 5 000 rpm for 15 min at 4 °C with an Avanti J-series centrifuge and a JLA9.1000 rotor. The supernatant was decanted and the cell pellet was resuspended in a solution of
10 mM PBS Buffer, pH 7.4. The cell pellet was then frozen at -80 oC.
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Figure 2-1
Protein preparation protocol for the synthesis of recombinant Isd proteins
from S. aureus
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2.4.2 Protein Purification
The cell pellet was then frozen at -80 oC, thawed, and lysed using the cell disruptor method
(3 passes at 25 kPSI) (Constant Cell Disruption Systems, UK). The freeze-thaw cycle allows for
easier lysing of the cells. Un-disrupted cellular debris was removed by centrifugation at 5 000
rpm for 15 min at 4 oC with an Avanti J-series centrifuge (Beckman-Coulter, Mississauga, ON,
Canada) and a JLA-25.50 rotor. Disrupted cellular debris was removed by ultra-centrifugation
at 50 000 rpm (150 000 x g) for 1.0 hr at 4 oC to remove insoluble materials.
Proteins were purified using a 1 ml HisTrap column (GE Healthcare) and an FPLC (ÄKTA,
US) system with a binding buffer containing 10 mM sodium phosphate, pH 7.4, 500 mM NaCl.
5 mM imidazole and an elution buffer containing 10 mM sodium phosphate, pH 7.4, 500 mM
NaCl, 100 mM imidazole. Proteins were then desalted by buffer exhchange to 10 mM PBS, pH
7.4, using Amicon Ultracel 10k centrifuge tubes (Millipore, USA) and a CS-6 swinging bucket
centrifuge (Beckman, USA) for three 15 minute spins at 5k rpm. The 6xHis-tags were removed
by incubation with thrombin (10 units/mg protein; GE Healthcare) at 4 oC for 20 hours and run
through a HisTrap column for final purification.

2.4.3 Adding heme to apo-Isd proteins
For heme loading to apo-protein, hemin (Fluka) at pH 10 was added to the Isd protein in
approximately 10x excess. Following incubation for 0.5 h, protein samples were separated using
G-25 size-exclusion chromatography. The extent of heme binding was verified with mass
spectrometry.

2.5 UV-visible absorption spectroscopy
2.5.1 Introduction to UV-visible absorption spectroscopy of heme protein
In absorption spectroscopy, the loss of light in an incident beam is measured as a function of
the frequency (or wavelength) of the radiation. A simple UV-visible absorption setup is shown
in Figure 2-2.
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Figure 2-2
Simplified sketch of a UV-visible absorption spectrometer based on a dual
beam approach.
The absorbance or optical density, A(λ), of a given sample is described by Beer's Law, Eq. 1:
A(λ)=

=ε(λ)cl

(1)

with incident light intensity, I0; light intensity after passing through the sample, I; extinction
coefficient, ε(λ); concentration, c; and path length, l. With the concentration in [M] and the path
length in cm, the unit of extinction coefficient ε is M-1cm-1. However, for heme binding proteins,
this coefficient is often reported in mM-1cm-1.
In proteins, three different internal chromophores give rise to electronic absorptions bands: 1)
the peptide bond linking the amino acids absorbs weakly at 220 nm, 2) the aromatic amino acids
phenylalanine, tyrosine, tryptophan and histidine contribute with bands in the range of 230-300
nm, and 3) most importantly, many biological molecules show strong absorbance in the visible
region of the spectrum as a result of the presence of metal ions and prosthetic groups with
extended π-electron systems, such as heme, chlorophyll, carotinoid and flavin [3, 4]. These
bands are sensitive to the surrounding polypeptide environment and reflect structural changes,
oxidation states and the binding ligands, making UV-visible absorption spectroscopy an
excellent tool for physical studies of protein function.

2.5.2 Calculating protein concentration
The 280 nm band is extremely useful for calculating protein concentration, especially in the
absence of heme binding. However, there is too much error when using an estimated ε(280)
value to determine protein concentrations for quantitative mass spectrometry experiments. By
coupling UV-absorption spectroscopy and atomic absorption spectroscopy (AAS) of the heme
bound holo-proteins (confirmed by ESI-MS), it was possible to measure the amount of bound
heme present (each protein only binds one heme). Hence, the accuracy of AAS can be combined
with UV-visible absorption spectroscopy to accurately calculate protein concentration and ε(280)
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values. Summarized in the table below are the calculated molar extinction coefficients ε(280) by
this technique. Note, for IsdB-N1 the ε(280) is estimated since this protein does not bind heme.
Table 2-2:
Absorption ε(280) values of Isd proteins used in this thesis. *: IsdB-N1 ε(280)
is estimated since this protein does not bind heme.
Isd Protein
IsdA-N
IsdB-N1
IsdB-N2
IsdB-N1N2
IsdC-N
IsdH-N3
IsdE

Absorption ε(280)
(mM-1cm-1)
28.85
17.21*
15.93
38.26
38.50
14.65
20.07

2.5.3 Protoporphyrin IX and heme spectroscopy
In metalloporphyrins, such as heme, Figure 2-3, there are two major electronic bands and a
strong vibronic band arising from π → π* transitions of the conjugated 18 e- system, Figure 2-4.
At higher energy (typically observed between 380 and 430 nm) is the very intense B (or Soret)
band. It represents an allowed transition with extinction coefficients on the order of 105 M-1cm-1.
At lower energy (500 - 600 nm) is the Q00, or α band, and the Qvib, or β band, arising from the
lowest porphyrin * singlet transition and its vibronic envelope, respectively. They represent
forbidden transitions and as such are typically weaker than the B band, possessing extinction
coefficients on the order of 104 M-1cm-1 [5-7].
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Figure 2-3
Structure of ferrous (Fe(II)) heme-b. Structurally, heme-b has pseudo-D4h
symmetry with a formula C34H32FeN4O4 and molecular mass of 616.48 g/mol.
Demetallation of a metalloporphyrin (for example forming protoporphryin IX (PPIX)),
reduces the symmetry of the molecule from psuedo-D4h (square) to D2h (rectangular). As a result
a splitting of the doubly degenerate Q bands is observed. The Q00 band splits into x and y
components (Qx, 00 and Qy, 00) as does the Qvib band (Qx, vib and Qy, vib). The result is a visible
region absorption spectrum consisting of four peaks, Figure 2-5 [8].
The three metalloporphyrin bands (B, Q00 and Qvib) vary considerably in band maximum and
relative intensity. These variations are characteristic of the oxidation and spin state of the central
iron. Overlaid on the 3 bands are charge transfer transitions between the central metal and the
ring, which occur in the same spectral region.

Charge transfer transitions are particularly

sensitive to the oxidation and spin state of the central iron and are observed at different
characteristic wavelengths in the visible region for all but the diamagnetic low spin ferrous iron.
The combination of * and charge transfer transitions produces a very complex UV-visible
absorption spectrum. In some instances this leads to a masking of important spectroscopic
information. For this reason, magnetic circular dichroism (MCD) spectroscopy has often been
utilized in the study of heme-containing proteins.
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Figure 2-4
UV-visible absorption spectrum of ferrous heme with pyridine axial ligands.
Shown is the B (Soret) band and the two Q bands (Qvib and Q00).

Figure 2-5
UV-visible absorption spectrum of PPIX-dimethyl ester in 2-butanone. Due
to the decrease in symmetry from D4h to D2h from the loss of the central iron, the double
degenerate orbitals split and now four Q bands (Qy, vib, Qx, vib, Qy, 00, Qx, 00) are now visible.

2.6 Magnetic circular dichroism (MCD) spectroscopy
2.6.1 Introduction to MCD spectroscopy
Magnetic circular dichroism (MCD) spectroscopy developed from magnetic optical rotary
dispersion (MORD) spectroscopy, a measure of the variation in the optical rotation of a
substance with a change in the wavelength of plane polarized light [9]. The change to MCD
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spectroscopy was slow partly because it was easier to measure ORD and MORD spectra than CD
and MCD spectra. However, the great value of the CD spectrum in structural analysis of both
biomolecules and chiral inorganic complexes accelerated the switch as new instruments became
available in the late 1960's [10]. The MCD spectrum also was easier to work with because of the
direct connection of the MCD signal morphology and magnitude with readily computed state to
state transition properties.

This is because the group theory of the 1960’s provided an

interpretation of the sign and estimate of the relative magnitudes of particularly, transition metal
complexes then being studied [11].
The instrumental difficulties in measuring CD spectra were greatly reduced with the
development of the acousto-optic modulator that allowed measurement in all regions of the
optical spectrum, through the use of different stress materials. As the Faraday Effect measured
in the MCD experiment occurs for all optical transitions it has been applied with great success
from the X-ray region using synchrotron radiation down in energy to the IR region. A number of
designs of CD machines have been introduced and all will work with the magnet required for the
MCD experiment.
Although the MCD experiment uses a CD machine, there is no connection between the
phenomena of circular dichroism and of magnetic circular dichroism and both the MCD and CD
spectral data of a sample are obtained simultaneously. For the MCD spectrum, the CD spectrum
in the region of interest must be subtracted.

Natural CD intensity requires a molecular

environment where molecular structure features distribute electric charge in a spatial array that
has helical “handedness.”

MCD intensity is due to interaction of the external field with

electronic structure within the sample, no matter how it is distributed. This is a universal
property of light absorption for all matter when placed in a magnetic field. A chiral molecular
structure is not a requirement for MCD intensity [12].
The MCD spectra of many different porphyrinoids were measured from the very first days of
MORD and MCD spectroscopy [13]. This is because the remarkably high value of the angular
momentum in S1 (commonly called the Q band) in the visible region meant that strong signals
were obtained readily in all instruments. This characteristic and intense MCD spectrum of
porphyrins allowed heme proteins to be studied. As a consequence, there is a rich and deep
literature of MCD spectra from a very wide range of both synthetic and natural porphyrins [5, 6,
14-21].
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Figure 2-6 Simplified sketch of an MCD spectrometer based on a CD spectrometer
using a traditional single beam approach. Reprinted with permission from [22]. Copyright
2011 World Scientific.
Figure 2-6 shows a simplified sketch of the instrument design used for MCD spectroscopy.
When measuring MCD spectra it is required that the sample be placed in a strong magnet with
field orientation of the magnet field vector (B) along the +z coordination direction, parallel to the
light. Typical instruments can measure absorption as well as the MCD (or CD in the absence of
the magnetic field) spectra simultaneously for a sample. However, other arrangements use a
separate higher-powered spectrometer to measure absorbance in order to obtain better data. In
the arrangement shown in Figure 2-6, a plane polarized, monochromatic light is passed through a
photoelastic modulator (PEM) which converts the light to alternating left circular polarized (lcp)
and right circular polarized (rcp) light.

This polarized and monochromatic light will pass

through a sample which is situated in the magnet and then to a detector which is normally a
photomultiplier tube (PMT) for the UV-visible region [12]. Because of the use of highly
polarized light for measurements, the cuvettes used must be strain free.
The measured intensity is ΔAl-r, where A is the absorbance of the lcp (-) or rcp (+). The ΔAl-r
for MCD spectrum results from a magnetic perturbation (the Zeeman effect) of the states
involved in optical transitions responsible for light absorption. ΔAl-r will be negative if Ar is
greater than Al. Typically older MCD data may be reported as ellipticity, ΘM (deg T -1) or molar
ellipticities, [Θ]M (deg dL mol-1dm-1T-1).

However, current studies use differential molar

absorptivities Δ = ΔAl-r/(cl), where c is the sample molar concentration and l is the path length
in centimeters. For MCD data, Δ is normalized for the magnetic field B in Tesla and written as:
ΔM. Older MCD data are normalized to Gauss. It should be noted that the older units do not
change the shape of the spectral features or affect the qualitative interpretation but when
comparing quantitatively old data with new data, one must take care to ensure compatible units
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of field and path length. The relations between Θ, [Θ]M, ΔA and ΔM are shown by the following
equations:
Equations 2-4: Conversion of measured MCD spectroscopy units:
CD: Θ = 32.982.ΔAl-r

(2)

(Θ in deg; but note that many instruments the intensity is reported in mdeg (10-3deg) units)
MCD: Θ/B = 32.982.ΔA(l-r)/B
MCD:

[Θ]M
3298.2 M

4
B / 10 Gauss
B/Tesla

(3)
(4)

Analysis of MCD spectroscopic data reveals that the MCD bands lie at the same energy and
have the same approximate band width as the corresponding absorption bands. It is important to
note that in MCD spectroscopy band morphology assignment is straightforward if the band
resolution is sufficient to separate other transitions by energies greater than their bandwidths;
overlapping transitions and congestion lead to more complicated spectra. MCD spectra consist
of 3 specific band morphologies (or terms), which come from the magnetically induced state
splitting (A1 and C0) or coupling (B0) [5, 6, 23].

2.6.2 The major spectroscopic features: The Faraday A1, B0 and C0 terms
The MCD spectral intensity at any wavelength, Al−r, can be described in terms of the
combined intensities of three components, each arising from different phenomena:
Al−r = 152.5Bcl[A1(−df() / d)  (B0  C0 / kT)f()]

(5)

where B is the field strength in Tesla, c is the concentration (mol L−1) and l, the path length (cm).
The normalized band shape f() is usually a Gaussianshaped curve and df() is the derivative of
this band envelope. The three Faraday terms, A1, B0 and C0 each arise from different transitions
as shown Figure 2-7 [5, 6].
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Figure 2-7
Three Faraday Terms (A1, B0 and C0) are the basis of the band envelope
measured in MCD spectroscopy. All transitions occur from a ground state but the difference in
the spectroscopic band envelopes arises from whether the ground state and/or excited state are
degenerate, which is a result of the degree of symmetry in the measured complex.
Since A1 terms arise from the splitting of degenerate excited states, they are a common and a
very useful feature in assigning the spectra of porphyrins and phthalocyanines. Indeed, many of
the earliest published MCD spectral data were from the porphyrinoids simply because the A1
terms dominated the spectrum and were relatively easy to measure [7]. This will be the case for
low spin ferrous heme [24]. With a non-degenerate ground state, A1 terms are temperature
independent, as such are studied using room temperature experiments as the only advantage of
low temperatures is to sharpen the band envelope.
From Figure 2-7, A1 and C0 terms can only be observed in the spectra of high symmetry
complexes where the ground and/or excited states are orbitally degenerate.

The
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derivative−shaped Faraday A1 term is temperature independent and identifies degenerate excited
states when the intensity cross-over point (ΔA = 0) aligns with the absorption band maximum in
the absence of strong B0 terms.

This spectroscopic feature is the most useful assignment

criterion from MCD spectra of porphyrinoids essentially providing polarized spectra from
solutions rather than the previous requirement for a good quality crystal in MORD spectroscopy.
In addition, for porphyrinoids the ratio A1/D0, D0 is the dipole moment, easily and directly
provides the difference in the angular momentum between the ground and excited states which is
related to the excited g-factor [9]. In this way we have an equivalent parameter to the ground
state g-factor of paramagnetic species obtained directly from the EPR spectrum. Although an
accurate estimation of the ratio A1/D0 requires good band fitting or integration via the Method of
Moments, 'back of envelope' calculations based on the peak-trough magnitude and the
absorptivity read from the absorption spectrum can give very good approximations [25]. Since,
in general for aromatic organic compounds, the angular momentum of the HOMO is less than
that of the LUMO, the equation for A1 will always return a positive value. For example, A1 terms
observed in the spectrum of an aromatic compound are expected to be 'positive'. The negative
lobe of the derivative shaped envelope is observed to the low energy side of the cross-over point.
The reduction in symmetry leads to differential splitting of the previously-degenerate ground
and excited states. When the degenerate LUMO pair splits to a greater extent than the HOMO
pair, then negative A1 terms may be measured. As a follow up, while the D0 magnitude might be
very small (in the porphyrinoids we can expect close to zero) A1/D0 still retains the value of the
nominally forbidden state. However, if there is appreciable geometry-induced splitting of both
HOMO and LUMO molecular orbital pairs, A1 may actually approach zero. The relatively new
reports of these spectroscopic signatures have great value in the interpretation of the optical data
with respect to the geometry and electronic structure of specific porphyrinoids.
The Gaussian−shaped C0 term is highly temperature dependent and identifies an orbitallydegenerate ground state. Since the C0 term arises from a field-split degenerate ground state, its
intensity changes dramatically with temperature. According to the Boltzman distribution, these
levels are relatively equally occupied at room temperature. The overall result is that the split
states cancel one another out, producing a weak signal. However upon reducing the temperature,
using liquid nitrogen or liquid helium, the lower ground state becomes more highly populated,
resulting in the temperature dependence of C0 terms. Variable temperature and variable field
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experiments can therefore be used to identify and quantify C0 terms.

The temperature range of

<4.2 - 100 K is the most useful in terms of analysis because of the effect of 1/kT in the C0 term
intensity above. The MCD spectra of heme proteins are dominated by C0 terms. However,
because the excited states are also degenerate, the room temperature MCD spectra may exhibit
A1-like spectra, pseudo A1 terms [9].
Complicating the spectral analysis is the appearance of the temperature independent Faraday
B0 terms, which exhibit a Gaussian shape of either sign. For symmetric porphyrinoids the
intensity of B0 terms is usually significantly less than either the A1 or C0 terms. B0 terms are
observed for all transitions resulting, as can be seen from the equations above, from
magnetically-induced mixing of states with appropriate symmetry [9].

The E parameter

between these excited states is important in determining the magnitude of the dominant B0 terms
in the MCD spectra of porphyrinoids, as we shall see below. B0 terms arising from a mixing of
excited states are predominant in molecules with low symmetry, such as D2h (rectangular), the
free bases of protoporphyrin IX or phthalocyanine. As we see above, the field induced mixing of
the excited states will result in a preference to proportionally absorb more of either left or right
handed circularly polarized light, depending on the nature of the mixed states. Like A1 terms, B0
terms are also temperature independent due to the non-degenerate ground state.
Another important feature of the MCD spectra of porphyrins and phthalocyanines (including,
heme proteins) is the appearance of pseudo-A1 terms, which may be seen when two, oppositelysigned B0 or C0 terms exist closely in energy. Pseudo-A1 terms may be of either sign. For
diamagnetic porphyrins A1-term like spectral envelopes are frequently measured where the
symmetry of the ring is lower than D4h and the degenerate excited states are split to some extent.

2.6.3 Connection between the optical spectra of porphyrinoids and MCD
spectral properties
It has been noted that the porphyrin absorption spectrum is remarkably consistent: usually a
strong absorption band near 400 nm and another weaker band near 600 nm. Closer observation
however shows many differences between the spectra of the different porphyrinoids, particularly
between symmetric porphyrins, peripherally substituted porphyrins and methylene-bridge
substituted porphyrins.

In addition, other major complications in the spectrum arise from
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interactions with the central metal, primarily metal-ligand or ligand-metal charge transfer, and
the vibronic bands associated with the formally-forbidden Q band.

ΔML = ±1
ΔML = ±9
1e*g

±5
±1

±9
B
Q
1a1u , 1a2u

±4

Figure 2-8
Summary of Gouterman’s 4 orbital Linear Combination of Atomic Orbital
(LCAO) model. The HOMO to LUMO transitions occur between the states with 4 to 5 units
of angular momentum (ML). Transitions between the HOMO and LUMO gives rise to the B and
Q bands. The B band corresponds to a change in angular momentum (L) of 1 and is an
allowed transition and, therefore, very intense. The lower energy Q band corresponds to a
change in angular momentum of L 9 and is, therefore, forbidden. As the selection rules for
absorption include L = 1, it can be predicted that the Q bands should be forbidden [6].
The model shown in Figure 2-8 summarizes the features important to MCD spectral
measurements from Gouterman's 4-orbital model, namely that the angular momentum in the Q
and B states (S1 and S2 respectively) have very different, but generally positive, nonzero
magnitudes. We can then predict that the MCD spectrum will exhibit two or more positive A1
terms with A1/D0 magnitudes that could differ by a factor of up to 9. Gouterman and his group
were very successful using the theoretical capabilities of the 1960’s (primarily Intermediate
Neglect of Differential Overlap (INDO)) to predict many of the optical spectroscopic properties
of porphyrinoids [26]. This was a remarkable discovery in view of the complexity of these-many
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electron molecules. As has been commented on by many authors, the reason that these old
techniques worked so well was that the optical spectrum is actually dominated by the Hückel
Rule. In effect the top two electron pairs are wonderfully stable and for MCD measurements, it
is the value of the ratio A1/D0 that becomes most important. The magnitude of A1 is related to the
magnetic moment of the excited state; however, as is clear in the formal equation, it is the
difference between the orbital angular momentum of the ground and excited states that is
measured in the MCD spectrum.
A sample absorption and MCD spectrum, Figure 2-9, for the pseudo-D4h symmetric Zn(II)protoporphyrin IX or Zn(II)-PPIX in MeOH shows the similar properties and optical origin of
the bands in the porphyrin ring. The use of zinc as a comparative model is well established [6]
as suitable for determining the ring-based components of porphyrin spectroscopy. The filled 3d
shell of Zn(II)-PPIX prevents the large number of charge transfer bands which are evident when
looking at ferric heme and ferric heme binding proteins. Therefore, the B and Q bands can be
readily identified. Figure 2-8, predicts that the Q band will be formally forbidden because of the
selection rule that restricts absorption transitions to ΔMJ = ±1. At this level, transitions to the B
or Soret band are predicted to be fully allowed with a positive MCD A1 term. The electronic
structure for Zn(II)-PPIX is shown in Figure 2-10. Of interest in the calculation of this electronic
structure is that the HOMO (162 and 163) and LUMO (164 and 165) are essentially degenerate,
and all orbital contributions come from the 18e- conjugated π system on the PPIX ring. As
many have shown previously, it is the accidental degeneracy of the HOMO pair of orbitals that
results in the quenching of the oscillator strength of the Q band [6, 26].
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Figure 2-9
UV-visible absorption and MCD spectra Zn(II)-protoporphyrin IX (Zn(II)PPIX). Zn(II)-PPIX in MeOH, B-band at 415 nm, Qvib at 545 nm and Q00 at 583 nm. The MCD
spectrum of Zn(II)-PPIX show pseudo A-terms centered on the B, Qvib and Q00 bands. Reprinted
with permission [27]. Copyright 2012 ACS Publications.
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Figure 2-10 Energy level diagram for Zn(II)-PPIX. Shown are the energies and molecular
orbital surfaces for the top five occupied MOs (green and blue phases) and the lowest five
unoccupied MOs (red and yellow phases). Hydrogen atoms have been omitted from structures
for clarity. The lowest shown molecular orbital for Zn(II)-PPIX is HOMO-5 at 158. Reprinted
with permission [27]. Copyright 2012 ACS Publications.

2.6.4 Heme protein MCD spectra
In the last part of this MCD section, the focus will be on the application of MCD spectroscopy
to the identification of amino acid heme binding ligands in heme proteins. This technique uses
the exquisite fingerprinting information provided for a large number of heme binding proteins.
The MCD spectrum is more useful than the absorption spectrum for this purpose because the
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angular momentum of the -* and charge transfer transitions that together make up the
absorption spectrum in the 300 – 800 nm region is highly dependent on the complexity of the
electronic state structure. Coupling and mixing between these states results in a unique set of
optical transitions, which are overlaid by the vibronic bands of the -* system. From the MCD
spectral data for a protein it is possible to extract very accurate and detailed information about
the heme environment and even elucidate the identity of the heme binding ligands. These studies
are perhaps the most important of any using the MCD technique because of the exquisite
fingerprinting information provided for a very wide range of proteins to characterize the heme
binding ligands in many novel heme enzymes.
Heme proteins typically bind one molecule of Fe(III)-protoporphyrin IX (Fe(III)-PPIX).
Fe(III)-PPIXs like other porphyrinoids have unique MCD spectral bands.

There are two

important -* transitions in hemes: the intense B band, often referred to as the Soret band, and
the Q00 or α and the corresponding vibronic Qvib band. The B band lies between 380 and 430
nm, with Q00 and the vibronic Qvib bands, between 450 and 650 nm [5]. The complexity in the
visible region spectra of porphyrins arises from the intensity-allowing mechanisms of the Q00
band, which is formally forbidden (especially when the two highest occupied molecular orbitals
are accidentally degenerate) [6] and the overlap of the B, Q00 and Qvib bands with metal-to-ligand
(MLCT) and/or ligand-to-metal (LMCT) charge transfer bands between the iron center and the
porphyrin ring. These greatly complicate the observed spectra however, as we will show below,
the MCD spectrum provides significantly enhanced resolution of the individual transitions
responsible for the overall, absorption band envelope and in doing so provides fingerprints
sensitive to the heme environment [7]. Typically for heme binding proteins a scan between 250800 nm will include all the necessary spectral features.

2.6.5 Elucidation of Heme-Binding Ligands
In a heme-protein, one or two amino acids bind the heme iron. Heme binding amino acid
ligand identification can be achieved by probing the heme site with ligands (eg. CN-, CO) and
changing the heme-iron oxidation states. Anionic ligands bind to ferric hemes closely following
the Spectrochemical Series with stronger field ligands displacing weaker-field ligands if the 5th
or 6th positions are vacant and if there is spacial access in the protein. Axial coordination of the
ferric heme in proteins with the 6th position accessible (for example, in myoglobin (5 coordinate
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with a histidine binding ligand), rather than in cytochrome c, (6 coordinate with a histidine and
methionine binding ligand), Figure 2-11) is possible across the entire range of the
Spectrochemical Series, starting with the very low OCT values of the halides and extending to
the strong field ligand cyanide.

Figure 2-11 Cartoon protein structure of human myoglobin (left) and horse heart
cytochrome C (right). Myoglobin (2W6W) has 5 coordinate heme with a histidine amino acid
binding ligand. Cytochrome C (1HRC) has a 6 coordiante heme with a histidine and methionine
amino acid binding ligands.

Ligation by anionic ligands such as cyanide is thermodynamically preferred and takes place
with strong binding constants. Strong field ligands such as cyanide systematically force a
change from high or intermediate to low spin if the existing ligand is a weaker field ligand.
Spectral data for several heme proteins have been studied at both room temperature and helium
temperatures, for example, myoglobin [28]. It is also well established that reduction to the
ferrous heme is possible in many cases resulting in a characteristic MCD spectrum of the 5coordinate iron. Addition of CO results in a major change in the MCD spectrum as the low spin,
6-coordinate iron usually forms. Together, these straightforward, chemically-induced changes
provide definitive information about the electronic properties of the iron in the native, hemecontaining protein. More subtle information about the identity/identities of the axial ligands
comes from the relative intensities and band maxima of all bands in the MCD spectrum using
fingerprinting from previously well-studied and characterized heme proteins [29-33]. Typically
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the native protein is measured first then followed by addition of excess CN-. Addition of a
reducing agent such as sodium dithionite and a strong axial ligand, such as CO, can be used to
probe the reduced state. The advantage of this type of ligand identification is that a single
solution can be used and is much easier than protein mutation analysis. The main advantage of
this technique stems from the fact that most heme-binding amino acids are common among many
protein systems so many fingerprint spectra exist.

Also, through this method, the native

oxidation and spin state of the heme-iron are identified as well as the protein heme binding
ligands. Where this technique starts to falter is when uncommon ligands are part of the heme
binding site and comparative fingerprint spectra have not been previously reported. It is well
established that all the band parameters change as a function of the protein environment of the
heme. The spectral changes arise largely as a result of changes that take place at or near the iron,
because charge transfer bands between the metal and the ring overlay the π to π* bands of the
porphyrin ring. These bands change in number, wavelength and intensity depending on the
oxidation state (ferrous, ferric, ferryl) and spin state (low, intermediate, high) of the iron, and the
axial ligands of the iron control the spin.

2.6.6 MCD spectral applications
The key to the interpretation of the MCD spectral data of complicated electronic systems is
that the observed MCD bands lie at the same energy and exhibit approximately the same
bandwidth as the absorption bands [5]. The absorption and MCD spectral data are very sensitive
to the nature of the two axial ligands of the heme-iron, and to the heme-iron oxidation and spin
state. These properties have such profound spectral effects that the key features in the observed
MCD envelope morphology (sign, relative magnitude, and band wavelength maxima)
systematically change for a range of heme proteins allowing ‘fingerprinting’ of the properties of
a novel protein with those well-studied. In this manner, the identity of the two axial ligands (the
proximal 5th position, and the distal 6th position), the oxidation state of the iron and its spin state,
may be determined with considerable confidence for heme binding proteins directly from dilute
solutions at room temperature.
However, an important point should be noted. This technique should be used in combination
with electrospray mass spectrometry data in order to determine the number of bound heme
molecules. If more than one heme is bound to the protein then the MCD spectra will be much
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more complicated to analyze. Also, the stability and purity of solutions of the protein must be
established. Mixtures of bound heme and free heme will also complicate the analysis. Finally,
mixtures of oxidation states, spin states and ligation number will also render analysis unreliable.
Despite the apparent complexity of the heme system, the MCD spectral bands are diagnostic of
the axial ligand identity, spin state and oxidation state allowing in many cases unambiguous
determination of each of these parameters. This diagnostic sensitivity has been used widely and
successfully to interrogate the spin, oxidation and ligation state of the heme in a wide range of
heme proteins, for example [24, 28, 33-40]. The MCD spectral data offer species identification
far superior to that from the absorption spectroscopic data alone.

2.6.7 MCD spectral measurements
Protein solutions were prepared in a 10 mM PBS buffer at pH 7.4.

Individual sample

concentrations were calculated by UV-visible absorption spectroscopy before mixing and
performing experiments. MCD measurements at room temperature were made in 1 cm cuvettes
at 5.5 T in an Oxford Instruments SM2 superconducting magnet, aligned in a J-820 CD
spectrometer (Jasco Inc, Japan). The stepped data pitch was 1 nm and the response time was 1
sec. Absorption measurements were made using a Cary 500 (Varian, Canada). All solutions
were measured in the Cary 500 before and after being measured in the MCD spectrometer to
ensure no changes were observed during experimentation.

2.7 Electrospray ionization mass spectrometry (ESI-MS)
2.7.1 Introduction to ESI-MS spectrometry
Mass spectrometry has become a widely used tool in both academic fields and industry due
to its ability to identify, through mass analysis, different components in suitable mixed solutions
[41, 42]. The application of ESI-MS to large biological molecules was initially developed by
John B. Fenn, who was awarded the 2002 Nobel Prize in Chemistry for his contributions to this
field [43, 44]. All mass spectrometers include the same basic components: a sample inlet, an ion
source, a mass analyzer, a detector, a data system that outputs mass spectra, and a vacuum
system [45, 46]. Mass spectrometry analysis involves the conversion of analyte molecules into
gas-phase ionic species, the separation of these molecular ions based on their mass-to-charge
ratio (m/z), the detection of the ions, and finally, the display of the mass spectrum [45, 46].
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There are various methods to ionize molecules, which may be grouped into two categories
[45, 46].

So called “hard” ionization methods like electron ionization (EI) often induce

fragmentation of the parent molecule upon ionization while “soft” ionization methods like
matrix-assisted laser desorption ionization (MALDI) and ESI induce little, or no, fragmentation
of the parent molecule. Soft ionization is ideal for larger molecules, particularly proteins. While
fragmentation may be useful for the identification of macromolecules like proteins, ionization of
intact macromolecules allows for the study of inter- and intra-molecular interactions such as
metalation to complexes. This important feature is exploited throughout this thesis and hence the
focus of this section will be on the ESI technique as all the experiments that will be described
involve the use of an ESI mass spectrometer.

2.7.2 Sample ionization and detection
In ESI-MS, the sample flowing through a capillary is dispersed into very small droplets
through the use of high positive or negative voltages applied to the capillary tip, Figure 2-12.
Figure 2-12A shows the “Z-spray” configuration for the ESI source in the Micromass LCT mass
spectrometer system (Waters Micromass Inc., Canada) used for all the experiments described in
this thesis unless otherwise stated. The sample solution is infused through a metal capillary that
has an applied electric potential of +3-5kV. This produces an electrostatic field that disperses the
solution into a fine mist of highly charged droplets [45]. Based on the “Charge Residue Model”,
these charged droplets undergo desolvation and fission until eventually the droplet contains only
a single solute molecule [45]. Evaporation of the droplets is assisted by the flow of a hot
nitrogen desolvation gas. The solvated ions undergo low energy collisions with the cone gas to
remove the remaining solvent before being focused through a hexapole ion bridge and then
immediately transferred into the high vacuum chamber of the mass analyzer [45].
Depending on the polarity of the voltage, droplets with excess positive or negative charge are
formed. Desolvated, charged protein molecules, Figure 2-12B, then enter the mass analyzer and
are ultimately measured at the detector [41]. One of the most common mass analyzers, and the
type used to measure the data presented here, is a time of flight (TOF) analyzer, Figure 2-12C.
TOF analyzers use an electric field (pusher) to move charged sample molecules within the
analyzer. The principle is that light, highly charged molecules will travel faster than heavy
molecules possessing few charges. Sample ions are timed between a shutter and the detector.
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Measured by the instrument is the mass to charge ratio (m/z). The m/z ratio is then plotted
against the relative intensities of all ions detected to produce a mass spectrum.
The mass spectrum displays a nearly Gaussian distribution of charge states with m/z values
that are dependent on the number of charging species attached. Typically, protons are the
charging species, thus the resulting charge state can be represented by [M + nH]n+ where M
stands for the molecular ion [45]. Possibly the greatest disadvantage of ESI is the technique’s
poor tolerance of salts like NaCl, which form adducts with the molecular ions and suppress
signal-to-noise ratios of the molecular ions.
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Figure 2-12 Schematic overview of electrospray ionization mass spectrometry machinery
and formation of charged protein molecules. A) Schematic diagram of an electrospray
ionization source B) charge residue model illustrating the formation of charged, gas phase
protein molecules C) schematic diagram of a time of flight (TOF) mass analyzer.
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2.7.3 Application of ESI-MS to heme proteins
Either negatively or positively charged analyte molecules can be produced at the ionization
source and then detected by the instrument. All of the spectra presented in this thesis were
recorded in positive ion mode, which is the common method for studying proteins. Nucleic
acids on the other hand are commonly studied in negative ion mode due to the presence of
numerous phosphate groups in a polynucleotide backbone [41]. In protein mass spectrometry,
sample ions arise from the protonation of basic amino acid residues (lysine and arginine) or
deprotonation of acidic residues (aspartic acid and glutamic acid). Depending on the number of
exposed acidic/basic residues, the amount of charge on a protein molecule can vary, producing a
number of charge states, Figure 2-13, unlike MALDI which typically produces analyte molecules
with a single charge [47, 48]. This allows ESI-MS to be used to monitor the extent of folding of
a protein. The exposed residues will be protonated/deprotonated before those residues that are
buried in the structure; so that if the structure changes for example, as a function of heme binding
or denaturation, then the number of residues exposed will change. Denatured proteins will show
higher charge states than the properly folded protein due to the increase in exposure of accessible
sites, Figure 2-13D. An observation that the center of the charge state distribution shifts to
higher numbers is strong evidence that the structure has become less folded or more open [41,
48, 49].
ESI-MS is also a powerful tool to determine the number of heme molecules a protein can
bind. Although typically proteins only bind one heme, the ESI-MS data produce unambiguous
stoichiometric measurement of heme binding. Typically, this is done through deconvolution of
the charge state spectra. Deconvolution software uses a maximum entropy algorithm to combine
charge state (m/z) values and calculate the most probable parent mass spectrum (mass). Since
the apo-protein mass is known, an increase of 616 Da indicates heme binding. Therefore, it is
possible to track heme binding stoichiometrically, as well as heme transfer in a mixture of
proteins in solution.
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Figure 2-13 ESI mass spectra of cytochrome c at pH 6.4, pH 4.2, pH 2.6 and pH 2.3. As
the pH of the solution is lowered, the protein becomes increasingly unfolded until complete
unfolding at pH 2.3. Since more of this globular protein is solvent exposed upon unfolding, the
charge states also increase from a maxima +8 at pH 6.4 to +17 at pH 2.3. Reprinted with
permission [47]. Copyright 1997 American Chemical Society Publications.

2.7.4 Quantification of ESI-MS charge state spectra
ESI-MS charge state spectra are not directly quantifiable from the measured intensity directly.
This is due to machine sensitivity to settings such as sample flow rate and ion suppression due to
other samples or salts [41, 46]. However, since globular heme binding proteins, specifically the
Isd proteins, have similar heme-bound (holo) and heme-free (apo) charge states [50], it can be
assumed that the flying efficiency, similar to ε in absorption spectroscopy, of the proteins is the
same for apo/holo pairs. Therefore, the concentrations of proteins can be calculated from the
relative apo/holo pairs of Isd proteins if the starting concentration of proteins is known.
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2.7.5 ESI-MS Sample Preparation (Desalting) and Measurements
Protein solutions were concentrated, desalted and buffer exchanged from 10 mM PBS buffer
pH 7.4 to 20 mM ammonium formate pH 7.4 using Millipore Amicon ultra-4 centrifuge filter
units (10 kDa MWCO) with a Beckman CS-6 swinging-bucket Centrifuge (3000 rpm for 10
minutes per run). Once thoroughly desalted, the protein concentrations were calculated using
UV-visible absorption spectroscopy.

The parameters used on the Micromass LCT mass

spectrometer system (Waters Micromass Inc., Canada) are shown in Table 2-3.
Table 2-3: Micromass LCT ESI-MS settings used to measure Isd protein reactions
Setting
Capillary
Sample Cone
Extraction Cone
RF Lens
Desolvation Temperature
Source Temperature
Sample Flow
Spectra Scan Time

Value
2800-3000 V
23-25 V
18-20 V
800-1000 V
20 oC
80 oC
5-15 μL.min-1
4 sec

2.8 Conclusion
The aim of this chapter was to explain the methods used in preparing recombinant Isd protein,
making UV-visible absorption measurements, the MCD spectroscopy technique in porphyrinoid
applications and finally, the methods used with ESI-MS to study proteins.
Recombinant protein production enables the user to produce high purity, apo-protein in high
yield. This technique is invaluable due to the advantages over extraction from the natural
system, bacterial Staphylococcus aureus. Expression plasmids in E. coli RP523 avoids safety
concerns that would have to be taken into consideration when working with S. aureus and due to
E. coli RP523 being a hemB mutant, apo-protein can be expressed and purified without using
harsh chemical techniques to extract heme. Furthermore, His-tagged proteins allow for less
isolation steps and high purity samples for analysis.
Although UV-visible absorption spectroscopy has been used extensively in the past for heme
protein amino acid ligand binding elucidation studies, MCD spectroscopy is a far superior
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technique as explained above. However, UV-visible absorption spectroscopy still provides a
quick and accurate method to calculate protein concentration via the common 280 nm band
shared by all proteins consisting of the aromatic amino acids phenylalanine, tyrosine, tryptophan
and histidine, which all Isd proteins have. Furthermore, UV-visible analysis provides a second
check of MCD spectral results since all MCD bands lie under absorption bands.
MCD spectroscopy is a very powerful technique and has unfortunately often been overlooked
because a good understanding of theoretical description has been deemed necessary. The value
of MCD spectroscopy comes from the information provided, which combines the absorption
energy, the absorption oscillator strength, and the magnetic moments of the ground and excited
states. Room temperature MCD spectroscopy proves to be a very useful tool when studying
heme binding proteins. Not only can MCD spectra be used to identify the oxidation and spinstate of the heme iron through extensive fingerprinting libraries, but also the spectral envelopes
can be used to identify the axial ligands involved in binding the heme-iron. This property was
used to elucidate heme transfer and heme binding ligands in the Isd series of proteins. Typically
when this technique is coupled with ESI-mass spectrometry a great deal of chemical information
can be extracted from an in vitro biochemical system.
ESI-MS data provide unambiguous results for heme binding stoichiometry, relative protein
folding and tracking heme transfer reactions. The power of the ESI-MS technique stems from
the ability to distinguish between apo- and holo-proteins. UV-visible absorption and MCD
spectroscopy are not able to do this unless a significant change in the absorption bands between
proteins exist. The power of the ESI-MS technique shines when looking at complex mixtures of
proteins where the technique is able to track heme transfer and concentrations of proteins in
solution.
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Chapter 3.

Demonstration of the Iron-regulated Surface

Determinant (Isd) Heme Transfer Pathway in Staphylococcus
aureus2
3.1 Introduction
Iron is an essential nutrient for the majority of living organisms. Although the human body
contains abundant iron, its low solubility in the ferric state of aerobic systems and the fact that
the majority is intracellular, means that very little soluble iron (estimated as approx. 10 -18 M [1])
is directly available to bacteria. As such, bacteria have developed multiple iron acquisition
systems to facilitate their survival in such low iron environments. The most abundant potential
iron source for bacteria is heme, or iron-protoporphyrin IX, which is typically bound in proteins
such as hemoglobin and myoglobin. Pathogenic bacteria have evolved specialized mechanisms
for acquiring heme-iron from the host [2-5].
The isd gene cluster of Staphylococcus aureus (S. aureus) was first identified in 2002 [6-8]
and then in 2003 Mazmanian et al. [9] were the first to propose that the Isd series of proteins
formulate a heme transfer pathway across the cell wall and through the membrane. Up to 2008,
there has been a significant amount of research into defining the Isd-mediated heme acquisition
system, especially in S. aureus. Briefly, the Isd system in S. aureus consists of nine ironregulated proteins: IsdA, IsdB, IsdC, and IsdH, which are cell-wall anchored surface proteins,
and IsdDEF, which constitute a membrane-localized transporter and, finally, IsdG and IsdI,
which encode heme-degrading enzymes in the cytoplasm [10]. IsdA is highly expressed on the
cell wall of iron-limited S. aureus and, in addition to several other reported functions [11-13], is
effective at scavenging heme [14, 15]. Additional reported functions of Isd proteins include the
binding by IsdB of hemoglobin [16], IsdH/HarA-dependent binding of haptoglobin and
haptoglobin-haemoglobin [17], and heme binding by IsdC and IsdE [18-21]. IsdE, a lipoprotein
and a member of the bi-lobed, alpha-helical backbone family of substrate binding proteins, binds
heme into a shallow groove between the two lobes of the protein, using His and Met to
coordinate to the heme-iron [18]. Conversely, proteins IsdA, IsdB, IsdC and IsdH each contain
2

A version of this work has been published:
Muryoi N., Tiedemann M. T., Plyum M., Cheung J., Heinrichs D. E., Stillman M. J., J. Biol. Chem., 2008, 283,
28125-28136.
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at least one so-called Near Transporter (NEAT) domain that adopt a beta sandwich structure to
bind one heme into a groove with heme-iron coordination via Tyr [14, 21, 22].
Together, the series of Isd proteins in S. aureus are believed to interact with heme proteins,
extract the heme molecule and transport it across the cell wall through to the membrane where it
is then translocated into the cytoplasm [23-26]. As described above, substrate binding by
individual components has been demonstrated, as has the heme degrading ability of IsdG and
IsdI [10].

Most recently, Liu and coworkers used UV-visible absorption spectroscopy to

demonstrate that heme transfers from IsdA to IsdC [27].
In this chapter, the use of detailed magnetic circular dichroism (MCD) spectral data together
with electrospray ionization mass spectrometry (ESI-MS) to determine the products, or lack of
products, when a heme-donor (i.e. heme-bound protein) and heme-accepter (i.e. apo-protein) are
mixed was described. MCD spectroscopy has been shown in many reports describing the heme
binding environment of both the complete proteins IsdA, IsdB, IsdC, IsdE and as well the
isolated NEAT domains of IsdA (IsdA-N), IsdB (domain 2) (IsdB-N2), IsdH (domain 3) (IsdHN3), and IsdC (IsdC-N), to exhibit parameters sensitive to the heme binding axial ligands,
oxidation state and spin state [15, 19, 20, 28-32]. Previous reports of the mass spectral data
have shown that the heme-free native apo-protein can be readily distinguished from the hemefree denatured apo-protein and the native, heme-bound holo-proteins [15, 20, 30]. Extending the
power of these two tools, direct evidence for an ordered, multi-protein, heme transfer system
between the Gram-positive bacterial surface Isd proteins was demonstrated.

Key to these

experiments is that the MCD signal intensity is a fingerprint of the oxidation state, spin state and
ligation state of the heme iron and that the ESI-MS technique indicates possible changes in
folding as a function of heme binding, and for mixtures the ESI-MS data show all components in
their relative fractions – so in total in heme exchange reactions, heme binding between the very
similar Isd-NEAT containing Isd proteins and the IsdE protein can all be clearly identified, thus
providing unambiguous information on the heme transfer.
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3.2 Experimental Methods
3.2.1 Materials and Methods
General techniques and experimental procedures pertaining to protein growth, protein
purification, protein sample preparation, instrumental techniques and analysis can be found in
Chapter 2.

3.2.2 Gene cloning
Over the course of the study, two different cloning methods were used to generate each of
His-tagged IsdB-N2 and IsdH-N3, resulting in a slight difference in amino acid composition in
the His-tag region of recombinant protein (i.e. non-Isd protein sequence), even after thrombin
cleavage. Sensitivity of MS illustrates these differences in mass. Construct 1 of each of the two
proteins was used in Figures 3-1 and 3-5, and construct 2 was used in Figures 3-8 and 3-9. There
was no change in heme binding properties between the two constructs.

3.2.3 Heme transfer reactions
To monitor heme transfer between the NEAT domains (IsdA-N, IsdC-N, IsdB-N2, IsdH-N3)
and IsdE, the protein samples were mixed with an approximate 1.5x excess of the appropriate
heme acceptor protein. The mixing times were varied from 10 min to 2 h. In all cases the
spectra remained the same.

3.3 Results
3.3.1 ESI-MS as a method to discriminate apo from holo Isd proteins
The heme binding NEAT domains from IsdA, IsdB, IsdC and IsdH, as well as IsdE, were
overexpressed in apo-form and purified. Holo-proteins were prepared by reconstitution of apoproteins with hemin. The proteins were analyzed by mass spectrometry to confirm that each was
heme-free (apo) or homogeneously heme bound (holo), and to establish the number of heme
molecules bound to each protein in the case of the unexplored IsdH-N3 and IsdB-N2 proteins.
The mass spectral data are shown as the charge states in Figure 3-1 with the deconvoluted
spectra in Figure 3-2.
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Figure 3-1
ESI-MS charge state spectra for four Isd NEAT domains and IsdE studied as
the heme-free, apo-IsdA-N, -IsdC-N, -IsdB-N2, -IsdH-N3 and -IsdE species (A, C, E, G, I) and
the heme-bound, holo-IsdA-N, -IsdC-N, -IsdB-N2, -IsdH-N3 and -IsdE species (B, D, F, H, J).
The charge states provide information about the change in conformation associated with heme
binding. The close similarities in charge state distribution between the apo-and holo- pairs of
data show that the proteins do not significantly change in folding following heme binding. Each
charge state arises from the same protein mass, as shown in Figure 3-2.
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Charge states in ESI-MS provide an indication of the volume of the protein or solvent access
to the protein’s basic amino acid residues [20]. In Figure 3-1, the lack of changes in charge state
distribution between the apo- and holo-species for IsdB-N2, and IsdC-N, in addition to the data
previously published for IsdE [20], indicates that no significant structural changes take place
with heme binding in any of these proteins. The ESI-MS data in Figure 3-1B and Figure 3-1A,
indicate that there is a very slight change in conformation of IsdA-N upon heme binding because
the charge state maximum increases to +8 from +7, suggesting solvent exposure of one
additional basic residue when the heme binds. Similarly, there exists a change in the relative
magnitude of the +9 and +8 charge states in Figure 3-1G and Figure 3-1H for apo and holo-IsdHN3, respectively; again, the implication is that there are conformational changes upon binding
the heme in holo-IsdH-N3, that, in this case, cause a reduction of solvent exposure. Compared
with changes that take place following acid-induced denaturation of, for example, IsdE [20], the
changes in conformation of IsdA-N and IsdH-N3 with heme binding are small and for IsdA-N in
agreement with the published crystal structures of the holo versus apo forms of the protein [14].
Following heme loading, mass spectrometry was used again to confirm that the holo-proteins
were formed (Figure 3-2A–J). The mass spectral data provide important evidence that the holoproteins were the only source of heme in the transfer reactions due to the lack of a mass near 616
Daltons. This is an important test, as absorption spectroscopy is not a reliable technique to
ensure the complete uptake and hence removal of free heme from a solution. The Soret band of
free heme can appear as a blue-shifted shoulder on the Soret band of bound-heme and may be
confused with its vibronic band, yielding complications in assessing heme transfer reactions
spectroscopically. Moreover, because each of the heme-binding Isd NEAT domains possess
heme-binding characteristics that result in similar optical properties, quantifying heme transfer
proves very difficult. Table 3-1 summarizes the UV-visible absorption band maxima for each of
the heme binding NEAT domains and IsdE. Given that the absorption spectroscopic properties
of the hemes bound in IsdA, IsdB-N2, IsdC, and IsdH-N3 are all very similar, monitoring NEAT
domain heme transfer reactions solely via absorption spectroscopy is, therefore, ambiguous and
likely to be imprecise as the spectral envelopes of the reactants and products significantly
overlap.
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Figure 3-2
Deconvoluted ESI-mass spectra of the heme-free and heme-bound Isd
proteins. Apo-IsdA-N, -IsdC-N, -IsdB-N2, -IsdH-N3 and -IsdE species (A, C, E, G, I) and Isd
heme-bound-IsdA-N, -IsdC-N, -IsdB-N2, -IsdH-N3 and -IsdE species (B, D, F, H, J). The data
show that only one heme binds to each of these species. The mass difference between the pairs
of data for the apo- and holo-species is approximately 616 Da, the mass of a single heme.
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Magnetic circular dichroism spectra do, however, exhibit additional assignment criteria that
provide far more information from heme-containing proteins and we have demonstrated this
sensitivity with both the full-length proteins and the isolated NEAT-domains [15, 20, 30]. When
the data from MCD measurements are combined with mass spectrometric data, heme transfer
reactions can be studied in detail and all protein species present can be identified together with
their relative concentrations.

Table 3-1: Absorption spectra properties for the heme-bound NEAT domains of IsdA-N,
IsdB-N2, IsdC-N and IsdH-N3, and IsdE
Protein
IsdA-N
IsdB-N2
IsdC-N
IsdH-N3
IsdE

Soret max
(nm)
406
404
403
403
415

Visible region max
(nm)
502, 535, 628
505, 533, 627
502, 533, 627
502, 533, 629
532, 563, 650

Reference
[15, 30]
This work
[19, 30]
This work
[19, 20]

The key focus of this study was determining the ability of heme to transfer among Isd proteins
in order to directly address the hypothesis that the proteins function in concert as a heme shuttle
system in the Gram-positive bacterial cell wall. A key test is whether the transfer reactions are
quite general and independent of the donor or, on the other hand, highly specific to the hemedonor as would be the case if specific protein-protein interactions were involved. Since each
NEAT domain contains a distinct amino acid composition and, therefore, a distinct mass
(making mass spectral peak assignment straightforward; demonstrated in Figure 3-2), heme
transfer reactions could therefore readily be followed using the ESI-MS technique.

3.3.2 Magnetic circular dichroism results
Magnetic circular dichroism spectral data indicate that heme transfer takes place from IsdAN, through IsdC-N to IsdE - While the optical spectral properties of the heme-bound-NEAT
domains are very similar due to the similarity in axial ligation of the heme-iron, IsdE contains a
novel heme binding domain, which is quite distinct from the NEAT domains and, as a result,
exhibits a very different absorption and MCD spectrum (see Table 3-1).

Indeed, IsdE

coordinates a single heme using both a histidine and a methionine residue, whereas the NEAT
domains bind a single heme using a proximal tyrosine for heme-iron coordination [14, 15, 18,
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20]. The Soret absorption band is red-shifted to 415 nm for IsdE, significantly separated from
the ~404 nm Soret band of the NEAT domains. Heme transfer reactions could, therefore, be
monitored using UV-visible absorption spectroscopy for Isd-NEAT to IsdE transfer reactions.
Despite the close similarity in absorption spectral properties between IsdA-N and IsdC-N, the
MCD spectral properties are slightly different because the heme-iron in IsdC-N is slightly lower
spin than in IsdA-N so the Soret region MCD bands distinctly change. Figure 3-3A shows the
sequence of spectra recorded for holo-IsdA-N in the presence of increasing concentrations of
apo-IsdC-N. Clearly, there is a change in the spectra but based on these data alone, it was
ambiguous as to whether heme transfer took place. However, unambiguous data showing heme
transfer in this reaction was obtained from the ESI-MS data shown below, confirming that the
heme in IsdA-N transferred stoichiometrically to apo-IsdC-N.

In other words, while the

absorption data recorded for this transfer are very poor discriminators, and even the MCD data
provide imprecise data, the ESI-MS data provide definitive data to support the conclusion that
heme transfer took place.
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Figure 3-3
Absorption and magnetic circular dichroism (MCD) spectra recorded for
heme transfer from Isd holo-IsdA-N to Isd apo-IsdC-N and for a mixed solution of Isd
holo-IsdA-N and apo-IsdE. (A) Changes in the spectra when apo-IsdC-N is added to holoIsdA-N in steps of 0.3 mol eq. Lines shown for additions to: 0, 0.3, 0.6, 0.9 and 1.2 mol eq. apoIsdE. The spectra have been corrected for dilution effects. In the absorption spectrum the only
significant change is the increase in absorbance at 390 nm and the slight blue shift from 405 to
402 nm; as marked by arrows. There is more change in the MCD spectrum because the MCD
spectrum of the holo-IsdC-N product is slightly blue-shifted when compared with the holo-IsdA-
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N reactant, and also exhibits a more prominent negative signal at 390 nm, a more positive signal
at 408, and a less negative signal at 424 nm than holo-IsdC-N resulting in a significant change in
the intensities of the bands at these wavelengths as the reaction proceeds. (B) Absorption and
magnetic circular dichroism (MCD) spectra recorded when heme-free, apo-IsdE was added to a
solution of heme-containing, Isd holo-IsdA-N. Three sets of spectra are shown: with a total of 0,
0.6 and 1.2 mol. eq. IsdE added. While there is little change in the absorption spectrum, addition
of apo-IsdE results in intensification of the Soret MCD band envelope centered on 416 nm, a
sign of increased low spin contribution in the ferric heme. There is no indication of the distinctly
different absorption and MCD spectra of heme-containing, holo-IsdE. The changes are a result
of interactions between the two proteins. Mass spectral data in Figure 3-7 also clearly show that
no heme transfer took place and that the solution after mixing contains only holo-IsdA-N and
apo-IsdE.
Figure 3-3B shows that the effect of adding apo-IsdE to holo-IsdA-N is essentially negligible
in the absorption spectrum but is actually quite significant in the MCD spectrum. The MCD data
clearly show that the heme does not transfer from IsdA-N to IsdE. However, an interesting
finding was that the MCD data show that spectral changes do take place at the heme site in holoIsdA-N (despite the fact that heme is not removed), which can be associated with a decrease in
the high spin g factor of the ferric ground state, a situation encountered when a weak field ligand
is replaced by a slightly stronger field ligand. The ESI-MS data described below confirm that no
heme transfer took place between IsdA-N and IsdE but, unlike the data obtained from MCD, do
not discriminate the fact that an interaction between the two proteins does occur.
Figure 3-4 shows results from heme transfer as increasing concentrations of apo-IsdE are
added to a solution of holo-IsdA-N and apo-IsdC-N (the same solution as that used to generate
the spectral data shown in Figure 3-3A – in fact, as shown conclusively above, that solution
rapidly shifts to apo-IsdA-N and holo-IsdC-N). Since the spectral properties of the heme in
holo-IsdE are completely different than when the heme is bound in either holo-IsdA-N or holoIsdC-N, there are dramatic and systematic changes that are observed in both the absorption and
MCD spectra. These data emphasize that transfers between NEAT-domains are difficult to
quantify by optical measurements alone, but that heme transfer to IsdE is readily measurable, and
the MCD spectra provide clear assignment criteria with respect to the exact heme-containing
protein at the end of the reaction.
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Figure 3-4
Changes in the absorption and magnetic circular dichroism spectra when
heme-free, apo-IsdE is added to a solution of heme-containing, Isd holo-IsdA-N and apoIsdC-N (the solution used in Figure 3-3A). Isosbestic change in spectral properties indicates
the formation of heme-containing, holo-IsdE that was transferred from the holo-IsdA-N, to the
apo-IsdC-N, then to the apo-IsdE. Spectra are shown for solutions with a total of: 0, 0.3, 0.6,
0.9, 1.2 and 2.1 mol eq apo-IsdE added. The lines show the direction of the spectral changes.
The final absorption and MCD spectra closely resemble those of heme-loaded-IsdE (holo-IsdE).

3.3.3 Electrospray ionization mass spectrometry results
In the following sections, ESI-MS was used to demonstrate that specific heme transfer
reactions occur between the NEAT domains of IsdH-N3, IsdB-N2, IsdA-N, and IsdC-N and the
IsdE protein.
Apo-IsdC-N efficiently removes heme from holo-IsdA-N, holo-IsdB-N2, and holo-IsdH-N3 –
In Figure 3-5, mass spectral data show that heme is transferred directly, rapidly and completely
from holo-IsdA-N Figure 3-5A, holo-IsdB-N2 Figure 3-5B, and holo-IsdH-N3 Figure 3-5C to
apo-IsdC-N. The heme donor proteins were mixed with an approximately 1.5x excess of the
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heme acceptor protein. Three major peaks are seen in each of the deconvoluted spectra (adjacent
panels in A, B and C in Figure 3-5), which are associated with (i) the heme-free form of the
donor, (ii) the heme-free form of the acceptor and (iii) the heme-bound form of the acceptor. No
remaining heme-bound form of the donor is observed (see Figure 3-2 for the masses of the holo
species). It is interesting to note that the relative magnitudes of the %-abundances cannot be
used to determine relative concentrations between different proteins because the uptake by the
mass spectrometer is different for each protein. However, the relative concentrations of the
heme-bound and heme-free species of the same protein can be related. In these data even though
the apo- and holo- masses might be close, there is no direct overlap and within the precision of
the experiment only three-separate species can be identified.

Figure 3-5
Mass spectral data for solution of mixed proteins showing heme transfer
from the Isd holo-NEAT domains (IsdA-N, IsdB-N2, and IsdH-N3) to apo-IsdC-N. (A)
Charge state and deconvoluted mass spectra measured for a mixture of heme-containing, Isd
holo-IsdA-N and apo-IsdC-N. Excess heme-free, apo-IsdC-N was added. Three species coexist
in solution and are identified in the charge state spectra with the abbreviations for apo-IsdC-N (aC; with a mass of 14,442 Da), apo-IsdA-N (a-A; with a mass of 14,626 Da) and holo-IsdC-N (h-
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C; with a mass of 15,059 Da). (B) Charge state and deconvoluted mass spectra measured for a
mixture of heme-containing, holo-IsdB-N2 and apo-IsdC-N. Excess heme-free, apo-IsdC-N was
added. Three species coexist in solution and are identified in the charge state spectra with the
abbreviations for apo-IsdB-N2 (a-B2; with a mass of 14,345), apo-IsdC-N (a-C; with a mass of
14,444 Da), and holo-IsdC-N (h-C; with a mass of 15,060 Da). (C) Charge state and
deconvoluted mass spectra measured for a mixture of heme-containing, Isd holo-IsdH-N3 and
apo-IsdC-N. Excess heme-free, apo-IsdC-N was added. Three species coexist in solution and
are identified in the charge state spectra with the abbreviations for apo-IsdH-N3 (a-H3; with a
mass of 14,640 Da), apo-IsdC-N (a-C; with a mass of 14,444 Da), and holo-IsdC-N (h-C; with a
mass of 15,060 Da). In each case heme transfer to IsdC-N was observed, resulting in a mixture
of the heme-free-Isd-NEAT domain of IsdA-N, IsdB-N2, IsdH-N3) and heme-free apo-IsdC-N
and heme-bound-holo-IsdC-N. No heme-bound-holo-IsdA-N (at 15,245 Da), IsdB-N2 (at
14,960 Da) or IsdH-N3 (at 15,256 Da) was observed in their respective mass spectra following
mixing with apo-IsdC-N. In each case, excess (approximately 1.5x) of the heme-acceptor
protein was used, so that there was also apo-heme-free protein remaining.
If the reverse reaction occurred in the presence of holo-acceptor protein, then four species
would be observed since none of the possible protein species would be completely removed from
solution. This was observed for only one experiment: namely for the heme transfer between
IsdB-N2 and IsdH-N3, described below.
Conclusions from these data are that, unlike the data obtained from absorption and MCD
spectra, the ESI-MS data unambiguously show that heme was transferred to apo-IsdC-N in every
case. Next, the heme-transfer hypothesis and the MCD data described above was tested by
adding IsdE to these solutions,
ESI-MS data show that apo-IsdE efficiently removes heme from holo-IsdC-N, -B2 and H3 –
Figure 3-6 consolidates two experiments; in part A, the mass spectral data recorded following
mixing of holo-IsdC-N and apo-IsdE are shown and, in part B, the separate absorption spectra
for the two heme-bound proteins, holo-IsdC-N and holo-IsdE after heme-transfer from the holoIsdC-N are shown. First, the mass spectral data (Figure 3-6A) shows that IsdC-N-bound-heme
was transferred entirely to apo-IsdE. Only apo-IsdC-N at 14,443 Da, apo-IsdE at 30,258 Da and
holo-IsdE, 615 Da heavier at 30,873 Da, are identified. The 616 Da mass is quite small with
respect to the apo-heme-free mass of IsdE, so the charge states overlap and we observe a
duplication from +11 to +13. There is only one set of charge states for the IsdC-N as there is no
holo-IsdC-N remaining. The +6 charge state overlaps with the +13 of IsdE. Inspection of the
charge states illustrate how heme binding does not change the overall conformation of either
IsdE or IsdC-N significantly (Figure 3-6A and Figure 3-1), since the +12 state for IsdE and +8
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for IsdC-N remain predominant following heme-binding. The absorption spectra in Figure 6B
show how the Soret band for holo-IsdC-N red-shifts when apo-IsdE is added.

For this

combination, the absorption spectra are different because the maximum of IsdE lies 12 nm to the
red near 415 nm, Table 3-1.

Figure 3-6

Heme transfer from holo-IsdC-N to apo-IsdE. (A) Charge state and deconvoluted
mass spectra of the solution made by mixing holo-IsdC-N and apo-IsdE. Excess apo-IsdE was added.
(B) Absorption spectra of holo-IsdC-N before (indicated by arrows) and following the addition of apoIsdE. The significant change in the Soret band maxima following heme transfer to the apo-IsdE means
that for this heme transfer experiment, absorption spectra can be used to monitor the progress of the
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reaction. The absorption spectrum of holo-IsdE is quite different from that of either apo-IsdC-N or holoIsdC-N.

Apo-IsdE does not accept heme from holo-IsdA-N – The ESI-MS data in Figure 3-7A show
that there is no heme transfer when apo-IsdE is mixed with holo-IsdA-N. This is the only
scenario, where no transfer to the heme-free Isd acceptor protein at all was observed. This lack
of transfer is emphasized in the absorption spectra (Figure 3-7B) where the spectrum of holoIsdA-N mixed with apo-IsdE is exactly the same as holo-IsdA-N – quite unlike the case in all the
other spectra shown previously. However, recall that the MCD spectra in Figure 3-4 suggest that
there is interaction between these two proteins, but without transfer of the heme.

63

Figure 3-7

Demonstration that no heme transfer takes place from holo-IsdA-N to apo-IsdE.
(A) ESI-MS spectra (charge states and deconvolution) for a mixture of holo-IsdA-N and apo-IsdE
showing the presence of only holo-IsdA-N and apo-IsdE; there is no indication of the presence of either
apo-IsdA-N or holo-IsdE showing that no heme transfer took place. (B) The absorption spectra recorded
before and after addition of the apo-IsdE are characteristic of holo-IsdA-N for both solutions. There is no
indication of formation of holo-IsdE, which has a significantly different absorption spectrum
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Figure 3-8
Heme transfer from holo-IsdB-N2 and holo-IsdH-N3 to apo-IsdE. Charge
state and deconvoluted mass spectra and absorption spectra measured for mixtures of (A) holoIsdB-N2 with apo-IsdE as a heme acceptor and (B) holo-IsdH-N3 with apo-IsdE as a heme
acceptor. In (A) the data show that holo-IsdB-N2 transfers heme to apo-IsdE. In each mass
spectrum are peaks that correspond to both the holo-and apo-proteins: peaks that correspond to
apo-IsdE (+11 to +13) at 30,218 Da, peaks that correspond to holo-IsdE (+11 to +13) at 30,832
Da and peaks that correspond to apo-IsdB-N2 (+7 to +8) at 15,272 Da. The absorption spectra
represent the holo-IsdB-N2 before the addition of IsdE (indicated by the arrow from the legend
‘holo-IsdB-N2’) and following mixing with IsdE for 25 min (indicated by the arrows from the
legend ‘after mixing with apo-IsdE’). The holo-IsdB-N2 was formed by binding heme to hemefree, apo-IsdB-N2 (construct 2), which was made using a different cloning strategy than that
used to make IsdB-N2 which was used for the data in Figures 3-1, 3-2 and 3-5. Residues in the
His-tag region (non-Isd) differ between the two constructs (see Experimental Procedures). The
experimental results were unchanged by the use of the second construct. In (B) the data show
that holo-IsdH-N3 transfers heme to apo-IsdE. In each mass spectrum are peaks that correspond
to both the holo-and apo-proteins: peaks that correspond to apo-IsdE (+11 to +13) at 30,250 Da,
peaks that correspond to holo-IsdE (+11 to +13) at 30,865 Da and peaks that correspond to apoIsdH-N3 (+7 to +8) at 14,156 Da. The absorption spectra of the holo-IsdH-N3 before the
addition of IsdE (indicated by arrows from the legend ‘holo-IsdH-N3’) and following mixing
with apo-IsdE for 25 min (indicated by arrows from the legend ‘after mixing with apo-IsdE’).
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The final spectrum corresponds to that of heme-containing, holo-IsdE. The apo-IsdH-N3
(construct 2) was made using a different cloning procedure than that used for the IsdH-N3 which
was used to generate the data shown in Figures 3-1, 3-2 and 3-5. Residues in the His-tag region
(non-Isd) were altered between the two constructs (see Experimental Procedures). The
experimental results were unchanged by the use of the second construct.
Apo-IsdE accepts heme from holo-IsdB-N2 and holo-IsdH-N3 – The ESI-MS data in Figure 38 show unambiguously that heme, whether it was initially in IsdB-N2 (panel A) or IsdH-N3
(panel B), was transferred rapidly and completely to apo-IsdE. The absorption spectra in Figures
3-8A and 3-8B again illustrate that when IsdE is the heme acceptor there are significant
differences in the absorption spectra. The spectra measured following mixing of holo-IsdB-N2
and apo-IsdE and of holo-IsdH-N3 and apo-IsdE are virtually identical, representing solely holoIsdE.
Apo-IsdA-N accepts heme from holo-IsdB-N2 and holo-IsdH-N3 – The ESI-MS data in
Figures 3-9A and 3-9B show that the heme in holo-IsdB-N2 and holo-IsdH-N3 transfers to apoIsdA-N. The transfer from holo-IsdH-N3 to apo-IsdB-N2 is inefficient since the data in Figure
9C show the presence of all four species.
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Figure 3-9
Heme transfer from holo-IsdB-N2 and holo-IsdH-N3 to apo-IsdA by ESIMS. Charge state and deconvoluted mass spectra Heme transfer from holo-IsdB-N2 to apoIsdA-N, and holo-IsdH-N3 to apo-IsdN-A and IsdB-N2. Charge state and deconvoluted mass
spectra, and absorption spectra measured for mixtures of (A) holo-IsdB-N2 with apo-NEAT-A as
a heme acceptor, (B) holo-IsdH-N3 with apo-IsdA-N as a heme acceptor, and (C) holo-IsdH-N3
with apo-IsdB-N2 as heme acceptor. In (A) the data show that holo-IsdB-N2 transfers heme to
apo-IsdA-N. In each mass spectrum are peaks that correspond to both the holo-and apo-proteins:
peaks in the mass spectra that correspond to apo-IsdA-N (a-A: +7 and +8) at 14,630 Da, peaks
that correspond to holo-IsdA-N (h-A: +7 and +8) at 15,245 Da and peaks that correspond to apoIsdB-N2 (a-B2: +7 to +8) at 14,347 Da. In (B) the data show that holo-IsdB-N2 transfers heme
to apo-IsdA-N. In each mass spectrum are peaks that correspond to both the holo-and apoproteins: peaks that correspond to apo-IsdA-N (a-A: +7 and +8) at 14,630 Da, peaks that
correspond to holo-IsdA-N (h-A: +7 and +8) at 15,245 Da and peaks that correspond to apoIsdH-N3 (a-H3: +7 to +8) at 14,640 Da. In (C) the data show that holo-IsdH-N3 transfers heme
to apo-IsdB-N2. In each mass spectrum are peaks that correspond to both the holo-and apoproteins: peaks that correspond to apo-IsdB-N2 (a-B2: +7 and +8) at 14,346 Da, peaks that
correspond to holo-IsdB-N2 (h-B2: +7 and +8) at 14,962 Da, and peaks that correspond to holoIsdH-N3 (h-H3: +7) at 15,256 Da, and to apo-IsdH-N3 (a-H3: +7 to +8) at 14,640 Da.
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3.4 Discussion
The Isd series of proteins are proposed to represent a complete heme acquisition and transport
system, together functioning to remove heme from proteins such as hemoglobin, then to shuttle
heme across the Gram-positive bacterial cell wall right through to membrane ABC transporters,
which translocate the heme molecule into the cytoplasm where it is eventually degraded by
proteins IsdG and IsdI. While significant evidence now exists demonstrating substrate binding
for the various proteins [9, 10, 14-21, 27, 30], the first direct evidence for heme transfer between
Isd proteins was only very recently obtained for the IsdA to IsdC transfer reaction [27]. In the
present study, a complete picture of heme transfer between all of the heme binding Isd proteins
that reside on the outside of the bacterial cell has been obtained for the first time.
All heme-binding Isd NEAT domains possess overlapping heme-binding properties. Each has
been shown to coordinate a single, 5-coordinate, high-spin ferric heme through a conserved
tyrosine residue [14, 15, 21, 30] and, as such, the absorption spectroscopic properties of the
hemes bound in IsdA, IsdB, IsdC, and IsdH are all very similar. The spectroscopic and structural
data reported to date do not provide information on the process or mechanism that would be
required if the Isd proteins are to capture and transfer heme molecules. Although the heme
binding properties of the NEAT domains appear very similar, the data presented here show that
the NEAT domains do, in fact, possess distinct qualities. The majority of heme transfer reactions
occurred rapidly and in a unidirectional fashion (except for the transfer between IsdB-N2 and
IsdH-N3) and, in the case of IsdA, very selectively, via apo-IsdC-N towards apo-IsdE
Together, the results suggest that specific protein-protein interactions must occur to promote
the removal of heme from Isd proteins since concentrations of free heme were extremely low and
if protein-protein reactions were not to occur, would result in very slow transfer rates.
Experimentally, this is not what was observed.

Also, in the absence of protein-protein

interactions the presence of equilibria would be exected to be observed in both optical data
(especially the MCD spectra) and ESI-mass spectra. No evidence for significant concentrations
of both donor and acceptor was observed. It is likely, then, that one or more of the remaining,
non-heme binding NEAT domains, that is, IsdB-N1 and/or IsdH-N1 or IsdH-N2 play crucial
roles in extracting heme from myoglobin or hemoglobin. In support of this, it is noteworthy that
IsdB-N1 binds hemoglobin [16] whereas IsdH-N1 binds hemoglobin-haptoglobin [17]. In the
proposed Isd-mediated heme transport system, the surface exposed Isd proteins interact with
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heme containing proteins such as hemoglobin (IsdB) or hemoglobin-haptoglobin (IsdH), which
are found in serum following erythrocyte lysis. Extraction of the heme then occurs, followed by
heme transfer to other Isd proteins present in spatially arranged locations within the cell wall
architecture.
Analysis of the optical data illustrates the difficulties in obtaining precise information for
transfer between the NEAT domains.

Even though the MCD spectra provide far more

information, there is only a small change following transfer from holo-IsdA-N to apo-IsdC-N.
The situation is far better when the transfer takes place to IsdE. The transfer to IsdE was further
confirmed by absorption spectroscopy since a gradual shift of the Soret band from 404 to 415 nm
was observed.

On the other hand, the mass spectrometric data show that holo-IsdH-N3

transferred heme to all other NEAT domains as well as to IsdE. Holo-IsdB-N2 showed similar
behavior, even supplying heme to apo-IsdH-N3 with heme. This was the only example of
bidirectional heme transfer that was observed in this study and suggests that IsdB and IsdH are
functionally closely related, in agreement with predictions based on bioinformatic analyses.
A key result of this study is that the IsdA NEAT domain (IsdA-N) behaved quite differently
than either IsdB-N2 or IsdH-N3. IsdA-N accepted heme from IsdB-N2 and IsdH-N3 in a
unidirectional fashion, and only transferred heme to IsdC-N not to apo-IsdE.

All three

techniques, mass spectrometry, MCD and absorption spectroscopy, confirmed that IsdE was
unable to accept heme from IsdA-N. Figures 3-3B and 3-7 show the MCD and absorption
spectra of holo-IsdA-N before and following the addition of excess apo-IsdE. No shift in the
Soret band or any change in the visible region was observed. IsdC has been proposed to function
as the central conduit in the cell wall for heme passage to the bacterial cell membrane. The
ability of IsdC-N to accept heme from IsdA-N, IsdB-N2, and IsdH-N3 (Figure 3-5) and to only
transfer it to apo-IsdE (Figures 3-4 and 3-6) offers strong support for this proposal; no increase in
holo-IsdE was observed after incubation with holo-IsdA-N whereas a significant increase in
holo-IsdE was obtained following incubation of apo-IsdE with holo-IsdC-N (Figure 3-7 and
Figure 3-6).

3.5 Conclusion
In conclusion, the data presented here support a model for heme transport as illustrated in
Figure 3-10, in strong agreement with the proposal first offered by Mazmanian et al. [9]. Of
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importance in these challenge experiments, is that the flow of heme is from the distally-located
IsdH and IsdB through to the membrane-proximal IsdE protein. Key to the mechanistic analyses
is that heme does not transfer from holo-Isd IsdA-N directly to apo-IsdE; apo-IsdC-N is the
required facilitator. This fact, taken together with the demonstrated unidirectionality of the
transfer reactions, suggests that specific protein-protein interactions must be a necessary part of
the mechanism required to drive the heme transfer towards the membrane.

Figure 3-10 A heme transport model based on analysis of the magnetic circular
dichroism and mass spectral data obtained from this study. Overall, heme transfer is from
membrane distal IsdH (studied using NEAT domain H3) and IsdB (studied using the NEAT
domain B2) proteins through to the membrane-proximal IsdE. There is unidirectional heme
transfer from IsdA-N to IsdC-N to IsdE. There is no transfer from NEAT-A to IsdE. The mass
spectral data to support the model are in agreement with the model first proposed by Schneewind
and colleagues [9]. The absorption and MCD data of the equilibrated solutions fully support the
conclusions reached from analysis of the mass spectral data.
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Chapter 4.

Characterization of IsdH (NEAT domain 3) and

IsdB (NEAT domain 2) in Staphylococcus aureus 3
4.1 Introduction
Critical to bacterial survival is the acquisition of iron which is an essential nutrient for
bacterial metabolism. Staphylococcus aureus (S. aureus) uses an iron-siderophore system for
iron acquisition and transport [1]. However, free iron is very limited in human hosts due to most
of the iron being sequestered by proteins such as hemoglobin, myoglobin and ferritin. In order to
flourish in these growth-limiting environments, pathogens like S. aureus have developed
mechanisms to sequester or scavenge iron from heme containing proteins such as hemoglobin.
S. aureus is able to scavenge heme using a series of iron-regulated surface determinant
proteins (Isd), which are heavily expressed in iron limited environments [2, 3]. This pathway
consists of four proteins anchored to the bacterial cell wall, IsdH, IsdB, IsdA and IsdC. Each of
these proteins contain at least one copy of a Near Transporter (NEAT) domain which comprises
of a 150 amino acid motif. However, the exceptions are IsdH, which has three NEAT domains,
and IsdB, which has two NEAT domains. Of these, only the third NEAT domain of IsdH (IsdHN3) and the second NEAT domain of IsdB (IsdB-N2) are known to bind heme. NEAT domains
are present in proteins whose genes are located in the vicinity of genes encoding putative Fe3+
scavenging transporters [4]. The final protein is an ABC membrane transport protein IsdDEF.
The proposed scheme entails heme being transferred from IsdH and IsdB on the outside of the
bacterial wall, to IsdA, IsdC and finally IsdE, and then transferred into the cytoplasm [2, 5]. The
current transfer model [6, 7] is based on the proposal of Scheenwind [2]. In this proposal each of
these proteins is involved in binding the heme in sequence. At present, the specificities for the
oxidation state of the iron in the heme, ferric or ferrous, and for a specific spin state are not
known. Spectroscopic analysis using MCD spectroscopy can provide evidence for stable protein
conformations that may form with either ferric or ferrous hemes and with high and low spin
states. The heme-iron binding site axial ligands of the wall-located heme binding Isd proteins
(IsdA, IsdC and IsdE) have been previously characterized using ESI-MS, and UV-visible
absorption and MCD spectroscopy [8-11]. Each of these NEAT domains binds one heme
3
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molecule axially in a heme binding pocket. IsdA contains a tyrosine ligand for the ferric (Fe3+)
state of the heme, switching to a histidine ligand for the ferrous (Fe2+) state. IsdC contains only a
tyrosine ligand and therefore, is found to not bind ferrous heme and finally, IsdE contains both
histidine and methionine ligands [8, 10, 12]. Furthermore, it has been experimentally determined
that the NEAT domain in the Isd proteins are the ‘workhorses’ of the heme binding system
where the rest of the protein is potentially used only for scaffolding [9, 11, 12].
In this chapter, characterization of the heme binding environment in the first two heme
binding NEAT domains in the Isd pathway, namely IsdB-N2 and IsdH-N3 is described.
Identification of the heme binding properties was achieved using a combination of absorption
and magnetic circular dichroism (MCD) spectroscopy and electrospray ionization mass
spectrometry (ESI-MS).

This study leads to a comprehensive understanding of the heme

scavenging and potential heme transfer properties of the first five proteins in the Isd heme
transfer pathway [6].

4.2 Experimental Methods
4.2.1 Materials and Methods
Experimental procedures have been previously reported; please refer to Chapter 2 for further
protein growth, protein purification, ESI-MS and MCD spectroscopy preparatory and running
procedures.

4.2.2 ESI-MS Protein Experiments
Denaturation experiments were performed by lowering the pH using dilute formic acid to pH
2.0. Renaturation was done using buffer exchange centrifugation with 20 mM ammonium
formate pH 7.4 using Millipore Amicon ultra-4 centrifuge filter units (10 kDa MWCO) with a
Beckman CS-6 swinging-bucket Centrifuge (3000 rpm for 10 minutes per run).

4.2.3 Protein Ligand Addition
Heme loaded proteins were diluted to give an absorbance of less than 1.0 absorbance units in
the Soret region before performing experiments. In all cases, addition of ligands to the proteins
was monitored by absorption spectroscopy until no further change was detected before
measuring the MCD spectra. After the MCD spectra were measured, the absorption spectra were
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taken again to ensure no change had taken place in the heme environment. Small amounts of
crystalline sodium cyanide were added to the proteins in approximately 5-fold, 10-fold or in
large excess (until no change in the absorption spectrum occurred) and then the MCD spectrum
was measured. Reduction of the iron was achieved by adding small amounts of crystalline
sodium hydrosulfite (Na2S2O4). Following the reduction and measurement of the absorption and
MCD spectra, CO was bubbled into the solution. Solutions were monitored closely to ensure
that re-oxidation to the ferric heme did not occur. The absorption and MCD spectra were
recorded for the same solution at the time the MCD spectrum was measured. The MCD spectra
are corrected for the zero-field CD spectral envelope.

4.3 Results and Discussion
It has been previously shown are that the NEAT domains of IsdA and IsdC, and the protein
IsdE, each bind one heme. Mass spectrometry (specifically ESI-MS) can provide specific
information on the changes in conformation upon heme binding (very slight) and upon
denaturation (heme is lost and the protein unfolds reversibly) [10-12]. On the other hand, while
the ESI-MS data cannot specifically indicate any properties of the iron of the bound heme,
magnetic circular dichroism (MCD) spectra have proven over many different systems to be
extremely sensitive to the electronic and ligation status of the bound iron [13-20].

4.3.1 ESI-MS data for IsdB-N2 and IsdH-N3
The ESI-MS data for IsdB-N2 and IsdH-N3 show that both only bind one heme group and
that the heme is bound with minimum conformational change, Figures 4-1 and 4-2. The ESI-MS
deconvoluted masses for both apo-proteins closely match the theoretical masses: for IsdB-N2,
experimental from Figure 4-1 is 15,303, theoretical mass is 15,300 Da, and for IsdH-N3,
experimental from Figure 4-2 is 14,172 Da, theoretical mass is 14,170 Da. For IsdB-N2 the ESIMS data clearly show that the +8 charge state dominates for both the heme-free and heme-bound
native proteins. Denaturation with acid results in loss of heme and unfolding of the protein
resulting in the +17 charge state dominating. Even under these conditions, there remains a small
fraction of native protein. Addition of base to raise the pH back to neutral refolds the protein and
the native form is found. Even though the deconvoluted masses for each of the heme-free
species (in A, C and D) are the same within the experimental error of the instrument, the
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dominant charge state for the refolded protein shifts from +8 to +7, indicating a slightly different
folding. The mass spectral data are excellent indicators of conformational change for very
specific conditions, namely heme-free native, heme-bound native and the denatured protein. The
data in Figure 4-1 and Figure 4-2 very clearly shows that both IsdB-N2 and IsdH-N3 fold in the
absence of the heme, resulting in conformations similar to those when the heme is bound. One
might consider that this is an excellent attribute in that heme transfer does not disrupt the folded
native structure. Indeed, heme transfer experiments suggest that each protein can transfer more
than one heme in sequence, implying that the heme-free protein formed following transfer can
subsequently bind heme again readily [7].

Figure 4-1
ESI-mass spectral data for IsdB-NEAT-domain 2 (IsdB-N2). (A) The charge
states and deconvoluted spectrum of heme-free, native apo-IsB-N2. (B) The charge states and
deconvoluted mass spectrum of heme-containing, native IsdB-N2. Note the increase in mass of
616 Da due to the iron protoporphyrin IX now bound. The charge state maximum at +8, which
is the same as that for the heme-free, apo-protein in (A). (C) The charge states and deconvoluted
mass spectrum of the denatured IsdB-N2 (using acid pH 2.0). Note the presence of a small
fraction of heme-free, native apo-IsdB-N2 with charge states at +8. The deconvoluted spectrum
shows that there is no heme bound. (D) The charge states and deconvoluted mass spectrum of
the refolded (using base to raise the pH to 7.4) heme-free, native IsdB-N2.
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Figure 4-2 shows the ESI-mass spectral data for IsdH-N3. The mass spectral data show that
when the heme binds to the heme-free, apo-native IsdH-N3 that only very slight conformational
changes occur. The dominant +7 charge state is measured for both species, with a slight shift to
lower charge state values for the heme-bound, holo-protein, which suggests that there may be a
minor conformational tightening with the heme bound. The deconvoluted mass difference
between the apo and holo proteins is the 617 Da of the heme. Denaturation again results in the
dominant charge state shifting to +15 representing an unwound protein; there is some folded
protein as well. The refolding with base results in the native protein reforming together with a
small fraction of heme-bound native that arises because a fraction of the released heme was still
available for binding. Other groups have proposed that IsdH-N3 can bind up to four hemes [21].
This was not shown by the ESI-MS measurements in this study which utilizes a soft ionization
technique; also free heme was not present in the spectra indicating that loosely associated heme
was not present. This data is more consistent with the previously characterized NEAT domains
and fit a biologically relevant model of heme transfer which we have previously proposed as
involving a single heme in this domain.
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Figure 4-2
ESI-mass spectral data for IsdH-NEAT-domain 3 (IsdH-N3). (A) The charge
states and deconvoluted spectrum of heme-free, native apo-IsdH-N3. (B) The charge states and
deconvoluted mass spectrum of heme-containing, native IsdH-N3. Note the increase in mass of
617 Da due to the iron protoporphyrin IX now bound. The charge state maximum at +7, which
is the same as that for the heme-free, apo-protein in (A). (C) The charge states and deconvoluted
mass spectrum of the denatured (using acid pH 2.0) IsdH-N3. Note the presence of a small
fraction of heme-free, native apo-IsdH-N3 with charge states at +8. The deconvoluted spectrum
shows that there is no heme bound. (D) The charge states and deconvoluted mass spectrum of
the refolded native protein, using base to raise the pH to 7.4 (mass 14,174 Da) and a small
fraction of residual heme bound (mass 14,790 Da) native IsdH-N3.

4.3.2 Native heme binding of IsdB-N2 and IsdH-N3
The experiments above show that both NEAT domains exist as native heme-bound and
native-heme-free forms and that denaturation is reversible. While the ESI-MS data clearly show
only one heme binding, there is no information about the electronic or ligation state of the bound
heme, which are critical properties for a heme transfer protein. Figures 4-3 and 4-4 compare the
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absorption and MCD spectral data for IsdB-N2 and IsdH-N3 with the previously wellcharacterized spectra of IsdA, IsdC and IsdE. Figure 4-3 shows the absorption and MCD
spectral data for the native NEAT domains of IsdH-N3 and IsdB-N2. Comparison with IsdE and
the NEAT domains of IsdA and IsdC is valuable in assessing the coordination properties of the
heme in each protein. The spectral envelope in three general regions centered on about 415, 540
and 630 nm can be used diagnostically.

High- to intermediate-spin Fe(III) hemes are

characterized by MCD spectral intensities in these three regions that are approximately equal.
Specifically for high-spin Fe(III) it is common to observe a three feature envelope in the Soret
region (393(-)/410(+)/430(-)) and derivative-like features at 530(+)/550(-) and 610(+)/640(-).
This detail is clearly absent from the absorption spectra. This is because the MCD spectrum is
dependent on both the electric and magnetic dipoles. We can conclude that IsdB-N2 and IsdHN3 are very similar in the ligand field strength and ligand character. That is, the axial ligation of
the Fe(III) in both these proteins is probably the same. Therefore, IsdB and IsdH most closely
resembles IsdC, rather than the coordination in IsdE, where the heme is coordinated by tyrosine
rather than histidine and 5-coordinate rather than 6. The coordination in IsdA is not like that in
IsdE, and close inspection of the MCD data reveal that the differences arise from an increase in
the ligand field strength but not a complete switch to low-spin Fe(III). Therefore, it can be
concluded that the native ferric hemes of IsdH-N3 and IsdB-N2 are coordinated by tyrosine with
the 6th position empty. This conclusion about ferric bound heme to IsdH-N3 also matches the
recently reported crystal structure of the protein showing a single tyrosine ligand binding the
heme [21].
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Figure 4-3
Absorption and MCD spectra of IsdH-NEAT domain 3 and IsdB-NEAT
domain 2. (A) Native, heme-bound IsdH-N3. (B) Native IsdB-N2. (C) Native IsdA (NEAT
domain). (D) Native IsdC (NEAT domain). (E) Native IsdE. The data for IsdA, IsdC and IsdE
have been previously published [9, 10] and are presented here to allow direct comparison of the
differences in spectral properties.
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4.3.3 Addition of CN- to IsdB-N3 and IsdH-N3
Figure 4-4 compares the absorption and MCD spectral data for the NEAT domains of IsdHN3 and IsdB-N2 following the addition of CN-. Cyanide is a well-known strong sigma donor
and π-acid, resulting in low spin ferric hemes. The MCD spectral envelopes for both IsdH-N3
and IsdB-N2 exhibit the characteristic fingerprint for low spin Fe(III) with a strong derivative
feature centered on the Soret band and a strong signal centered on 540 nm. The spectrum of
IsdE with cyanide Figure 4-4E arises from a low spin Fe(III) heme. Neither IsdH-N3 nor IsdBN2 exhibits this typical low spin spectral character with added cyanide. Both resemble IsdA,
which was characterized as binding a low spin ferric heme. However, despite the addition of
excess CN- to IsdH-N3, it was found that there is equilibrium between bound and unbound iron.
The CN- bound heme gives the strong A term in the 420 nm region, whereas the remaining high
spin heme results in the Soret band maximum at 406 nm. This would suggest that there is
considerable congestion in the region of the 6th position of the ferric heme resulting in much
weaker binding for the CN- than one would predict. The low spin ferric heme forms readily and
nearly completely for IsdB-N2, with the Soret band maximum at 419 nm being essentially at the
cross-over point of the A term.
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Figure 4-4
Absorption and MCD spectra of the cyanide complexed heme in IsdH-NEAT
domain 3 and IsdB-NEAT domain 2. (A) Spectra when NaCN is added to native IsdH-N3.
(B) Spectra when NaCN is added to native IsdB-N2. (C) Spectra when NaCN is added to native
IsdA (NEAT domain). (D) Spectra when NaCN is added to native IsdC (NEAT domain). (E)
Spectra when NaCN is added to native IsdE. The data for IsdA, IsdC and IsdE have been
previously published [9, 10] and are presented here to allow direct comparison of the differences
in spectral properties.
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4.3.4 Reduced (Fe(II)) heme and CO ligand binding of IsdB-N3 and IsdH-N3
Figure 4-5 compares the absorption and MCD spectral data for the NEAT domains of IsdHN3 and IsdB-N2 following the addition of Na2S2O4, a well-known heme reducing agent. Upon
heme reduction, both Soret bands red shift to 434 nm. Inspection of the ferrous heme spectra
from IsdA and IsdE in Figure 4-5 immediately identifies differences: the ferrous hemes in IsdHN3 and IsdB-N2 are six-coordinated like IsdE rather than the 5-coordination of IsdA. A key
property of 5-coordinate ferrous heme is that the MCD spectrum appears inverted in the 430 nm
region. A key property of 6-coordinate hemes is that the MCD spectrum in the Soret region
exhibits a simple, positive A-term.

The B:Q intensity ratio in the MCD spectra are

approximately in a 1:1 ratio indicating that the heme binding environment is lower spin than in
IsdE, but not the low spin found with CO added (Figure 4-6). The spectra now closely resemble
that of IsdE with a characteristic derivative shaped A term centered at 559 nm. This is an
indication of an unusual methionine ligand present in IsdE [10]. The increased intensity of the B
band in IsdH-N3 and IsdB-N2 suggests that there has been a shift in axial ligands from tyrosine
to histidine and methionine when heme was reduced from the ferric oxidation state to the ferrous
oxidation state. This is not unexpected as the ferrous iron is more likely to bind to the neutral
histidine nitrogen and soft methionine sulphur than to the anionic oxygen of the tyrosine. This
oxidation state dependent ligand switch is modeled in Figure 4-7. Using the X-ray structure for
IsdH-N3 (pdb code 2Z6F), it is possible to rotate histidine (His647) to allow the heme to be
coordinated by both histidine (His647) and methionine (Met565). Finally, the data for addition
of CO in Figure 4-6 result in the formation of the 6-coordinate ferrous heme for both proteins.
The data more closely resemble those of a carbon monoxide bound ferrous myoglobin [13, 18]
rather than IsdE, further confirming that one of the axial ligands binding the ferrous heme is now
a histidine nitrogen.
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Figure 4-5
Absorption and MCD spectra of ferrous (FeII) heme in IsdH-NEAT domain
3 and IsdB-NEAT domain 2. (A) Spectra when Na2S2O4 is added to native IsdH-N3. (B)
Spectra when Na2S2O4 is added to native IsdB-N2. (C) Spectra when Na2S2O4 is added to native
IsdA (NEAT domain). (D) Spectra when Na2S2O4 is added to native IsdC (NEAT domain). (E)
Spectra when Na2S2O4 is added to native IsdE. The data for IsdA, IsdC and IsdE have been
previously published [9, 10] and are presented here to allow direct comparison of the differences
in spectral properties.
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Figure 4-6
Absorption and MCD spectra of ferrous (FeII) heme with the addition of CO
in IsdH-NEAT domain 3 and IsdB- NEAT domain 2. (A) Spectra when CO is added to native
IsdH-N3. (B) Spectra when CO is added to native IsdB-N2. (C) Spectra when CO is added to
native IsdA (NEAT domain). (D) Spectra when CO is added to native IsdC (NEAT domain).
(E) Spectra when CO is added to native IsdE. The data for IsdA, IsdC and IsdE have been
previously published [9, 10] and are presented here to allow direct comparison of the differences
in spectral properties.
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4.3.5 Conformation of IsdH-N3 crystal structure and protein conformation
change upon reduced (Fe(II)) heme binding
Figure 4-7 compares the structure of the protein reported of IsdH-N3 (pdb number 2Z6F)
[21], drawn using a ribbon for the protein backbone and showing the axial ligands of the heme
iron. The heme iron is coordinated by tyrosine 642 in the fifth position with no ligand in the
sixth position. In this native structure the heme is in a crevice with one surface exposed as
shown in Figure 4-7 [21]. This coordination geometry fits the observed MCD spectral data well,
resulting in a stable, high spin ferric heme. The image on the right hand side of Figure 4-7
shows the results of a calculation starting with the X-ray diffraction model using MM3
techniques in which the heme was rotated and bound axially to the nearest His (647) and Met
(565). The calculation was carried out as follows: 1) The ground state geometry of the complete
protein was calculated using MM3 methods with the ring bound to His647 and Met565; 2)
following structural optimization, the heme and the axial ligands were subject to ground state
structure optimization using ZINDO/1 methods. The structure shown is a composite of the MM3
optimization for the protein and ZINDO/1 optimization of the heme and its axial ligands.
Examination of the folds of the tertiary structure of the two images reveals very little change
suggesting that the ring could readily exchange axial ligands following reduction accounting for
the spectral changes described above.
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Figure 4-7
Structure of IsdH-N3 (pdb code 2Z6F). (Left) The structure as deposited in the
protein data base [21], which shows the coordination of the heme iron by Tyr642. (Right) The
structure calculated using MM3 and ZINDO/1 techniques showing the orientation of the heme
when coordinated to His647 and Met565.

4.4 Conclusion
ESI-MS data for the heme-free forms (apo) and the heme-bound forms (holo) showed that
both proteins, IsdH-N3 and IsdB-N2, remain in a folded state in the presence and absence of
heme in the heme binding pocket and that each only binds one heme, in a similar manner to the
other Isd proteins already characterized [8-10]. When denatured with acid, the heme dissociates
and the unfolded, denatured state is observed by ESI-MS. Both proteins can then be refolded to
a conformation that exhibits almost identical charge state properties as the folded apo-state. In
the case of IsdH-N3, upon refolding, the protein was able to rebind some free heme, still in
solution, showing that denaturation of the holo-protein is reversible.

These results are in

agreement with the current crystal structure of IsdH-N3, which indicate a tyrosine binding ligand
in the ferric heme state and presence of a methionine in the binding pocket [21]. The absorption
and MCD spectroscopy indicate that both IsdH-N3 and IsdB-N2 bind high-spin ferric hemes by
tyrosine. The heme binding pocket of IsdB-N2 is accessible to small anionic ligands such as
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cyanide while the heme binding pocket of IsdH-N3 is not nearly as accessible. The spectral data
recorded in the reduced state indicate that the axial ligand of the iron changes from tyrosine to
histidine and a methionine. This tri-ligand binding property of the two main heme scavenging
proteins in the Isd pathway of S. aureus makes it versatile in heme transfer selectivity and able to
bind heme regardless of the oxidation state. This becomes evident in our previous heme transfer
study showing that IsdH-N3 and IsdB-N2 can transfer heme to all of the Isd proteins in the
pathway while the other proteins are quite specific regarding which proteins can transfer heme
[7]. Finally, upon reduction of the heme, the heme binding pockets open up and CO axial
ligation is possible for both NEAT domains.
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Chapter 5.

Heme binding to the IsdE(M78A; H229A)

double mutant: Challenging unidirectional heme transfer
in the Iron Regulated Surface Determinant (Isd) protein
heme transfer pathway of Staphylococcus aureus4
5.1 Introduction
During infection, one pathway for Staphylococcus aureus (S. aureus) to scavenge iron is via
the iron-regulated surface determinant (Isd) protein system. This system extracts iron from heme
in hemoglobin following the lysing of red blood cells [1, 2]. The Isd system consists of nine
iron-regulated proteins: IsdA, IsdB, IsdC, and IsdH are cell-wall anchored surface proteins;
IsdDEF make up a membrane-localized ABC transporter; and finally, IsdG and IsdI encode
heme-degrading enzymes in the cytoplasm [3, 4]. This system has been proposed [5-7] and
shown [8] to pass heme through the gram-positive cell wall and cell membrane into the
cytoplasm where heme is deconstructed and free iron is released. These nine proteins mediate
the delivery of heme from the host’s plasma into the S. aureus cytoplasm [9].
Traditionally, it has been considered that heme transfer pathways are facilitated through an
association/dissociation mechanism. This means that heme transfer is intimately linked to the Kd
of heme dissociation or Ka (1/Kd) of heme binding and the transfer of heme can be understood
under highly predictable equilibrium conditions. However, the heme binding protein HasA
(Kd~10-11 M) and its receptor HasR (Kd~10-6 M), interact which allows heme to transfer from the
high-affinity protein to the lower-affinity protein [10]. In order for this to occur, there must be a
protein-protein driven mechanism rather than an affinity-driven mechanism. The heme transfer
is accomplished by shifts in the protein conformation and the spin state of the heme [10].
The Isd proteins of S. auerus, are a remarkable set of heme binding proteins because the
overall heme transfer reactions span at least four proteins. Previous studies have shown that
ferric heme transfer occurs in a unidirectional fashion and heme propagates down the pathway
through the following sequence (with the heme proximal amino acid residue shown) IsdB-NEAT
2 (Tyr)  IsdA-NEAT (Tyr)  IsdC-NEAT (Tyr)  IsdE (His) or alternatively, initiating from
4

A version of this work has been submitted:
Tiedemann M. T., Stillman M. J., J. Biol. Inorg. Chem., 2012, JBIC-12-02-00019.
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IsdH-N3, IsdH-N3 (Tyr)  IsdA-NEAT  IsdC-NEAT  IsdE. Significantly, IsdA does not
transfer heme directly to IsdE under any conditions [11-13]. Typically the Kd of these proteins
decrease along the chain of proteins, which means the heme binding becomes stronger. However,
since the experimental data shows that IsdA does not transfer heme directly to IsdE, it is clear
that the system does not function under an affinity mechanism. This unusual unidirectional
property must require highly specific protein-protein interactions [11], which are currently
unknown.
In terms of a mechanism for heme acquisition by the Isd system, previous work has shown
that IsdB and IsdH capture heme from Hb released from erythrocytes by hemolysins [2, 13].
IsdH binds haptoglobin (a serum glycoprotein that protects the host from free hemoglobin) and
the haptoglobin-hemoglobin complex [14, 15].

IsdA is proposed to function as a heme

scavenging protein and a “heme reservoir” for IsdH and IsdB [16, 17]. IsdC, which is located in
the cell wall, acts as the central conduit of heme transfer in the Isd system [9, 11, 18]. The
membrane bound complex IsdDEF pumps heme across the membrane [19-22]. Heme is finally
deconstructed by IsdG monooxygenase or its paralog, IsdI [3, 23]. The proteins IsdA, IsdB, IsdC
and IsdH each contain at least one Near Transporter (NEAT) domain that adopts a beta sandwich
structure to bind one ferric heme into a groove with heme-iron coordination via Tyr [1, 9, 11, 12,
16, 20, 22, 24, 25]. IsdE, a lipoprotein, binds heme into a shallow groove between two lobes of
the protein using His to coordinate to the ferric heme-iron [19, 21]. Current studies on the Isd
system in S. aureus are focusing on the structural aspects of the heme and heme analog binding
[26], mechanistic details in terms of heme transfer/binding [27], and the heme degradation
reaction [23]. However, none of these studies has yet addressed the question of how the heme
transfer is constrained to a unidirectional mechanism in the sequence from IsdA to IsdC to IsdE.
In this study, the origin of the unidirectional heme transfer was investigated by utilizing the
double mutant IsdE(M78A H229A) (IsdE(MH)). The double mutant effectively removes the
two possible heme binding ligands within the heme binding cleft. It is shown that the protein
structure of the double mutant is identical to that of native IsdE. As expected, knocking out the
heme iron-amino acid ligands does significantly reduce heme binding but heme-protein
associations through hydrophobicity and hydrogen bonding is not prevented, allowing heme
associates in the crevice of the protein. Electrospray ionization mass spectrometry (ESI-MS),
UV-visible absorption and magnetic circular dichroism (MCD) spectroscopy were used to probe
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the heme binding and heme transfer properties of the double mutant of IsdE. The data shows
that the amino acid ligands of the native IsdE protein also play a key role in the unidirectional
heme transfer. The mutation disables the unidirectional mechanism of heme transfer to IsdE and
imparts an affinity-like mechanism by heme transfer backwards up the chain from IsdE(MH) to
IsdC-N and also to IsdA-N.

5.2 Materials and Methods
General techniques and experimental procedures pertaining to protein growth, protein
purification, protein sample preparation, instrumental techniques and analysis can be found in
Chapter 2.

5.2.1 Mutation techniques
Mutations were performed by the Heinrichs' lab. Site-specific mutations were introduced into
the isdE gene using the QuikChange™ kit and procedure from Statagene, and confirmed by
sequencing. The mass of IsdE (MH) matched the theoretical mass of 30,173 Da.

5.2.2 Equilibrium studies
For the mutant protein heme affinity measurements, stoichiometric amounts of heme in 20
mM ammonium formate buffer at pH 10, was added to apo-IsdE (MH) at pH 7.4. Samples were
pH was adjusted to 7.4. ESI-mass spectral data were used to measure the relative proportions of
the apo- and the reconstituted holo-IsdE(MH). The heme affinity of the IsdE was measured
using a competitive reaction with apo-myoglobin. Myoglobin was made to >95% apo-form by a
modified Teale’s method [28]; the ratio of apo/holo was determined by mass spectrometry. 5
μM holo-IsdE was added to a solution 25 μM in apo-myoglobin. Heme transfer was monitored
by ESI-mass spectrometry over a period of one hour.

5.2.3 Computational methods
Calculations were performed with CAChe 6.1.12.33 (Fujitsu, America). All calculations were
carried out using the crystal structure of IsdE (Q6Q8). Using CAChe, M78 and H229 was
changed to A78 and A229, respectively. Geometry optimization using the MM3 basis was
performed to determine changes in protein conformation. All structural figures were created
using Pymol.
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5.3 Results
5.3.1 Structural Studies - native IsdE vs the mutant IsdE (MH)
ESI-mass spectral data were used to investigate the integrity of the mutant protein to see if it
maintained a native structure. IsdE is a bilobed protein where the two lobes form a heme binding
crevice [9]. This crevice is sensitive to the overall structure of the protein. Charge states in the
ESI-mass spectral data provide an indication of the volume of the protein or solvent access to the
basic amino acid residues [21, 29, 30]. A comparison of the ESI-MS charge state spectra of the
mutant IsdE(MH) and intact IsdE, Figure 5-1, reveal that the mutant IsdE(MH) and the native
IsdE essentially have an identical charge state distribution with a range from +13 to +10, +12
being the dominant peak for both proteins. Upon deconvolution the mass of the native and
mutant proteins match their theoretical masses of 30,300 and 30,173 Da, respectively. Based on
the similarity between the charged states of wild type and mutant proteins, it can be concluded
that the overall structure of the protein is preserved in the mutant.

Figure 5-1
Mass/charge and deconvoluted ESI-mass spectra of the heme-free IsdE
proteins (pH 7.4). A) Apo-IsdE and B) apo-IsdE(M78A; H229A) (IsdE(MH)), the mutant
species. The almost identical charge state distributions, with maxima at +12, shows that the
general structure and relative volumes of the two proteins are the same.
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5.3.2 Equilibrium Studies with native IsdE and the mutant IsdE (MH)
No heme transfer from holo-IsdE to apo-Mb - In order to obtain a quantitative comparison of
heme binding between the native IsdE and the mutant IsdE(MH) proteins, the heme binding
affinity was measured under equilibrium conditions. The ESI-MS technique can be used as a
quantitative technique with respect to the apo- and holo-protein pairs since both species have
similar ionization efficiencies in the mass spectrometer due to the lack of conformational
changes that take place upon heme binding [11]. First, in order to obtain a comparison, the heme
binding properties of the native IsdE were measured.

The Isd family of proteins are

characterized by exceptionally strong heme binding [13, 31]. In order to accommodate this
property, apo-myoglobin was used in conjunction with holo-IsdE to act as a competitor for heme
binding. An important feature of the ESI-MS method is that the relative concentrations of all
four species, namely, apo- and holo-myoglobin and apo- and holo-IsdE were determined
simultaneously. In Figure 5-2A, the ESI-mass charge state spectra reveals that no heme transfer
has taken place when 5 μM holo-IsdE is mixed with 5 equivalents of apo-myoglobin for 60
minutes, under equilibrium conditions. The dominant apo-myoglobin +7 to +10 charge states are
present with no corresponding holo pairs, which would be present at the mass/charge ratio for
holo-myoglobin. To support this claim, only the +13 to +10 charge states of holo-IsdE are
observed in the spectrum. Upon deconvolution, the only two species that are present after one
hour of the reaction are holo-IsdE at 30,916 Da and apo-myoglobin at 17,202 Da. Myoglobin
has a well-known Kd of 10-14 M [32]. Therefore, it would be reasonable to conclude that the Kd of
IsdE is less than 10-14 M. In that case, heme should transfer from IsdE to apo-myoglobin.
No heme transfer from holo-Mb to apo-IsdE - 5 μM holo-myoglobin was mixed with 5
equivalents of apo-IsdE for 60 minutes; this is the reverse of the experiment sequence shown in
Figure 5-2A. In Figure 5-2B, the ESI-mass charge state spectra reveal that no heme transfer has
taken place. Even after 60 minutes, only the holo-myoglobin (labeled HM) +7 and +8 charge
states are present with no corresponding apo pairs (labeled AM in Figure 5-2A). Only the +13 to
+11 charge states of apo-IsdE (labeled AE) are observed in the spectrum. No holo-IsdE (labeled
HE) charge state peaks are found. Upon deconvolution, only two species are present after one
hour of the reaction: apo-IsdE at 30,288 Da and holo-myoglobin at 17817 Da.
These apparently confusing results mean that there must be specific protein-protein release
factors that contribute to the heme transfer reactions involving IsdE.
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Figure 5-2
Charge state and deconvoluted ESI-mass spectra recorded during
equilibrium experiments with IsdE and myoglobin (pH 7.4). A) Results after incubation of 5
μM holo-myoglobin (HM) with 5 equivalents of apo-IsdE (AE) for one hour. ESI mass spectra
(charge states and deconvolution) for the mixture show the presence of only apo-IsdE and holomyoglobin. There is no indication of the presence of either holo-IsdE (HE) or apo-myoglobin
(AM) showing that no heme transfer or loss took place. B) Results after incubation of 5 μM
holo-IsdE with 5 equivalents of apo-myoglobin for one hour. ESI mass spectra (charge states and
deconvolution) for the mixture show the presence of only holo-IsdE and apo-myoglobin. There is
no indication of the presence of either apo-IsdE or holo-myoglobin showing that no heme
transfer or loss took place.
Determination of relative Kd for heme binding to IsdE(MH) - The Kd value for heme binding
was obtained for the mutant IsdE(MH). Since the heme binding efficiency in the mutant was
predicted to be low, it was possible to measure a direct equilibrium constant, Figure 5-3. 1.5
equivalents of heme were added to 3.0 μM apo-IsdE(MH) and under equilibrium conditions,
ESI-MS was used to measure the relative heme binding. The charge states range from +13 to
+11, the same as the parent apo-IsdE(MH) peaks, indicating that no major protein conformation
changes have taken place. A free heme peak is present at 616 Da. Upon deconvolution, only
two protein peaks are found, apo-IsdE(MH) at 30,174 Da (100% intensity) and holo-IsdE(MH)
at 30,789 Da (40% intensity). The 615 Da increase in mass compared to the apo-protein,
indicates heme binding. As there were no major protein conformation changes upon heme
binding, it can be assumed that the protein ionization efficiency for both the apo- and holo-
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IsdE(MH) are the same. Therefore, using the relative intensities of the deconvoluted mass
spectra multiplied by their relative concentrations, the Kd values can be calculated directly from
the deconvoluted mass spectrum with equation 1.
Kd =

[Heme][apo - IsdE(MH)] ([Heme 0 ]  [holo - IsdE(MH)])[apo - IsdE(MH)]

[holo - IsdE(MH)]
[holo - IsdE(MH)]

(1)

The resultant Kd for IsdE(MH) is 9.1x10-6 M.

Figure 5-3
Charge state and deconvoluted ESI-mass spectra recorded during an
equilibrium heme experiment with IsdE(MH) (pH 7.4) A) Results after incubation of 3 μM
apo-IsdE(MH) with 1.5 equivalents of heme. Free heme is present in the charge state spectra at
616 m/z with apo- and holo-IsdE(MH) peaks with charge states +13 to +11. From analysis of
the relative abundances in the deconvoluted spectra, it can be determined that the IsdE mutant
protein is about 25% holo. The Kd of heme binding was calculated to be 9.1x10-6 M.

5.3.3 Nature of Heme Binding within IsdE (MH)
The location of the single heme found with ESI-MS cannot be on the outside of the protein. If
this were the case, previous ESI-MS studies on IsdE would also show this result, indicating that
IsdE would “bind” two hemes.

Seeing as the mutations do not affect the overall protein

conformation, the heme bound in holo-IsdE(MH) must be located in the heme crevice of the
protein.
The optical spectra of heme proteins have been used to determine axial ligation of the heme in
many proteins. In order to investigate the nature of heme binding in the protein crevice of
IsdE(MH), UV-visible absorption and MCD spectroscopy were measured for solutions of holoIsdE(MH) and free heme. The MCD and absorption spectra for free ferric heme in buffer
(Figure 5-4, dotted line) match those that have been previously reported [33]. The MCD bands
are a fingerprint for a high-spin ferric heme [34]. The addition of one equivalent of free heme to
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apo-IsdE(MH) results in a shift in both the absorption and MCD spectra as seen in Figure 5-4. In
the absorption spectrum (Figure 5-4A, full line), the B band broadens and red shifts from 393 to
397 nm. The shoulder to the blue of the B band peak is maintained. The broad Q band at 605
nm red-shifts to 610 nm. The MCD spectrum (Figure 5-4B, full line), is very sensitive to the
heme environment and the spectral pattern changes significantly when the heme binds to the
mutant. The magnitude of the B band region diminishes and the Q band magnitude increases so
that the B and Q band envelopes are of about the same intensity. This is an indication of a highspin complex, which contrasts the lower spin reported previously for the heme-bound to the
native IsdE [11, 20, 21]. Overall, the MCD spectra of the free heme and the heme bound to
IsdE(MH) indicate that the spin-state of the iron-heme changes only slightly when bound to the
mutant protein. This differs to the dramatic spectral changes when bound by the His amino acid
ligand in native IsdE [21].
The MCD spectrum in particular has been used successfully in the determination of the axial
ligands binding the heme in many proteins. The major difference in the MCD spectrum of free
heme compared with holo-IsdE(MH) is that the trough at 542 nm and the peak at 473 nm reverse
in sign and there exists shifts in the bands from 360 to 366 nm, 395 to 400 nm and 416 to 422
nm. The sign of the MCD visible region envelope in the spectra of ferric hemes arises from the
superposition of several transitions of similar magnitude but of the opposite sign. Minor changes
in energies due to increases or decreases in spin can result in significantly different spectra.
Therefore, the overall changes in the heme spectra indicate that the heme environment has
changed when it is bound to apo-IsdE(MH). However, the MCD spectrum, is not characteristic
of other heme binding proteins [12, 16, 21]. Consequently, we conclude that the heme is not
directly bound by a normal amino acid residue in the protein but rather, it must be bound by -
interactions with the heme ring, or hydrogen bonding with the heme carboxylic acid residues.
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Figure 5-4
A) Absorption and B) MCD spectra recorded for free heme and heme bound
to the mutant IsdE(MH) (pH 7.4)
Computational model - These results are supported by computational models. The crystal
structure of IsdE (pdb: Q6Q8) [19] was used as a starting point for structure optimization and
subsequently used as a model for the mutant IsdE(MH). A MM3 geometry optimization was
carried out and the resultant structure was compared with the crystal structure to ensure there
were no changes, Figure 5-5A. It can be seen for the calculation of the native IsdE that the MM3
optimized structure (green) is the same as the crystal structure (pink). The heme binding ligands
in IsdE, M78 and H229, were then changed to A78 and A229, respectively. Another geometry
optimization using MM3 forcefields was performed to view how the overall protein
conformation and heme locations would change without heme binding ligands locking the heme
into the heme crevice. As shown in Figure 5-5B, the heme in IsdE(MH) (red) is still located in
the crevice. In order to approximate the interactions that keep the heme in the pocket, all
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hydrophobic residues are colored orange, Figure 5-6. There are some potential hydrophobic
interactions and π-π bonding orbital interactions with the heme ring. Furthermore, the buried
carboxylic acid chain of heme is hydrogen bonded to the NH backbone of the protein from Val41
and the exposed carboxylic acid tail is hydrogen bonded with Lys62 [19].

Figure 5-5
Computational model of IsdE and IsdE(MH) A) MM3 optimization (green) in
comparison with the crystal structure of IsdE (pdb Q6Q8) (pink). Overall, no change in
conformation is observed. B) MM3 optimization of IsdE(MH) (red) overlayed with the MM3
optimization of IsdE (green). There is no significant change in the heme location and protein
conformation. Therefore, IsdE(MH) is still able to bind heme in the heme binding crevice
without amino acid-heme-iron direct contact interactions.
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Figure 5-6
Calculation of IsdE(MH) with space filling atoms. The hydrophobic residues
are colored orange to show potential interaction with the heme ring either through
hydrophobicity or π-π interactions.

5.3.4 Heme Transfer from IsdC-N to IsdE(MH)
Figure 5-7 shows the UV-visible absorption, MCD spectra, and the ESI-MS charge state
and deconvoluted spectrum recorded when 1.5 equivalents of apo-IsdE(MH) was added to holoIsdC-N. It is clear that there are no shifts in the UV-visible absorption B band spectrum at 403
nm or in the Q band region at 490, 530, and 625 nm.

The MCD spectrum shows the

characteristic holo-IsdC-N peaks at (+) 610 nm, (+) 527 nm, (+) 483 nm, (+) 408 nm, and
troughs at (-) 643 nm, (-) 550 nm, (-) 424 nm, (-) 390 nm. The lack of any changes in the optical
spectra means that there are no ligand field effects or major heme environment changes when
heme is bound to IsdC-N and heme transfer is initiated by addition of IsdE(MH). The lack of
spectral changes suggests that no heme transfer or loss from holo-IsdC-N has taken place.
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These observations are confirmed by the ESI-MS data, Figure 5-7C and Figure 5-7D. The
charge state spectrum shows the previously reported +7 to +9 charge states for apo-IsdC-N and
+13 to +10 for apo-IsdE(MH). However, under equilibrium conditions there is a new charge
state (+14) for apo-IsdE(MH) while reacting with holo-IsdC-N. This suggests that the mutant
apo-IsdE(MH) adopts a slightly more open conformation than the native apo-IsdE protein. The
deconvoluted spectrum only shows two species, the holo-IsdC-N at 15,056 Da and the apoIsdE(MH) at 30,173 Da.

Figure 5-7
Absorption (A) and MCD (B) spectra recorded when heme-bound, native
holo-IsdC-N was added to a solution of heme-free, apo-IsdE(MH) (pH 7.4). The two
absorption spectra are almost superimposed. There is little change in the absorption and MCD
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spectrum indicating no heme transfer between the two proteins. Mass spectral data, charge states
(C) and deconvoluted (D) clearly show that no heme transfer took place and that the solution
after mixing contains only holo-IsdC-N and apo-IsdE(MH).

5.3.5 The Loss of Forward Unidirectional Heme Transfer
A significant feature of the Isd pathway in S. aureus is the highly selective nature of heme
transfer. Not only is heme transfer completely unidirectional from IsdAIsdC and IsdCIsdE,
but there is no heme transfer from IsdAIsdE [11]. Clearly, these highly specific reactions
require protein-protein interactions. Holo-IsdE(MH) was used to challenge the irreversibility of
heme transfer in the Isd system. The reverse heme transfer reactions (IsdE(MH)IsdA,
IsdE(MH)IsdC and IsdE(MH)IsdE) were tested in order to investigate the importance of the
IsdA, IsdC, and IsdE heme binding ligands in establishing this phenomena. Reaction of holoIsdE(MH) with either apo-IsdA-N or apo-IsdC-N or apo-IsdE yielded the same results under
equilibrium conditions: the heme from IsdE(MH) transferred to each of IsdA-N, IsdC-N and
IsdE.
Heme transfer from holo-IsdE(MH) to apo-IsdA-NEAT - The data in Figure 5-8A show the
results of mixing 3 μM holo-IsdE(MH) with 5 μM apo-IsdA-NEAT, followed by incubation for
30 minutes. In the absorption spectrum, the B band shifts from 398 nm to 404 nm, which is
typical when heme is bound to a tyrosine, as in IsdA-N. In the Q band region, a band at 627 nm
appears. Further support for complete transfer of the heme to IsdA-N from the mutant IsdE is
observed in the ESI mass spectral data, Figure 5-8. Under equilibrium conditions, the charge
state spectra contain a mix of holo-IsdA-N (+8, +7), apo-IsdA-N (+8 to +6) and apo-IsdE(MH)
(+13 to +11). Upon deconvolution it becomes apparent that the IsdE(MH), with mass 30,173
Da, contains no heme. There are now two IsdA-N peaks, one for apo-IsdA-N, at 14,632 Da and
the second for holo-IsdA-N at 15,248 Da.
Heme transfer from holo-IsdE(MH) to apo-IsdC-NEAT - The data show the same result when a
3 μM holo-IsdE(MH) is incubated with 5 μM apo-IsdC-NEAT. The B band shifts from 398 nm
to 402 nm. The appearance of the 627 nm band is a good indication of heme transfer to the heme
binding tyrosine in IsdC-N Once again the charge state spectra only contain three species, the
apo-IsdC-N (+9 to +7), the holo-IsdC-N (+9 to +7) and the apo-IsdE(MH) (+13 to +11). Upon
deconvolution, only three protein species are present, the apo-IsdC-N, at 14,447 Da, the holo-
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IsdC-N, at 15,063 Da and the apo-IsdE(MH) at 30,173 Da. The data show that all the heme had
transferred from the mutant IsdE to the IsdC-N.
Heme transfer from holo-IsdE(MH) to apo-IsdE - The same result is found when 3 μM holoIsdE(MH) is incubated with 5 μM apo-IsdE. Heme transfer to the native IsdE is signaled by the
appearance of the strong 415 nm B band, which is characteristic of heme binding to the native
IsdE due to histidine binding to the iron. The ESI mass spectral data again provide excellent
conformation that all the heme transfers to the native IsdE. Figure 5-8C shows that only apoIsdE (+13 to +11) and holo-IsdE (+13 to +11) and apo-IsdE(MH) (+13 to +11) are present in the
charge state spectrum. This is confirmed by deconvolution, with only three species present in
the deconvoluted spectra, the apo-IsdE at 30,300 Da, the holo-IsdE at 30,916 Da and the apoIsdE(MH) at 30,173 Da. In each of these three cases, there is no heme bound to the mutant
IsdE(MH). It is important to note that no major changes in the charge state distribution between
the apo- and holo-species for either IsdA-N, IsdC-N, IsdE or IsdE(MH) were observed.

Figure 5-8
Absorption and mass spectral data for a mixture of holo-IsdE(MH) with 1.5x
excess apo-IsdA-NEAT (A), apo-IsdC-NEAT (B) and apo-IsdE (C) (pH 7.4). (A) The
absorption bands shift from a free-heme like spectra (Soret band centered at 398 nm) to a
spectrum characteristic of holo-IsdA-NEAT (Soret band at 404 nm) indicating heme transfer.
From the charge state and deconvoluted mass spectral data, three species are seen to be present
in solution, apo-IsdA-NEAT (14,632 Da), holo-IsdA-NEAT (15248 Da) and apo-IsdE(MH)
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(30173 Da). (B) The absorption bands shift from a free-heme like spectra (Soret band centered
at 398 nm) to a spectrum characteristic of holo-IsdC-NEAT (Soret band at to 402 nm) indicating
heme transfer. The charge state and deconvoluted mass spectral data show that there are three
species present in solution: apo-IsdC-NEAT (14,447 Da), holo-IsdC-NEAT (15,063 Da) and
apo-IsdE(MH) (30,173 Da). (C) The absorption spectrum changes from a free-heme like spectra
(Soret band centered at 398 nm) to a spectrum characteristic of holo-IsdE (Soret band 415 nm)
indicating heme transfer. The charge state and deconvoluted mass spectral data show that there
are three species present in solution: apo-IsdE (30,300 Da), holo-IsdA-NEAT (30,916 Da) and
apo-IsdE(MH) (30,173 Da).

5.4 Discussion
Typically, many heme transfer systems are thought to be affinity driven, where a
dissociative/associative mechanism drives heme transfer. However, in some species, proteinprotein interactions are used to circumvent heme affinity differences and to ensure heme transfer
from high-affinity proteins to lower-affinity proteins [10, 35] especially with transfer from one
protein with high ligand affinity, the “donor,” to another with lower ligand affinity. The Isd
system in S. aureus is also driven by protein-protein interactions and may be unique in that all of
the heme transfer reactions studied in detail to date occur unidirectionally over a three-protein
chain. Heme transfer in the Isd system cannot be dominated by a binding affinity mechanism.
As shown in previous work on Isd proteins, protein-protein interactions drive heme transfer
forward and down the protein chain (IsdA to IsdC to IsdE) [11]. Two significant properties are
that heme cannot be transferred from IsdA to IsdE, skipping the IsdC intermediary, and heme
cannot be transferred back from IsdE to IsdA. Clearly, if this system was under
association/dissociation control, this reaction would take place resulting in equilibrium with
measureable components. In the data reported in this study, a preliminary exploration of the
molecular properties that control the protein-protein interactions in the Isd heme transfer system
by changing the heme binding residues were investigated. It is important to note that this is a
starting point for more selective mutations that can be carried out on this system to further
explore the unidirectional protein-protein interaction driven system.
Figure 5-9 shows a summary of the data found in this work and a comparison of past results.
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Figure 5-9
Summary of heme transfer mechanism for the native Isd proteins: IsdA, IsdC
and IsdE (left) and the new results for the mutant IsdE(MH) (right) showing changes in heme
transfer properties.

5.4.1 Conformation of the integrity of the IsdE double-mutant: the mutant is
not denatured
IsdE is a bilobed protein, therefore, maintenance of structural protein integrity is important for
comparisons of the mutant IsdE to be compared to native IsdE. The charge state distribution of
proteins can be associated with the size (volume) of the protein, which can be related to the
number of protonation sites. Furthermore, charge states from the ESI mass spectra very clearly
distinguish between folded and unfolded or denatured proteins. Denaturation would dramatically
change the heme binding properties and heme transfer properties of the IsdE protein. Denatured
proteins show a high charge state value and also a large number of charge states, which typically
results in a shift of charge state maxima to a lower mass to charge ratio, while a folded protein
generally has fewer charge states and a prominent charge state value much lower than that of the
unfolded protein [16, 21, 22]. The apo-IsdE and apo-IsdE(MH) proteins, Figure 5-1, exhibit the
same charge states (+13 to +10) and charge state distribution of relative abundances are almost
exactly the same. It can be concluded that altering the heme binding ligands inside the heme
crevice did not affect the overall shape or folding of the protein of the mutant IsdE compared
with the native IsdE. Hence, it may be proposed that the heme binding and heme transfer
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properties of IsdE(MH) are entirely dependent on the available amino acids in the binding site
with no contribution from changes in the structure of the protein.

5.4.2 Heme binding and affinity of IsdE(MH) compared with native IsdE
The equilibrium reaction studies show expected results where IsdE(MH) binds heme weaker
than native IsdE, Figure 5-2 and Figure 5-3. Significantly, native IsdE does not bind heme from
the dissociation of heme from myoglobin and myoglobin does not bind heme from the
dissociation of heme from native IsdE. This result was not expected. This is specific evidence
of the unique nature of IsdE in that protein-protein interactions are required to release heme. The
mutant protein has a Kd = 9.1x10-6 which is much higher than the other Isd proteins, indicating
weak heme binding. Key to the heme binding and heme binding efficiency as expected, are the
amino acid ligands of the ferric iron-heme. The Kd values for each Isd protein currently known
are summarized in Table 5-1. The heme binding efficiency for the Isd proteins increases while
moving down the heme transfer pathway. However, IsdE(MH) has a lower heme affinity than
that of IsdA.
Table 5-3: Summary of heme dissociation constants (Kd) for the Isd system
Protein

Heme Dissociation Constant
(Kd /M)

Reference

Myoglobin

1x10-14

[32]

IsdA

2.6x10-12

[31]

IsdC

2.6x10-13

[31]

IsdE

Undetectable

This work, [13]

IsdE(M78 AH229A)

9.1x10-6 + 0.9x10-6

This work

MCD spectroscopy was used to further investigate the location of the heme bound to the
mutant IsdE. The MCD spectrum is sensitive to changes in the heme environment, not just
through the specific donor atom of the amino acid binding to the heme but also through the heme
binding site structure.

Following addition of heme to IsdE(MH), there was a change in the

MCD spectrum, however this change was not as significant as for heme binding to the native
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IsdE where there are specific heme-amino acid binding ligand interactions [21]. Slight shifts in
the B band region in the MCD spectrum result in a spectrum that does not resemble known
spectra with ligation by donor atoms typically found binding ferric heme, such as tyrosine (with
donor atom O), glutamic acid (O), histidine (N) or cysteine (S). However, while there are little
changes in the B region, the MCD spectrum of the Q band region following heme binding to the
mutant IsdE changes significantly as the troughs and peaks at 450 nm to 550 nm are inverted in
sign. As this region is normally dominated by charge transfer between the ring and the Fe 3+,
clearly the donor atoms of the proximal and distal residues play an important role. The lack of
these residues in the double mutant results in a spectrum reflecting more the porphyrins Q band
-* nature and the effect of the electrostatic properties of the binding site. The changes in the
heme spectra must arise because the heme is bound in the normal protein crevice. Further
support that the heme can be bound even if loosely within the heme crevice comes from
computational experiments. The MM3 geometry optimization calculations of IsdE(MH), Figure
5-5, show that the overall protein conformation does not change when the heme is bound.
Overall, the ESI-MS and MCD data indicate that the heme is still in the crevice of protein and
the computational modeling shows that other interactions besides the specific amino acid ligandheme interactions, although weak, result in heme binding.

5.4.3 Challenging unidirectional heme transfer
The absence of heme binding ligands in IsdE(MH) is not only influential to the reduced heme
binding affinity, but also critical in allowing forward unidirectional heme transfer to take place.
The heme binding ligands must in some manner be involved in the (IsdC-N)(IsdE) proteinprotein interactions that allow for heme transfer to take place in the native proteins.
The key mechanistic information reported in this paper can be summarized as follows in
comparison to the mechanistic details known for the native proteins. Holo-IsdA-N does not
transfer heme directly to IsdE and IsdE does not transfer heme to apo-IsdA-N. From both a
protein-protein interaction point of view and an affinity based point of view, this means that
there is a significant and highly unusual gate that restricts the heme transfer process. This study
was aimed to begin to identify the controls of that gate. It was shown that holo-IsdE(MH) will
transfer to apo-IsdA-N. In this case, heme was transferred backwards to the IsdA-N protein
completely and irreversibly. This transfer is now under equilibrium control since the Kd of heme

106
binding for IsdE(MH) (~10-6) is significantly higher than that of IsdA-N (~10-12). Since heme
transfer now takes place to all members of the Isd chain, it becomes apparent that the proximal
and distal heme binding amino acid ligands in IsdE must control the gate and restrict the heme
transfer direction.

The mutations in IsdE(MH) eliminate the protein-protein interactions,

unlocking the gate and allows the system to drive forward under affinity control. The system
now works with an association/dissociation mechanism and heme transfer can now be accounted
for using the relative Kd’s of heme binding.

5.5 Conclusions
Heme transfer from protein to protein down the chain of proteins in the Isd system must be
governed by a gate triggered by key protein-protein interactions. From this study, it is proposed
that the gate residues are in the heme crevice that binds the heme in place and prevents loss due
to dissociation. The heme affinities alone cannot explain the unidirectional heme transfer results
from previous studies. The data show that only apo-IsdE can unlock holo-IsdC-N and only apoIsdC-N can unlock holo-IsdA-N. Apo-IsdE cannot unlock the heme in holo-IsdA-N. Therefore,
the Isd heme transfer system makes use of specific protein-protein interactions that are the key to
the observed complete absence of reversal of the heme transfer reactions.
The important transfer reaction from the central conduit of the Isd system, IsdC-N to
IsdE(MH) does not occur from holo-IsdC-NEAT to apo-IsdE(MH) meaning that important heme
releasing triggers do not exist with IsdE(MH), effectively neutralizing important protein-protein
interactions. Without the heme binding ligands the mutant IsdE now acts under affinity control
transferring heme to apo-IsdA-N, apo-IsdC-N, and apo-IsdE.
In summary, the heme binding ligands in IsdE, the histidine, and methionine are essential
elements in the reaction mechanism that drives the protein-protein interactions of heme transfer
with regards to the unidirectional nature of the Isd system. Not only do the heme binding ligands
play crucial roles in decreasing Kd values, from IsdA to IsdC and IsdE, but these ligands also
dictate the selectivity and unidirectionality of the system.

Finally, key protein-protein

interactions and protein ligand-heme interactions must exist in order to facilitate selective
transfer.
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Chapter 6.

The multi-protein heme shuttle pathway in

Staphylococcus aureus: Isd cog-wheel kinetics5
6.1 Introduction
Iron is an essential nutrient to all forms of life being critical for a range of functions including
oxygen transport and energy metabolism. However, free ferric (Fe3+) iron is almost insoluble in
aerobic systems with an estimated concentration of approximately 10-18 M [1, 2]. Under normal
biological conditions iron is sequestered in ferritin, transferrin, and heme proteins in mammals.
As a result, bacteria have developed multiple iron acquisition systems to facilitate their survival
[3-6]. A readily accessible, and the most abundant iron source for bacteria in mammals, is ironprotoporphyrin IX (heme), which is typically bound in proteins such as hemoglobin and
myoglobin. Bacteria can extract heme from hemoglobin and myoglobin using protein-based
extraction pathways that generally isolate and subsequently bind the heme to the amino acid
ligands His and Tyr [7-9]. The heme is then transferred through the bacterial cell wall via a
series of heme binding proteins and finally to an ABC heme transporter to cross the membrane
into the cytoplasm where the iron is then extracted from the protoporphyrin IX with heme
degrading proteins. Examples of bacterial heme acquisition systems include the phu system in
Pseudomonas aeruginosa, the has system in Serratia marcescens, and the shu system in Shigella
dysenteriae [9]. The isd system in Staphylococcus aureus also carries out this function and is
the heme scavenging protein system that is the focus of this present study [9].
Antibiotic-resistant bacterial infections by S. aureus cause a range of infections and diseases,
most significantly life-threatening pneumonia, meningitis, endocarditis, and septicemia [10, 11].
The iron-regulated surface determinant (Isd) protein system extracts iron from heme in
hemoglobin and myoglobin [12, 13]. The isd gene cluster was first identified in 2002 [14-16]
and in 2003 Mazmanian et al. [17] proposed that the Isd series of proteins act as a heme transfer
pathway across the cell wall and through the membrane of the Gram positive S. aureus. In S.
aureus the Isd system consists of nine iron-regulated proteins: IsdA, IsdB, IsdC, and IsdH, which
are cell-wall anchored surface proteins, and IsdEF, which constitute a substrate binding protein

5
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and cognate membrane-localized ABC transporter and, finally, IsdG and IsdI, which are hemedegrading enzymes in the cytoplasm [18-20].
Considerable research has provided the structures and some mechanistic details of the Isdmediated heme acquisition systems in S. aureus. A number of individual reactions of the Isd
protein system have been reported including the binding of hemoglobin by IsdB [13, 21], the
IsdH-dependent binding of haptoglobin and haptoglobin-hemoglobin [22, 23], and heme binding
by IsdA, IsdB, IsdC, IsdE, and IsdH [8, 24-27]. The proteins IsdA, IsdB, IsdC and IsdH each
contain at least one Near Transporter (NEAT) domain that adopts a beta sandwich structure to
bind one ferric heme into a groove with heme-iron coordination via Tyr [28, 29]. IsdE, a
lipoprotein and member of the class III substrate binding proteins, binds heme into a shallow
groove between two / lobes of the protein, using His and Met to coordinate to the ferric-hemeiron [30].
Key to the proposal for the role of the Isd series of proteins in iron acquisition in S. aureus, is
that heme passes from protein to protein in such a manner as to move spatially through first the
~90 nm thick bacterial wall and then through the bacterial membrane into the cytoplasm.
Experimental evidence for the trans-wall and trans-membrane sections of the mechanism for this
channeling process have not been reported to date. Techniques previously used to study the Isd
system include UV-visible absorption spectroscopy (heme transfer from IsdA to IsdC),
crystallography for protein structure and heme binding ligands, magnetic circular dichroism
(MCD) spectral data to elucidate ligand binding to heme, and ESI-MS to elucidate the heme
transfer pathway. Individual heme transfer reactions have been predominantly studied by UVvisible spectroscopy where the heme transfer kinetics between pairs of proteins has been
analyzed by stopped flow spectroscopy [13, 21, 27, 31, 32]. However, a major difficulty arises
when using UV-visible spectroscopy to monitor heme binding when the amino acid residues
binding the iron of the heme in both the donor and receiver proteins are similar or the same,
which is the case for several proteins within the Isd system. This results in very similar optical
spectra leading to very small ΔA changes in the spectra during heme transfer. However, mass
spectral data overcome the UV-visible absorption limitations by readily distinguishing the hemefree apo-proteins from heme-free denatured apo-proteins and from the native heme-bound holoproteins. In previous work, it was shown that ferric heme transfer occurs in a unidirectional
fashion down the pathway of the series of Isd proteins, where we indicate the proximal amino
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acid residue in parenthesis, IsdB (Tyr) IsdA (Tyr)  IsdC (Tyr)  IsdE (His) or,
alternatively, initiating from IsdH, IsdH (Tyr)  IsdA  IsdC  IsdE. Finally it was shown
that heme transfer through the cell wall must occur via IsdC indicating that IsdC acts as the
central conduit of the Isd system [32].
Here, the first real-time measurement of heme transfer between the three key proteins in the
Isd system involved in the trans-wall channeling are reported. By exploiting the unidirectional
nature of the Isd system (that is heme transfer only takes place from IsdA  IsdC  IsdE) and
by using limiting concentrations of IsdC, we have explored the real-time heme transfer kinetics
across these three proteins by ESI-MS. Time-resolved mass spectral data provide firm evidence
for a sequential, multi-protein, heme transfer system. Determining the reaction rates from kinetic
measurements for heme transfer between these three Isd proteins provides new information that
directly addresses the hypothesis that the proteins function in concert as a heme shuttle system in
the Gram-positive bacteria cell wall.

6.2 Experimental Methods
6.2.1 Materials and Methods
Experimental procedures have previously been reported; please refer to Chapter 2 for further
protein growth, protein purification, ESI-MS and MCD spectroscopy preparatory and running
procedures.

6.2.2 ESI-MS measurements
ESI-MS sample preparation can be found in previous work [32]. A Bruker micrOTOF II ESITOF mass spectrometer (Bruker, Canada) operated in the positive ion mode was used for all ESIMS measurements. Samples were infused into the spectrometer at a rate of 600 μL h−1 using a
microliter infusion pump. The instrument was calibrated with an external CsI standard solution.
Data were processed using the Bruker DataAnalysis 4.0. Parameters: sample range = 500-4000
m/z; rolling average = 2 × 0.5 Hz; end plate offset = -500 V; nebulizer = 2.0 Bar; dry gas temp =
293 K; flow rate = 8.0 L/min; capillary voltage = 4200 V; capillary exit = 180 V; skimmer 1 = 22
; hexapole = 22.50 V; hexapole rf = 600 V. The complete kinetic run was measured from a
single mixture.
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6.2.3 Heme transfer reactions
To monitor heme transfer between the two NEAT domains (IsdA-N and IsdC-N) and IsdE,
apo-IsdC-N (for MCD) or holo-IsdC-N (for ESI-MS) was added to a mixture of holo-IsdA-N and
apo-IsdE. Previous reports have shown that there is no heme transfer between holo-IsdA-N and
apo-IsdE and that no free heme can be detected so that this mixture is stable [32]. Following
mixing of the holo-IsdA-N and the apo-IsdE, apo-IsdC-N was added. The solution was rapidly
mixed and then immediately infused into the mass spectrometer.

Data were measured

continuously for up to 30 minutes; however, only the first 20 minutes of data are shown. The
protein concentrations were deduced from the normalized relative abundances summed from the
charge states of the apo/holo pairs of the respective proteins at each time interval. The samples
were held at a thermostatted temperature of 15 ˚C during infusion for ESI-MS measurements.
Each transfer reaction is an average of three separate runs.

6.2.4 Kinetic Analysis
The concentration data for each species (holo-IsdA-N, apo-IsdA-N, holo-IsdC-N, apo-IsdC-N,
holo-IsdE, and apo-IsdE) at each time interval for the complete kinetic reaction were analyzed
using the program Copassi [33]. The reaction scheme used is described below in results section.
Errors were calculated using the standard deviation for each k calculated from the fit.

6.2.5 MCD spectral measurements
MCD spectra were measured using an SM2 5.5 T superconducting magnet (Oxford, UK)
attached to a J-810 CD spectrometer (Jasco Inc., Japan) with a range of 500-350 nm at 2 nm
steps with a 1 sec response time and no delay between scans. A To spectra was measured with a
solution containing holo-IsdA-N and apo-IsdE with the absence of apo-IsdC-N (No heme
transfer). Spectra were then measured continuously for 40 minutes. A T∞ spectra was taken 90
minutes after the kinetic run.

6.2.6 UV-visible absorption spectral measurements
Continuous UV-visible absorption scans were measured on a Cary50 Bio spectrometer
(Varian, USA) using the Scanning Kinetics Application with a range of 200-700 nm at a scan
rate of 4800 nm.min-1 with two cycles (0.2 min delay between scans for 3 minutes and 1.0 min
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delay between scans for 50 minutes). Apo-IsdC-NEAT was denatured by adding SDS (2% by
m/v) and then boiling the protein for 30 minutes.

6.3 Results
6.3.1 Problems with species identification with MCD spectroscopy
MCD spectroscopy has been shown to be a powerful technique not only in ligand
identification of the Isd heme binding proteins but also tracking heme transfer [26, 32, 34, 35].
A solution of 6 µM holo-IsdA-N, 0.6 μM apo-IsdC-N and 9 μM IsdE was studied with
continuous scanning MCD spectroscopy, Figure 6-1.

As shown previously, holo-IsdA-N

possesses a much different MCD spectral trace than holo-IsdE due to a switch in amino acid
binding ligands, Tyr (IsdA-N) to His (IsdE) and the heme spin shift from high to low spin [32,
34, 35]. This is shown by a large increase in the B band MCD signal at 408 nm (+) and 423 nm
(-) in the MCD spectrum. Due to the substoichiometric amount of apo-IsdC-N present in
solution and the significant overlap of the spectral envelops of holo-IsdA-N and holo-IsdE
species in solution, it was not possible to track the concentration of holo-IsdC-N and very
difficult to track the concentration holo-IsdA-N in solution by MCD spectroscopy. Therefore, in
order to track all species in solution and create an accurate kinetic map of the reaction, ESI-MS
was used to solve the problem.
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Figure 6-1
MCD spectra of the reaction between holo-IsdA-N, stoichiometricallylimiting apo-IsdC-N and apo-IsdE. Spectral changes are observed for the heme transfer from
IsdA-N to IsdE through IsdC-N. The large difference between the MCD spectra of holo-IsdA-N
and holo-IsdE is due to a heme binding ligand switch from Tyr (IsdA-N) to His (IsdE). A large
increase in B band intensity at 423 nm (-) and 408 nm (+) can be observed throughout the
reaction.

6.3.2 ESI-MS data show real-time transfer of heme from IsdA-N to isdC-N
and then to IsdE
The ESI-MS technique is able to identify all of the six protein species involved in the heme
transfer reaction which include heme-bound, holo-IsdA-N, holo-IsdC-N and holo-IsdE. ESI-MS
can also measure spectroscopically silent apo-IsdA-N, apo-IsdC-N and apo-IsdE. The mass
spectral data were obtained from a single mixed solution.
From previous work, it was shown that apo-IsdC-N efficiently removes heme from holoIsdA-N, and then transfers heme to apo-IsdE [21, 32]. Apo-IsdE does not remove heme from
holo-IsdA-N. Each NEAT domain contains a distinct amino acid composition, and therefore, a
distinct mass. Hence, a similar reaction to the MCD experiment was performed using timeresolved ESI-MS, Figure 6-2, with Isd species concentration of 6 µM holo-IsdA-N, 0.45 μM
holo-IsdC-N and 12 μM IsdE. Holo-IsdC-N was used because using ESI-MS the first measured
point was approximately 0.5 minutes. Therefore, by starting with holo-IsdC-N, the first filling
step of apo-IsdC-N is skipped and the kinetic map is more accurate. With these concentrations
the stoichiometric ratio of IsdA-N:IsdC-N:IsdE was approximately 1:0.075:2 meaning that IsdC-
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N must turnover approximately 13 times to complete the reaction and transfer all heme to apoIsdE thereby imparting the role of heme shuttle onto IsdC-N.
Over the course of time the charge state data reveal all six possible species in solution. IsdANEAT (AA), apo-IsdC-NEAT (AC), and apo–IsdE (AE) species and the heme-bound, holoIsdA-NEAT (HA), holo-IsdC-NEAT (HC), and holo–IsdE (HE) species. +8 and +7 charge
states were observed for IsdA-N, +9 and +8 for IsdC-N and +13 to +11 for IsdE. Early in the
reaction (0.5 min), the formation of holo-IsdE is detected. Only holo-IsdC-N and no apo-IsdC-N
is detected indicating that the filling of IsdC-N from IsdC-N is faster than transfer to IsdE.
Progressing through the reaction the disappearance of holo-IsdA-N is observed with the
appearance of apo-IsdA-N charge states. By the 10 minute mark, only apo-IsdA-N peaks are
observed with no holo-IsdA-N charge state peaks. After 20 minutes, some holo-IsdC-N peaks
are left, only apo-IsdA-N is observed. IsdE is approximately 50% holo which corresponds
stoichiometrically to the predicted stiochiometry of the reaction.
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Figure 6-2
Mass spectral data recorded during heme transfer from IsdA-N to IsdE via
IsdC-N. ESI-MS charge state at nine time intervals (0.5, 1.0, 2.0, 3.0, 5.0, 7.5, 10, 15 and 20
min) for the heme-free, apo-IsdA-NEAT (AA), apo-IsdC-NEAT (AC), and apo–IsdE (AE)
species and the heme-bound, holo-IsdA-NEAT (HA), holo-IsdC-NEAT (HC), and holo–IsdE
(HE) species. +8 and +7 charge states were observed for IsdA-N, +9 and +8 for IsdC-N and +13
to +11 for IsdE. At the start of the reaction the concentrations were: HA= 6.0 μM, AC = 0.45
μM, and AE = 12 μM. The temperature was 15 oC.

6.3.3 Determination of the reaction mechanism and the rates of reaction
To determine the mechanism of the reaction and the associated reaction rates, multifunctional
analysis [33] was carried out. Quantification of charge state data requires that both apo- and
holo-Isd proteins have a similar charge state distribution and, therefore, by measuring the
intensity of the apo- and holo- peaks relative to each other, it is possible to calculate
concentrations [32, 36]. For this analysis, all data points were fitted with a set of sequential
bimolecular reaction equations. The changes in the concentrations of each of the six species as a
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function of time are best seen in the three summary plots, Figure 6-3 with predicted fits and
Figure 6-4 with an actual fit.

Figure 6-3A shows concentration data extracted from the

continuous series of ESI mass spectral scans with an irreversible scheme shown below.

Scheme 1: Irreversible heme transfer from holo-IsdA-N to apo-IsdC-N to apo-IsdE.

Scheme 1 was based primarily on known chemistry which shows that static transfer from holoIsdA-N to apo-IsdC-N and transfer from holo-IsdC-N to apo-IsdE is complete and irreversible
[32]. Figure 6-3A shows the time dependant ESI-MS data and multivariable fit. Clearly, this
scheme does not fit this reaction. Importantly, although the IsdA-N and IsdE line fits are off, the
IsdC-N fit is completely misaligned and do not overlap. Observed in the raw data, Figure 6-2, is
that holo-IsdC-N never fully does transfer heme to apo-IsdE. Therefore, a reversible fit with
scheme below was tried next.

Scheme 2: Reversible heme transfer from holo-IsdA-N to apo-IsdC-N to apo-IsdE.
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Figure 6-3
Time dependence fit using Scheme 1 and Scheme 2 with the data from Figure
6-2. A) Irreversible fit showing that this mechanism does not match what is experimentally
observed. The thin lines are the experimentally determined concentrations; the thick lines
represent the best fit to all the data based on Scheme 1. B) Reversible fit showing that this
mechanism does potentially match the experimentally observed data except in the starting region
with holo-IsdC-N. The thin lines are the experimentally determined concentrations; the thick
lines represent the best fit to all the data based on scheme 2. At the start of the reaction the
concentrations were: HA= 6.0 μM, AC = 0.45 μM, and AE = 12 μM. The temperature was 15
o
C.
Although the reversible fit from Scheme 2 correctly fits the data, Figure 6-3B, there is
significant error in first half of the fit with regards to holo-IsdC-N. A summary of the reaction
rate constants can be found in Table 6-1.

Table 6-4: Bimolecular rate constants for Figure 6-3B: A reversible mechanism
Kinetic parameters using the
Scheme 2 mechanism

Specific rate constant
/L μmol-1 s-1

(Second order rate constants)
k1

2.3x10-2  0.2x10-2

k2

8.6x10-3  0.5x10-3

k3

1.1x10-3  0.1x10-3

k4

1.4x10-2  0.1x10-2
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From these rate constants, the forward rate constant of the transfer from holo-IsdC-N to apoIsdE (k3) is approximately 20 times smaller than the forward rate constant of the transfer from
holo-IsdA-N to apo-IsdC-N (k1). The reversible rate constant for the transfer of holo-IsdA-N to
apo-IsdC-N (k1) is only approximately 3 times greater than the reverse transfer rate (k2). This
would have been a detectable result with ESI-MS during static experiments [32]. To further
complicate analysis, the forward rate constant of holo-IsdC-N to apo-IsdE (k3) is approximately
13 times smaller than the reverse rate constant of the reverse reaction (k4). This result does not
account for the fact that holo-IsdC-N fully and irreversibly transfers heme to apo-IsdE [32].
Therefore, this scheme must not be correct.
The cog-wheel like mechanism of heme transfer where IsdC-N acts as a heme shuttle is not a
straightforward reaction. Key to the analysis is that most reactions studied in terms of heme
transfer only involve the turn-over of heme once [21, 32]. Therefore, the origin of the strange
chemistry that results in some of the heme being frozen in IsdC-N must lie in the turnover of
IsdC-N itself. That is, the filling of apo-IsdC-N from holo-IsdA-N and transfer to apo-IsdE.
This is taken into account with Scheme 3. Scheme 3 adds a third reaction: heme transfer from
holo-IsdA-N to apo-IsdC-N which results in apo-IsdA-N and holo-IsdC-N*. Where holo-IsdCN* is an inactive heme transfer protein. The time dependent ESI-MS results from Figure 6-2 are
plotted using Scheme 3 and can be found in Figure 6-4. A summary of the reaction constants
can be found in Table 2. The rate constant for transfer from holo-IsdA-N to apo-IsdC-N (k1) is
approximately 2.5 times as fast as transfer from holo-IsdC-N to apo-IsdE (k2). The reaction rate
constant that disables IsdC-N is approximately 9 times slower than heme transfer from holoIsdC-N to apo-IsdE. Therefore, the progression to the disabled IsdC-N is slow and progressive.

Scheme 3. Reaction mechanism used to fit the experimental data
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Figure 6-4
Time dependence fit using Scheme 3 with the data from Figure 6-2. The thin
lines are the experimentally determined concentrations; the thick lines represent the best fit to all
the data based on Scheme 3. At the start of the reaction the concentrations were: HA= 6.0 μM,
AC = 0.45 μM, and AE = 12 μM. The temperature was 15 oC.
Table 6-5: Bimolecular rate constants for Figure 6-2B: A mechanism based on Scheme 3
Kinetic parameters using the
Scheme 3 mechanism

Specific rate constant
/L μmol-1 s-1

(Second order rate constants)
k1

2.3x10-2 + 0.2x10-2

k2

9.6x10-3 + 0.3x10-3

k3

1.1x10-3 + 0.1x10-3

Reaction Scheme 3 was tested by performing the same reaction as Figure 6-2 but with an
increase in holo-IsdC-N, Figure 6-5. At the start of the reaction the concentrations were: HA=
6.0 μM, AC = 1.2 μM, and AE = 12 μM. By doubling the amount of holo-IsdC-N, both parts of
the reaction would be affected by a concentration change. This reaction was fit with the kinetic
parameters from Table 2. The fit from Figure 6-5 confirms the results from Table 2. This model
is an accurate and simple explanation of the kinetics observed when IsdC-N acts as a heme
shuttle and turnovers heme from IsdA-N to IsdE.
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Figure 6-5
Time dependence fit using Scheme 3 with a second data set. At the start of the
reaction the concentrations were: HA= 6.0 μM, AC = 1.2 μM, and AE = 12 μM. The
temperature was 15 ˚C. This fit supports the mechanism from Scheme 3. The thin lines are the
experimentally determined concentrations; the thick lines represent the best fit to all the data
based on Scheme 3.

6.3.4 UV-visible absorption data indicate that protein conformation is
important for heme transfer
The mass spectral data in Figure 6-2 provide one more important piece of information about
the reaction. Charge states in the ESI mass spectrum are sensitive to changes in the volume of
the protein and, therefore, provide a measure of changes in solvent access to the protein’s basic
amino acid residues. Protein integrity during the heme transfer reaction can be determined
directly from the charge state distribution [25, 26, 32, 34, 35]. The data show that no major
changes in the charge state distribution occur for the apo- and holo-species of IsdA-N, IsdC-N
and IsdE. This indicates that no significant structural changes took place as a result of heme
binding or release in any of these proteins.

No protein degradation was observed; this

observation was particularly important with respect to IsdC-NEAT following its turnovers.
A control experiment was performed in order to test if intact apo-IsdC-N must bind heme from
holo-IsdA-N in order to transfer heme to apo-IsdE or if IsdC-N acts as an independent facilitator,
whereby apo-IsdC-N acts as a trigger to facilitate heme transfer between holo-IsdA-NEAT and
apo-IsdE, Figure 6-6. Figure 6-6A shows that heme does not dissociate or transfer from holo-
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IsdA-NEAT to IsdE within the timeframe of the kinetic measurements. The Soret band for holoIsdA-N and holo-IsdC-N is at 403 nm due to Tyr ligand binding while it would shift to 413 nm
for holo-IsdE due to His binding. However, this Soret band shift is immediately observed when
apo-IsdC-N is added to a solution of holo-IsdA-N and apo-IsdE, Figure 6-6B, showing that heme
transfer from holo-IsdA-N to apo-IsdE has occurred. This result was mirrored in Figure 6-1 with
the time dependant MCD results. In a further test, denatured apo-IsdC-N was added to a mixture
of holo-IsdA-N and apo-IsdE to test if native IsdC-N is required for the heme transfer reaction to
take place, Figure 6-6C. The data show that no heme transfer from holo-IsdA-N occured to apoIsdE within the experimental timeframe, although a slight wavelength change is detectable in the
Soret band of the holo-IsdA-N. This could indicate slight interactions with SDS that was added
to the solution when apo-IsdC-N was added. Nonetheless no heme transfer was observed.
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Figure 6-6
Heme transfer reactions investigating the importance of intact IsdC-N by UVvisible absorption spectroscopy. A) 6.0 uM holo-IsdA-N with 12 uM apo-IsdE showing lack of
heme transfer due to no shift in the Soret band (403 nm IsdA-N (Tyr) to 413 nm IsdE (His)) B)
6.0 uM holo-IsdA-N, 0.6 uM apo-IsdC-N and 12 uM apo-IsdE showing heme transfer from
IsdA-NIsdC-NIsdE (Shift in the Soret band from 403 nm to 413 nm indicating heme
transfer to IsdE) and C) 6.0 uM holo-IsdA-N, 0.6 uM denatured apo-IsdC-N and 12 uM apo-IsdE
indicating no heme transfer. Each experiment was run for 30 minutes (within the experimental
timeframe of the other kinetic experiments presented)
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6.4 Discussion
The proposed role of the Isd proteins is to shuttle heme through the cell wall and membrane of
S. aureus. Two important questions are: (i) what is the actual mechanism for the heme transfer
following heme acquisition? And, (ii) can the Isd system act as a catalyst with respect to heme
transfer? With respect to question (i), previous equilibrium studies have shown that heme
transfer that takes place from holo-IsdA-N to apo-IsdC-N and also from holo-IsdC-N to apo-IsdE
is unidirectional [21, 32] implying protein to protein transfer is involved rather than a
dissociative reaction mechanism, which would not impose the specificity of the reaction
observed. These weak protein-protein interactions have been shown by other groups where
heme transfer results from a hand-clasp model between the alpha and beta loops in the Isd
protein structure just outside of the heme pocket.

These interactions facilitate the NEAT

domains of IsdA-N and IsdC-N coming together and forming an interactive complex [31].
Furthermore, it was determined that the heme transfer rate from IsdA to IsdC and IsdC to IsdE
were >70,000 times faster than simple heme dissociation due to protein-protein interactions [27].
The data presented in this work also show a requirement for protein-protein interactions rather
than a series of coupled dissociative/associative reactions.
Key to being able to answer question (ii) is the development of a technique that can
differentiate between spectroscopically similar species and spectroscopically silent species
regardless of the number of protein species in solution. Time dependant ESI-MS is able to
perform this task. Quantitative analysis of charge state data can be performed since the apo- and
holo- conformation of the Isd proteins contain similar charge states. Hence, apo- and holocharge states can be used relatively to eac hother to quantitate the Isd species measured by ESIMS [7, 26, 32, 37]. To answer question (ii), consideration to the complete system and the values
of the rate constants reported here must be taken. IsdB or IsdH were proposed as the starting
points of the heme transfer through the relatively thick (ca. 90 nm) peptidoglycan cell wall with
transfer via IsdA to IsdC and then on to IsdE. It is reasonable to assume that IsdE, which is
located at the membrane surface, serves as the acceptor for heme prior to its passage through the
membrane and into the cytoplasm where heme is then met by the heme degrading enzymes IsdG
and IsdI [18-20].
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6.4.1 Relative rates of heme transfer between Isd species
The values of the specific rate constants for heme transfer from Table 6-1 for the model that
fits the reactions mechanism in Scheme 3 are 2.3x10-2 μM-1s-1 for the first step from holo-IsdA-N
to apo-IsdC-N (k1) and 9.6x10-3 μM-1s-1 for the second step from holo-IsdC-N to IsdE (k2). The
reaction rates are different by a factor of ~2.5 (k1/k2). Since NEAT to NEAT heme transfer is
relatively fast [21], this difference between the first step and the second step has a major
ramification: heme will rapidly build up in IsdC in the cell wall before slowly transferring to
IsdE, the protein located on the membrane as part of the ABC transporter.
Overall, these results may explain the importance of a multi-step heme passage mechanism.
The introduction of the requirement for the intervention of a single protein in the heme transfer
mechanism is restrictive. The data presented here, and specifically the disparity in transfer rates,
suggest a possible explanation: if heme transfer was slow from IsdA to IsdC then free heme
exposed during the extraction from hemoglobin, which involves IsdH and IsdB, might be lost to
the bacterium. With a fast heme transfer rate into a wall-bound protein (IsdC), heme is moved
deeper into the cell wall of the bacterium where it is more protected from the extracellular
milieu. The subsequent slower heme transfer from IsdC to IsdE can act as a throttle for the
system to control the eventual heme transport into and build up in the cytoplasm; indeed Skaar
and coworkers have demonstrated heme toxicity in S. aureus [38].
The disabling step of IsdC-N is slow. Interestingly, this protein would still contain the same
charge state mass as normal IsdC-N. This slow progressive step, ~9 times slower than normal
transfer from IsdC-N to IsdE, affects the overall kinetic model and the heme transfer kinetic
results. Key to the reaction is the treatment of IsdC-N. The limited concentration of IsdC-N
imparts a catalytic role on this protein so that IsdC-N acts a central cog-wheel in the heme
transfer system. IsdC plays the role of shuttling heme from IsdA-N to IsdE, where IsdC-N
would need to turnover approximately 10 times before the reaction is finished under the
experimental conditions used in this work. This disabling step might also impart protection of
the Isd system. Since the Isd system is efficient at heme extraction, the central conduit of the Isd
system may impart further protection from heme toxicity due to the disabling of IsdC-N.
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6.4.2 Intact Isd proteins are required to transfer heme
The UV-visible absorption experiments show how important intact IsdC-N is to proteinprotein interactions with regards to heme transfer. Importantly, disruption of the hand-clasp
model by protein denaturation completely disables heme transfer [31].

6.5 Conclusion

Figure 6-7
A heme transport model based on analysis of the mass spectral data obtained
from this study. Unidirectional heme transfer takes place from IsdA-NEAT to IsdC-NEAT to
IsdE, and the diagram indicates that IsdC-NEAT cycles round acting as a cog-wheel in the
overall transfer reaction. There is no direct transfer from holo-IsdA-NEAT to apo-IsdE. The
mass spectral data to support the model are in agreement with the model first proposed by
Schneewind and colleagues [17].

127
Overall, the model proposed treats IsdC-N as a catalyst in the important through cell wall heme
transfer pathway of the Isd system (IsdA-N, IsdC-N and IsdE). The model suggests that intact
catalytic amounts of IsdC-N are crucial to heme transfer from IsdA-N to IsdE because heme does
not transfer from IsdA-N directly to IsdE. Overall, the rate of transfer from IsdA-N to IsdC-N is
faster than transfer from IsdC-N to IsdE, which may impart heme cytotoxicity relief on the
bacterium by throttling the heme transfer reaction into the cell interior. Key to the transfer
reaction mechanism used to account for the experimental data is the disabling of IsdC-N, which
also may important heme toxicity protection. Figure 6-7 summarizes the results found in this
research. The conclusions are that IsdC (here studied as IsdC-N) is the central cog-wheel in
heme transfer through the S. aureus wall, and acts as a courier between IsdA and IsdE, by
cycling between IsdC and IsdE multiple times and that the differential in rates support an
hypothesis that heme stockpiling in the wall may take place as a result of efficient scavenging
but more restricted influx via the membrane transporters reduces possible subsequent heme
toxicity.
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Chapter 7.

Mechanism of heme scavenging from bovine

hemoglobin by IsdB from Staphyloccocus aureus:
Importance of the intact Isd protein6
7.1 Introduction
Staphylococcus aureus (S. aureus) is an invasive Gram-positive coccoid bacterium that
innocuously colonizes the anterior nares of approximately 30% of the human population [1, 2].
In hospitals, S. aureus is one of the most commonly acquired bacterial infections as it is the
leading cause of nosocomial infections [3]. Bacterial infection requires the acquisition of host
iron. Iron is an essential component of living biological systems [4] due to the ability to undergo
changes in oxidation and to take part in ligand binding. Since free iron is not typically available,
it is sequestered by host proteins. As a result, invasive organisms need high affinity systems to
acquire and store iron [5]. S. aureus responds to the iron-restricted environment of the host with
an array of iron-uptake and acquisition systems. It has been shown that S. aureus is able to grow
on heme, hemoglobin, hemoglobin-haptoglobin, transferrin and ferric or ferrous iron [6-8].
Interestingly, approximately 75% of the total host body-iron is locked up in heme. This
source of iron is considered largely inaccessible to siderophores [9]. Furthermore, about 70% of
the total body iron is contained within hemoglobin (Hb), making it a particularly attractive iron
source for invading microbes. S. aureus has also evolved mechanisms to exploit and scavenge
heme as an iron source. S. aureus secretes hemolysins [10] to lyse host red blood cells and
release Hb into the serum where it is accessible to the bacteria. Utilization of Hb in S. aureus is
mediated by the Isd heme transfer system [6, 11], whose motif is also found in other Grampositive pathogens such as Bacillus anthracis, Clorstridium tetani and Listeria monocytogenes
[12-14].
The S. aureus iron-regulated surface determinant (isd) gene cluster was first identified in 2002
[8, 11, 15], and then in 2003, Mazmanian et al. [6] reported that, when grown in iron-limiting
medium, S. aureus expresses genes that are involved in iron acquisition and were the first to
propose that the Isd series of protein formulate a heme transfer pathway across the cell wall and
through the cell membrane. The Isd system consists of nine iron-regulated proteins, named
6

A version of this work will be submitted.
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IsdA, IsdB, IsdC, and IsdH, which are cell-wall anchored, surface proteins, and IsdDEF, which
together constitute a membrane-localized ABC transporter and, finally, IsdG and IsdI, which
encode heme-degrading enzymes in the cytoplasm [16, 17]. This system was proposed [8, 11,
15] and later demonstrated [6] to be able to pass heme through the gram-positive cell wall and
cell membrane into the cytoplasm where heme is deconstructed and free iron is released. These
nine proteins mediate the delivery of heme from the host’s plasma into the S aureus cytoplasm
[18]. IsdB and IsdH are exposed to the environment, while IsdA is partially exposed and IsdC is
buried within the cell wall [6]. In terms of a mechanism for heme acquisition IsdB and IsdH
capture heme from Hb released from erythrocytes by hemolysins [14, 19].

IsdH binds

haptoglobin (a serum glycoprotein that protects the host from free hemoglobin) and the
haptoglobin-hemoglobin complex [7, 20, 21].

IsdA is proposed to function as a heme

scavenging protein and a “heme reservoir” for IsdH and IsdB [22, 23]. IsdC, which is located in
the cell wall, acts as the central conduit of heme transfer in the Isd system [24-26]. The
membrane bound complex IsdDEF complex pumps heme across the cell membrane [18, 27].
Heme is finally deconstructed by IsdG monooxygenase or its paralog, IsdI [17, 18]. The proteins
IsdA, IsdB, IsdC and IsdH each contain at least one Near Transporter (NEAT) domain that
adopts a beta sandwich structure to bind one ferric heme into a groove with heme-iron
coordination via Tyr [22-25, 28-30].
Previous studies have shown that ferric heme transfer takes place in a unidirectional fashion
as heme propagates down the pathway in the sequence (with the heme proximal amino acid
residue shown) IsdB-N2 (Tyr) IsdA-N (Tyr)  IsdC-N (Tyr)  IsdE (His) or, alternatively,
initiating from IsdH-N3, IsdH-N3 (Tyr)  IsdA-N  IsdC-N  IsdE. Significantly, IsdA does
not transfer heme directly to IsdE under any conditions [25, 27, 28, 31]. In order to facilitate
such transfer protein-protein interactions have been shown to be key factors in heme transfer
from IsdA-N to IsdC-N [32]. Heme is transferred by a handclasp model of the transfer complex
and reveal that kinetics of heme transfer between IsdA and IsdC can be attenuated by alternating
key β7/β8 loops and 310 helices in the proteins.

Overall, weak transient stereospecific

interactions facilitate the selective transport seen in the Isd system.
Recent studies on IsdH show that the NEAT domain interaction with Hb capture is important
to heme extraction. IsdH-N1 interacts weakly through loop interactions with the α-chain of Hb
(αHb) and mutants of Hb are defective in IsdH-N1 binding [21, 30]. Therefore it was speculated
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that IsdB may also function in a similar manner with Hb binding through weak interactions of
the IsdB-N1 domain and heme extraction with the heme binding IsdB-N2 domain due to IsdBN1 having 40% sequence identity to IsdH-N1 and IsdB-N2 possessing 56% sequence similarity
to IsdH-N3. Past studies on IsdB binding to Hb have revealed that oxidized metHb directly
transfers heme to apo-IsdB, but apo-IsdA, apo-IsdC or apo-IsdE are not able to extract heme
from metHb. However, holo-IsdB transfers heme from metHb in much that same way as heme is
transferred from recombinant holo-IsdB-N2 [19, 25]. Overall, heme transfer facilitated by
protein-protein interactions is much faster than a dissociated mechanism [19].
Interestingly, the mechanism of heme transfer and the importance of metHb compared to
ferrous oxy (O2Hb) or the importance of the intact IsdB protein when looking at heme transfer
remains unknown. In this study the individual IsdB NEAT domains, IsdB-N1 and IsdB-N2 and
their interaction with metHb and ferrous oxyHb by electrospray ionization mass spectrometry
was investigated. Separated, the NEAT domains do not alter any Hb solutions. Furthermore,
intact IsdB-N1N2 is not able to interact with ferrous oxy Hb. However, when the intact domains
(IsdB) are added to metHb significant denaturation of Hb occurs and heme is "stolen" from Hb.
Extraction of heme from metHb is enhanced with the addition of IsdC-N.

7.2 Experimental Methods
7.2.1 Materials and Methods
General techniques and experimental procedures pertaining to protein growth, protein
purification, protein sample preparation, instrumental techniques and analysis can be found in
Chapter 2.

7.2.2 Gene cloning and protein expression
DNA encoding residues 144-462 of IsdB (IsdB-N1N2) was, 144-269 of IsdB (IsdB-N1) and
337-462 of IsdB (IsdB-N2) were incorporated into E. coli so recombinant protein could be
produced. The proteins were analyzed by ESI-mass spectrometry to confirm that each was
heme-free (apo).
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7.2.3 Hemoglobin Preparation
Bovine ferrous

oxy

Hb was was prepared from fresh hemolysate via slightly modified method

from standard procedures [33, 34]. Fresh bovine blood was extracted into a chilled glass bottle
containing sodium citrate as an anticoagulant to a final concentration of 0.3% (w/v).
Centrifugation at 5,500g for 20 min gave a RBC pellet. Plasma and buffy coat (containing white
blood cells and platelets) were removed with suction. Isolated RBCs were resuspended and
washed in isotonic 0.9% (w/v) sodium chloride and then centrifuged again at 5,500g for 20 min.
This washing step was repeated four times to rid the samples of plasma proteins and cellular
debris. Hemolysate was obtained through osmotic shock, and stromal impurities were extracted
into an organic phase. This was achieved by mixing the packed RBCs with an equal volume of
distilled water containing 10% (v/v) toluene. Centrifugation at 15,000g for 30 min yielded an
aqueous layer of purified hemolysate, which was then dialyzed at 4 °C against 10 mM
ammonium acetate over a period of 36 h with multiple buffer exchanges.
In order to produce ferric metHb, a small amount of crystalline potassium ferricyanide was
added to ferrous oxyHb prepared above in order to oxidize the Hb. Potassium ferricyanide was
then separated from ferric metHb using G-25 sephadex column chromatography. Samples were
further purified by buffer exchange using using Millipore Amicon ultra-4 centrifuge filter units
(10 kDa MWCO) with a Beckman CS-6 swinging-bucket centrifuge (3000 rpm for 10 minutes
per run).
Acid denaturation of Hb was performed by titrating dilute formic acid into hemoglobin
samples until the desired pH was obtained.

7.3 Results
7.3.1 Apo-Isd proteins and bovine hemoglobin using ESI-MS
Figure 7-1 shows the ESI-MS spectra of the Isd proteins apo-IsdBN1, apo-IsdBN2 and apoIsdBN1N2. ESI-mass spectrum of apo-IsdB-N1 results in a charge state distribution similar to
other Isd NEAT domains such as IsdA and IsdC with charge states +8 to +6 [23, 25, 28]. The
deconvoluted mass matches the theoretical mass of 15.1 kDa with a mass of 15127 Da. The ESIMS data of IsdB-N2 is similar to previously reported results with a charge state distribution of
+8 to +5 with a deconvoluted mass of 15303 Da. The * indicates a +11 charge state dimer of
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apo-IsdB-N2 [28]. IsdB-N1N2 is a larger protein with a theoretical mass of 37.8 kDa. ApoIsdB-N1N2 has a five charge state manifold, +14 to +10, with a deconvoluted mass of 37783 Da.
The charge state manifold of IsdB-N1N2 is more similar to IsdE than to the smaller NEAT
domain proteins due to the size of the protein [35]. Previous studies have shown that IsdB-N1
does not bind heme [7, 14, 20], IsdB-N2 binds one heme through a tyrosine amino acid ligand
and IsdB-N1N2 binds one heme in a similar manner as IsdB-N2 [19, 28, 36].

Figure 7-1
ESI-MS spectra for A) apo-IsdB-N1, B) apo-IsdB-N2 and C) apo-IsdBN1N2.
A) Charge state and deconvoluted mass spectra of apo-IsdB-N1. The ESI-mass spectrum of apoIsdB-N1 shows three charge states (+8, +7, +6) which deconvolute to 15127 Da. B) Charge state
and deconvoluted mass spectra of apo-IsdB-N2. These results match those that have been
previously reported [25, 28]. The ESI-mass spectrum of apo-IsdB-N2 shows four charge states
(+8 to +5). The * indicates dimer-apo-IsdB-N2. The charge states deconvolute to 15303 Da. C)
Charge state and deconvoluted mass spectra of apo-IsdB-N1N2. Apo-IsdB-N1N2 possesses five
charge states (+14 to +10), which deconvolute to 37783 Da.

For comparison, the ESI-MS spectra of bovine hemoglobin pH 7.40 and pH 1.21 are shown in
Figure 7-2. These results match the spectra that were previously reported [34, 37]. Briefly, four
Hb components can be found in a solution of blood extracted Hb: tetramer holo-Hb (αhβh)2 with
charge states of +15 to +18, dimer holo-αhβh with charge states of +10 to +12 , apo-α strands
with charge states of +7 and +8 and holo-α strands with charge states of +7 and +8. Overall, the
amount of tetramer present in solution is much greater than the amount of dimer and single
strands [34, 37].

Typically, when heme proteins are acid denatured and hence unfolded,
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protonation of the protein amino acids is increased and a distinct increase in charge states is
observed [28, 34, 38]. Upon formic acid denaturation, the denaturation of tetramer into single
strand components (α and β) and loss of heme is observed with ESI-MS, Figure 7-2B. The
efficiency of ionization of the α strand is much greater than the β strand which results in a greater
intensity and distribution of denatured α than denatured β. Apo-α has a centered denatured
charge state of +16 while apo-β has a centered denatured charge state at +11. Overall, the
deconvoluted masses of bovine hemoglobin are 64513 Da for (αhβh)2, 32254 Da for (αhβh),
15055 Da for apo-α and 15955 Da for apo-β.

Figure 7-2
ESI-mass spectra of intact bovine hemoglobin at pH 7.40 and denatured
bovine hemoglobin at pH 1.21. These ESI-mass spectra match results that have been
previously reported for bovine hemoglobin [34, 38]. A) Measured results for bovine hemoglobin
at pH 7.40. Tetramer holo-Hb (αhβh)2 are observed with charge states of +18 to +15 and
deconvoluted mass of 64513 Da. Dimer holo-(αhβh) are observed with charge states +12 to +10
and deconvoluted mass 32254. Small peaks are observed for the apo/holo pair of single intact α
bands at +8 and +7. B) Measured results for acid denatured bovine hemoglobin at pH 1.21. The
denatured charge states for apo-α and apo-β have a peak maximum of +16 and +11, respectively.
Non-denatured apo-α and apo-β have charge states of +8 to +7. The deconvoluted apo-α and
apo-β subunit mass is 15055 Da and 15955 Da, respectively.

7.3.2 Heme scavenging from Hb by apo-IsdB-N1 using ESI-MS
The importance of the first NEAT domain of IsdB, IsdB-N1, with regards to heme extraction
from Hb was investigated. Upon addition of 4 μM apo-IsdB-N1 with 4 μM metHb, Figure 73A, no change in the charge states of IsdB-N1 and metHb were observed. For both ferrous and
ferric Hb, IsdB-N1 still has a charge state manifold of +8 to +6. Only tetramer Hb with a charge
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state distribution of +18 to +16 was present. No apo-tetramer Hb charge states are observed.
Dimer hh(αβ) is present with a charge state manifold of +12 to +10. Overall, the Hb charge states
remain similar to that observed with a solution consisting of holo-Hb.

The same result is

obtained with the addition of 4 μM apo-IsdB-N1 and 4 μM ferrous Hb, Figure 7-3B. No
significant changes in the charge states are observed and Hb remains intact.

Figure 7-3
Interaction of 4 μM IsdB-N1 with A) 4 μM ferric Hb and B) 4 μM ferrous
Hb. A) Charge state data for the addition of apo-IsdB-N1 with ferric Hb from 500-6000 m/z and
the zoomed in region 2300-4500 m/z. +8 to +6 charge states are present for apo-IsdB-N1 (aBN1). No peaks indicating heme binding are present. The overall charge manifold of ferric Hb
remains intact for Hb. No interaction with Hb is evident. B) Charge state data for the addition
of apo-IsdB-N1 with ferrous Hb from 500-600 m/z and the zoomed in region 2300-4500 m/z.
Again, no interaction with Hb is evident as no change in the charge manifold of apo-IsdB-N1
and Hb was observed.

7.3.3 Heme scavenging from Hb by apo-IsdB-N2 using ESI-MS
The importance of the second NEAT domain of IsdB, IsdB-N2, with regards to heme
extraction and heme binding from Hb was investigated next. Upon addition of 4 μM apo-IsdBN2 with 4 μM ferric Hb, Figure 7-4A, no changes in the charge states of IsdB-N2 and ferric Hb
were observed. Interestingly, although IsdB-N2 has been found to be a heme binding NEAT
domain [28], IsdB-N2 is not able to extract heme from ferric Hb as either the tetramer, dimer or
single heme bound strands. For both ferrous and ferric Hb reactions, IsdB-N2 still has a charge
state manifold of +8 to +5. Only tetramer Hb with a charge state distribution of +18 to +16 were
present. No apo-tetramer Hb charges states were observed. Dimer

hh

(αβ) is present with a

charge state manifold of +12 to +10. Overall, the Hb charge states remain similar to that
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observed with a solution consisting of holo-Hb. The same result is obtained with the addition of
4 μM apo-IsdB-N2 and 4 μM ferrous Hb, Figure 7-4B. No significant changes in the charge
states are observed and the Hb remains intact.

Figure 7-4
Interaction of 4 μM IsdB-N2 with A) 4 μM ferric Hb and B) 4 μM ferrous
Hb. A) Charge state data for the addition of apo-IsdB-N2 with ferric Hb from 500-6000 m/z and
the zoomed in region 2300-4500 m/z. +8 to +5 charge states are present for apo-IsdB-N2 (aBN2). The dimer charge state peak is indicated with a *. No peaks indicating heme binding are
present. The overall charge manifold of ferric Hb remains intact for Hb. No interaction with Hb
is evident. B) Charge state data for the addition of apo-IsdB-N2 with ferrous Hb from 500-600
m/z and the zoomed in region 2300-4500 m/z. Again, no interaction with Hb is evident as no
change in the charge manifold of apo-IsdB-N2 and Hb was observed. Apo-IsdB-N2 does not
extract or bind heme from ferrous Hb.

7.3.4 Heme scavenging from Hb by apo-IsdB-N1 and apo-IsdB-N2 using
ESI-MS
The importance of the first and second NEAT domain of IsdB, IsdB-N1 and IsdB-N2, was
explored. Upon addition of 4 μM apo-IsdB-N1 and 4 μM apo-IsdB-N2 to a solution of 4 μM
ferric Hb, Figure 7-5A, no changes in the charge states of IsdB-N2 and ferric Hb were observed.
For ferrous Hb, IsdB-N1 still has a charge state manifold of +8 to +5 and IsdB-N2 still has a
charge state manifold of +8 to +5. Tetramer holo-Hb with a charge state distribution of +18 to
+16 was observed. No tetramer apo-Hb species were present. Also, only holo dimer hh(αβ) were
observed with a charge state manifold of +12 to +10.

Interestingly, the separate domains

combined in solution do not interact with Hb. No heme extraction to IsdB-N2 or significant
alteration in the charge states of Hb was observed. This result is surprising as IsdB-N1N2 has
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been previously shown to interact with and extract heme from ferric Hb [19]. Overall, the Hb
charge states remain similar to what is observed with a solution of just holo-Hb. The same result
is obtained with the addition of 4 μM apo-IsdB-N1 and 4 μM apo-IsdB-N2 with 4 μM ferrous
Hb, Figure 7-5B. No significant changes in the charge states are observed and the Hb remains
intact.

Figure 7-5
Interaction of 4 μM IsdB-N1 and 4 μM IsdB-N2 with A) 4 μM ferric Hb and
B) 4 μM ferrous Hb. A) Charge state data for the addition of apo-IsdBN1 (a-BN1) apo-IsdBN2 (a-BN2) with ferric Hb from 500-6000 m/z and the zoomed in region 2300-4500 m/z. +8 to
+5 charge states are present for both apo-IsdB-N1 and apo-IsdB-N2. The dimer charge state
peak is indicated with a *. No peaks indicating heme binding of apo-IsdB-N2 are present. The
overall charge manifold of ferric Hb remains intact for Hb. No interaction with Hb is evident.
B) Charge state data for the addition of apo-IsdB-N1 apo-IsdB-N2 with ferrous Hb from 500-600
m/z and the zoomed in region 2300-4500 m/z. Again, no interaction with Hb is evident as no
changes in the charge manifold of apo-IsdB-N1 and apo-IsdB-N2 and Hb were observed.

7.3.5 Heme scavenging from ferrous Hb by apo-IsdB-N1N2 using ESI-MS
With null results regarding the interaction of IsdB-N1 and IsdB-N2 with Hb, the effect of the
combined protein, IsdB-N1N2 with ferrous Hb, Figure 7-6, was investigated. Again, only apo
charge states are present for IsdB-N1N2 (+14 to +11). No heme extraction from Hb had
occurred. The overall charge state manifold for Hb remains the same as a solution of free Hb
without the Isd protein. Only tetramer holo-Hb with a charge state distribution of +18 to +16
and holo dimer hh(αβ) with a charge state manifold of +12 to +10 were observed. Therefore, it
may be concluded that IsdB is not able to extract heme from ferrous Hb despite evidence
suggesting that IsdB-N2 can bind ferrous heme [28].
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Figure 7-6
Interaction of 4 apo-IsdB-N1N2 with ferrous Hb. 4 μM apo-IsdB-N1N2 with
4 μM ferrous Hb. Charge state data for the addition of apo-IsdBN1 (a-BN1) apo-IsdB-N2 (aBN2) with ferric Hb from 500-6000 m/z and the zoomed in region 2300-4500 m/z. +8 to +5
charge states are present for both apo-IsdB-N1 and apo-IsdB-N2. The dimer charge state peak is
indicated with a *. No peaks indicating heme binding of apo-IsdB-N2 are present. The overall
charge manifold of ferric Hb remains intact for Hb. No interaction with Hb is evident.

7.3.6 Heme scavenging from metHb by apo-IsdB-N1N2 using ESI-MS
With null results observed regarding heme extraction by IsdB-N1 and IsdB-N2 with Hb, heme
extraction from 1 μM metHb with 4 μM apo-IsdB-N1N2 by time dependant ESI-MS, Figure 7-7,
was investigated next. To aid in the explanation of the mass spectral data, time-dependent
relative trace data for the apo/holo-IsdB-N1N2 +13 charge state, the +12 charge state of the
dimer (αβ) and the +8 charge state for the single intact apo-α strand, Figure 7-8, is shown below.
Mass spectral data analysis cannot be used quantitatively to analyze raw charge states. The
charge states must be made relative to a protein with a similar conformation in order to be
interpreted quantitatively. For heme binding proteins this can be carried out using the apo/holo
charge state pairs [25, 39]. Therefore, since single intact holo-β, denatured holo-β, denatured
holo-α and apo-tetramer Hb are not present in the mass spectral data then therefore, these traces
cannot be analyzed quantitatively.
In the early stages of the reaction following addition of apo-IsdB-N1N2 with metHb at about
1 minute, there are significant changes in the mass spectral data compared to the previous null
reactions above. The appearance of holo-IsdB-N1N2 charge states is evident by one minute but
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significantly most of the IsdB-N1N2 protein is now apo indicating a slow heme transfer relative
to other Isd-NEAT to Isd-NEAT transfers [19, 31]. Over time, by 5 minutes, the appearance of
holo-IsdB-N1N2 charge states matching the apo-IsdB-N1N2 charge states of +13 to +11 become
apparent. From Figure 7-8A, it can be seen that heme extraction by IsdB-N1N2 is slow and that
the overall shape appears to be multiphasic, meaning IsdB-N1N2 may be able to extract heme
from not only from intact tetramer Hb but also from dimer (αβ) Hb and single stranded α and β
strands. Over time, approximately 50% of IsdB-N1N2 binds heme meaning this reaction is slow
and not as complete as seen with the other Isd proteins [19, 25, 31].
Interestingly, holo-tetramer metHb is present throughout the reaction with apo-IsdB-N1N2.
No apo-tetramer metHb charge states were present. Therefore, when apo-IsdB-N1N2 interacts
with tetramer metHb the tetrameric structure of metHb is disrupted into smaller components.
Present in Figure 7-7 are the +13 to +11 charge states of the (αβ) dimer proteins. At first the
relative amount of

ah

(αβ) and

aa

(αβ) are the same while the amount of

hh

(αβ) is very low.

Progressing through the heme extraction reaction, it is clear that the relative amounts of aa(αβ)
increases while

hh

(αβ) and ah(αβ) decreases. Analysis of Figure 7-8B shows the disappearance

of hh(αβ), which is present in the starting metHb solution, and slow tailing of ah(αβ) indicating the
formation of these species from the interaction of IsdB-N1N2 with metHb.
Normal metHb production produces a small amount of single stranded non-denatured apo-α
and holo-α strands. Relative to acid denaturation the amount of single α strands is very low.
This is the same case for single non-denatured β strands which is not present in purified metHb
solutions. Figure 7-7 shows that early in the reaction the presence of apo- and holo-α strands are
present with charge states +8 to +6. The relative amount of non-denatured α strands are shown
in Figure 7-8C. A steady increase of apo-α is produced and a tailing decrease in holo-α is
observed. Single α strands are produced from dissociation of tetrameric and dimer metHb. Only
apo-β strands are present which may indicate a preference of IsdB-N1N2 towards extracting
heme from the β domain of Hb first and then subsequently from the α strand. This is supported
by the appearance of denatured apo-α and apo-β with charge state maximum of +14 and +11
respectively. When compared with the ESI-MS data for acid denatured metHb from Figure 7-2,
the charge state maxima for denatured apo-α was measured as +16 and for denatured apo-β was
measured as +11. Therefore, the denatured apo-β strands from heme extraction by IsdB-N1N2
resemble acid denatured conformations compared with apo-α which while still denatured, would
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be slightly more folded as charge state envelopes have been shown to indicate size of the protein
[23, 28, 35]. When IsdBN-N1N2 extracts heme from metHb, a higher ratio of denatured apo-β
to apo-α compared with acid denatured metHb was observed. This is shown by the large
difference of relative abundance between denatured apo-α and apo-β in acid denatured metHb
(approximately a 5:1 ratio from maximal charge states) from Figure 7-2B and the small
difference between denatured apo-α and apo-β in heme extracted apo-IsdB-N1N2
(approximately a 2:1 ratio from maximal charge states) from Figure 7-7.

Figure 7-7
Heme extraction from 1 μM metHb and binding by 4 μM IsdB-N1N2 over a
time period of one hour. 1 min: The appearance of mostly apo and a small fraction of holo
IsdB-N1N2 peaks with charge states +13 to +11. Holo-tetramer charge state peaks at +17 to 14
were observed. No apo-tetramer charge states were measured. Over time, the appearance of
holo-hh(αβ), single heme bound-ah(αβ) and fully apo-aa(αβ) Hb dimer are present with charge
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states +12 and +11. Also intact apo/holo pairs of single stranded α and β strands are present with
charge states of +8 and +7 are present. 5-60 min: Important changes in the mass spectra are
observed in the 1000 to 2000 m/z region where the appearance of denatured apo α and β strands
(red and blue highlights respectively) are measured. The ratio of apo-IsdB-N1N2:holo-IsdBN1N2 charge state pairs decrease over time. No apo-tetramer Hb peaks are present in any of the
resulting spectra. The holo-hh(αβ) charge states decrease while single heme bound-ah(αβ) and
fully apo-aa(αβ) increases as heme is extracted and bound by IsdB-N1N2.

Figure 7-8
Time dependant mass spectral charge state data for A) IsdB-N1N2 B) αβ of
Hb dimer and C) intact single stranded α of Hb extracted from the data from Figure 7-7.
A) Relative % abundances of apo-IsdBN1N2 and holo-IsdB-N1N2 +13 charge state data. A
steady increase in the relative amount of holo-IsdB-N1N2 is observed with a decrease in the
relative amount of apo-IsdB-N1N2. B) Relative % abundance of the αβ dimer +12 charge state
data. Four species are possible for the αβ dimer (hh(αβ), ha(αβ), ah(αβ) and aa(αβ)). It should be
noted that there is no mass distinction between ha(αβ) and ah(αβ) and hence these data are plotted
together. hh(αβ) steadily decreased early in the reaction while ah(αβ) lagged behind. Ultimately
aa
(αβ) is formed as a result of heme extraction by IsdB-N1N2. C) Relative % abundance of α
intact single strand from Hb +8 charge state data. Heme extraction from metHb by apo-IsdBN1N2 produced single stranded holo-α. IsdB-N1N2 is also able to interact with the single
domain and extract heme.

7.3.7 Extraction of heme with apo-IsdB-N1N2 from metHb and transfer to
apo-His-IsdC-N using ESI-MS:
Addition of 2.5 μM metHb to a mixture of 3 μM apo-IsdB-N1N2 and 20 μM apo-His-IsdC-N
tests heme extraction by apo-IsdB-N1N2 and transfer to apo-His-IsdC-N, Figure 7-9. Apo-HisIsdC-N was used because some Hb charge state peaks overlap with native IsdC-N charge state
peaks. The His-tag results in an increase in mass and circumvents this problem. Importantly,
neither apo-IsdC-N nor apo-His-IsdC-N extracts heme from metHb or causes any denaturation of
metHb as seen with apo-IsdB-N1N2 above [19]. After 30 minutes, there exists a mixture of apoand holo-His-IsdC-N with a charge state manifold of +13 to +6. These charge states are different
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from those of normal apo-IsdC-N which has a charge state manifold of +8, +7 and +6 [25]. The
large range of charge states is due to the 6xHis-tag on IsdC-N which significantly increases the
overall charge volume and protonatable basic amino acid residues of the protein and hence the
charge state manifold. Approximately 30% of His-IsdC-N is holo meaning that 4 μM heme is
left in metHb of the original 10 μM of heme. Interestingly, only apo-IsdB-N1N2 is present with
a charge state manifold of +15 to +12.

Any heme present in apo-IsdB-N1N2 has been

transferred to apo-His-IsdC-N. No tetramer metHb peaks are present in the range from 3700 to
4600 m/z. Apo-IsdB-N1N2 has deconstructed tetramer holo-metHb.

The resultant metHb

species exist as either the αβ dimer (hh(αβ), ha(αβ), ah(αβ) and aa(αβ)) with a charge state manifold
of +13 to +11 or as denatured single strand apo-α or apo-β with a charge state manifold from +15
to +8 or +17 to +10 respectively.

Figure 7-9
Heme extraction from 2.5 μM metHb and binding by 3 μM apo-IsdB-N1N2
and 20 μM apo-His-IsdC-N after 30 minutes. A mixture of apo- and holo-His-IsdC-N is
observed with charge states +13 to +6. The large range of charge states is due to the His-tag on
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IsdC-N, which significantly increases the overall number of charges on the protein and hence the
charge state manifold. Apo-IsdB-N1N2 is present with a charge state manifold of +15 to +12.
No tetramer metHb peaks are present in the range from 3700 to 4600 m/z. All metHb species
exist as either the αβ dimer (hh(αβ), ha(αβ), ah(αβ) and aa(αβ)) with a charge state manifold of +13
to +11 or as denatured single strand apo-α or apo-β with a charge state manifold from +15 to +8
or +17 to +10, respectively.

7.3.8 Extraction of heme from metHb by apo-IsdB-N1N2 and subsequent
transfer to other Isd proteins using UV-visible absorption and MCD
spectroscopy
The ESI-MS results above were confirmed by UV-visible absorption and MCD spectroscopy
with transfer down the core of the Isd system through apo-IsdA-N, apo-IsdC-N and apo-IsdE,
Figure 7-10. MetHb (blue line) exhibits a B band at 407 nm, which is mirrored in the MCD
spectrum with an A term peak maximum at 403 nm and trough at 420 nm. A large B:Q ratio of
~10 is observed with a solution of MetHb. Stepwise addition of apo-IsdB-N1N2 to metHb
results in a decrease in intensity of the B band and a significant red-shift from 579 nm to 553 nm
in the Q band region in the MCD spectrum. Overall, the spectra start to resemble typical IsdBN2 binding [28]. Addition of small amounts of IsdE did not result in a spectral shift. IsdE
possesses a much different MCD fingerprint spectrum than Isd-NEAT domain proteins due to a
shift in amino acid heme binding ligands from tyrosine to histidine [25, 28]. However, addition
of IsdA-N and IsdC-N results in a B band shift to 415 nm. A Q band shift to 572 nm and a
decrease of the 642 nm band is a fingerprint of heme transfer and binding to IsdE [25, 28].
Heme is transferred by IsdA-N to IsdC-N and then to IsdE.

144

Figure 7-10 UV-visible absorption and MCD spectroscopic results for heme extraction by
apo-IsdB-N1N2 and heme transfer to apo-IsdE via apo-IsdA-N and apo-IsdC-N for a
stepwise titration. MetHb heme is possesses a large B:Q ratio of ~10. Upon addition of apoIsdB-N1N2 and following heme extraction the absorption B band decreases while the MCD B
band starts to shift from 403 nm to 407 nm. A significant decrease in the B:Q ratio from ~10 to
~3 is observed. This ratio is much more typical of Isd NEAT domain binding [25, 28]. Addition
of IsdE does not change the MCD spectra to typical IsdE heme bound spectrum [25, 35].
However, addition of apo-IsdA-N and IsdC-N result in a spectra typical of holo-IsdE due to
heme transfer from holo-IsdBN1N2 to IsdE via IsdA-N and IsdC-N. The B:Q ratio increases
back to 10:1 and the resulting spectra are indicative of IsdE. Previous studies have shown that
IsdA-N, IsdC-N and IsdE are not able to extract heme from metHb [19].

7.4 Discussion
7.4.1 Bovine Hb as a model for human Hb
The importance of freshly extracted Hb from bovine blood compared to lyophilized,
commercially bought Hb has been stressed by other groups using ESI-MS [34, 37, 38].
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Importantly, Hb extracted from fresh blood results in Hb that has much greater tetrameric
fractions whereas lyophilized commercially-available Hb contains a very low fraction of
tetrameric Hb. Due to this fact, we have used bovine Hb as a model for human Hb heme
extraction by the Isd heme scavenging system in S. aureus. Interestingly, humans are not the
only hosts susceptible to infection by S. aureus. Cows have also been found with S. aureus
infections [40-42]. Potentially, the Isd system is able to extract heme from bovine Hb in the
same way as human Hb since Hb is a very well conserved protein.

7.4.2 Importance of intact IsdB-N1N2 and oxidation of state of Hb for heme
extraction
Apo-IsdBN1, apo-IsdBN2 and combinations of apo-IsdBN1 and apo-IsdB-N2 in solution do
not extract heme from metHb or native oxyHb. The charge states of the IsdB proteins and both
forms of Hb do not change in the mass spectral data. Charge states can indicate the overall size
of proteins as unfolded or larger proteins have a higher surface area with solvent access to basic
amino acids and hence more and higher charge states [25, 38, 43]. Therefore, with no changes in
charge states the overall protein conformation of Hb and the IsdB components do not change.
This interesting result is not what is observed with IsdH, the other Isd protein that interact with
haptoglobin-hemoglobin complex and hemoglobin. Other work has shown that IsdH-N1 and
IsdH-N2 interacts and binds to the αHb chain.
However, when intact IsdB-N1N2 is added to a solution of metHb significant changes in the
structure of metHb are observed and the heme is trasnferred to IsdB-N1N2. In summary,
tetramer metHb is shredded to dimer

hh

(αβ). Dimer

hh

(αβ), is further deconstructed into single

stranded α and β chains which are subsequently denaturated upon heme extraction by apo-IsdBN1N2. The denatured apo- α and apo-β strands resemble acid denatured apo-α and apo-β strands
meaning that full denaturation of these strands has occurred. Overall, the only apo-Hb structures
present during heme extraction are ah(αβ) aa(αβ) and apo-α and apo-β strands. Never present in
solution is apo-tetrameric metHb, which indicates important protein-protein interactions exist
with intact IsdB-N1N2 which interact with metHb to enable heme extraction and subsequent
deconstruction and denaturation of metHb. Importantly, just as IsdH contains two non-heme
binding NEAT domains that interact with metHb, IsdB might also require two contact points for
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heme extraction from metHb.

One, which would be located in the non-heme binding NEAT

domain, IsdB-N1 and another, in the linker region between the two IsdB NEAT domains.
Furthermore, intact IsdB-N1N2 can only extract heme from metHb and not ferrous oxyHb.
This result is important for two reasons: 1) heme in Hb found in the human body is ferrous.
Therefore, S. aureus must secrete an oxidizing compound that is able to oxidize the heme in Hb
in order to be able to extract heme. It is possible to speculate that this maybe another form of
regulatory control since S. aureus is sensitive to heme as free heme is cytoxic [44]. 2) IsdC is
the central conduit of Isd heme transfer system [18, 19, 25, 45]. Therefore, IsdC must bind and
transfer heme through the system. However, IsdC is not able to bind ferrous heme [23, 46].
Therefore, the importance of starting with ferric heme extraction is crucial in the flow of heme
through the system.

7.4.3 Extraction of heme by IsdB-N1N2 becomes efficient with IsdA-N and
IsdC-N
From Figure 7-7 and Figure 7-8A it is clear the heme extraction by solely IsdB-N1N2 is not
efficient or complete as is seen with heme transfer between other Isd NEAT domain proteins
[25]. Approximately 50% of the IsdB-N1N2 is apo and there still exists tetrameric Hb. Addition
of metHb to a solution of apo-IsdB-N1N2 and apo-His-IsdC-N results in holo-His-IsdC-N. As
apo-His-IsdC-N does not extract heme from metHb, heme could only then be transferred from
holo-IsdB-N1N2 which extracts heme from metHb. Interestingly, denaturation of α strands and
β strands results and no tetrameric metHb mass spectral charge states are observed in solution.
Apo-His-IsdC-N with a combination of apo-IsdB-N1N2 in solution results in a more efficient
system where all tetrameric metHb is deconstructed to either the αβ dimer or the single stranded
species.
A summary of the transfer and mechanism of heme extraction is presented in Figure 7-11.
Heme extracted from metHb by IsdB-N1N2 does not transfer directly to IsdE. Addition of apoIsdC-N and apo-IsdA-N results in heme transfer to IsdE. Since IsdA is partially exposed on the
cell surface, [6, 13] the importance of IsdA-N as a mediator as heme reservoir in the Isd system
becomes apparent as other groups have shown that heme transfer from IsdB-N1N2 to IsdA-N is
relatively fast but transfer to IsdC-N is relatively slow [19]. Therefore, just as addition of apo-
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His-IsdC-N to apo-IsdB-N1N2 and metHb results in a more efficient system, addition of apoIsdA-N enhances the heme scavenging and extraction properties of the system.

Figure 7-11 Schematic showing the pathways of heme extraction from metHb by IsdBN1N2. Heme extraction by IsdB-N1N2 results in denatured α strands and β strands as well as
dimeric ha(αβ), ah(αβ), aa(αβ) species. Holo-IsdB-N1N2 is not able to transfer to IsdE however,
holo-IsdB-N1N2 is able to transfer heme to IsdA-N and IsdC-N.

7.5 Conclusion
In summary, unique protein-protein interactions exists with apo-IsdB-N1N2 and Hb with
regards to heme extraction and the mechanism of heme removal. Interestingly, only fully intact
apo-IsdB-N1N2 is able to extract heme from ferric metHb. Protein-protein ineractions must be
located in the first NEAT domain of IsdB and the linker region between the two NEAT domains.
Upon heme extraction, IsdB-N1N2 is able to denature and deconstruct metHb into subunit
components that compose of

ah

(αβ)

aa

(αβ) dimer and the apo-α and apo-β strands.

Heme

scavenging is not efficient as tetramer metHb still exists in the presence of IsdB-N1N2.
However, addition of apo-IsdC-N makes heme scavenging from metHb more efficient. With the
presence of apo-IsdC-N in a solution with IsdB-N1N2 and metHb, the disapearance of all
tetrameric metHb is observed. Interestingly, IsdB-N1N2 is not able to transfer heme from Hb to
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IsdE but can transfer to IsdA-N and IsdC-N. Overall, when looking at heme extraction from
metHb, the Isd system forms an efficient machine that is able to "shred" metHb and extract the
precious iron containing heme resource inside.
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Chapter 8.

Insight into blocking heme transfer by

exploiting molecular interactions in the core Isd heme
transporters IsdA-NEAT, IsdC-NEAT and IsdE of
Staphylococcus aureus7
8.1 Introduction
Iron is an essential component of living biological systems [1] due its ability to undergo
changes in oxidation and to take part in ligand binding. Since free iron is not typically available,
as it is sequestered by proteins, invasive organisms need high affinity systems to acquire and
store iron [2]. S. aureus responds to the iron-restricted environment of the host with an array of
iron-uptake and acquisition systems. It has been shown that S. aureus is able to grow using
heme, hemoglobin, hemoglobin-haptoglobin, transferrin, ferric iron or ferrous iron as the sole
iron source [3-5]. Siderophores are examples of iron uptake through the use of low molecular
weight iron binding molecules (usually 400-1000 Da) that are secreted by bacteria into their
extra-cellular environments. Siderophores have high affinity for iron and are found in numerous
bacterial systems, those secreted by bacteria are able to remove iron from transferrin. S. aureus
is no exception as two structurally characterized polycarboxylate-type siderophores,
Staphyloferrin A and Staphyloferrin B [6].
Since the majority of iron is sequestered and bound as heme-iron, S. aureus has also evolved
mechanisms to exploit and scavenge heme as an iron source.

The iron-regulated surface

determinant (isd) gene cluster was first identified in 2002 [5, 7, 8], and then in 2003, Mazmanian
et al. [3] reported that, when grown in iron-limiting medium, S. aureus expresses genes that are
involved in iron acquisition and were the first to propose that the Isd series of protein formulate a
heme transfer pathway across the cell wall and through the cell membrane. The Isd system
consists of nine iron-regulated proteins, named IsdA, IsdB, IsdC, and IsdH, which are cell-wall
anchored, surface proteins, and IsdDEF, which together constitute a membrane-localized ABC
transporter and, finally, IsdG and IsdI, which encode heme-degrading enzymes in the cytoplasm
[9, 10]. This system was proposed [5, 7, 8] and later demonstrated [3] to be able to pass heme
7
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through the gram-positive cell wall and cell membrane into the cytoplasm where heme is
deconstructed and free iron is released. These nine proteins mediate the delivery of heme from
the host’s plasma into the S aureus cytoplasm [11]. IsdB and IsdH are exposed to the cell
exterior, while IsdA is partially exposed and IsdC is buried within the cell wall [3]. In terms of a
mechanism for heme acquisition IsdB and IsdH capture heme from Hb released from
erythrocytes by hemolysins [12, 13]. IsdH binds haptoglobin (a serum glycoprotein that protects
the host from free hemoglobin) and the haptoglobin-hemoglobin complex [4, 14]. IsdA is
proposed to function as a heme scavenging protein and a “heme reservoir” for IsdH and IsdB
[15, 16]. IsdC, which is located in the cell wall, acts as the central conduit of heme transfer in
the Isd system [17-19]. The membrane bound complex IsdDEF complex pumps heme across the
membrane [11, 20]. Heme is finally deconstructed by IsdG monooxygenase or its paralog, IsdI
[10, 11]. The proteins IsdA, IsdB, IsdC and IsdH each contain at least one Near Transporter
(NEAT) domain that adopts a beta sandwich structure to bind one ferric heme into a groove with
heme-iron coordination via Tyr [15-18, 21-23].
Previous studies have shown that ferric heme transfer takes place in a unidirectional fashion.
Heme propagates down the pathway in the sequence (with the heme proximal amino acid residue
shown) IsdB-NEAT 2 (Tyr) IsdA-NEAT (Tyr)  IsdC-NEAT (Tyr)  IsdE (His) or,
alternatively, initiating from IsdH-N3, IsdH-N3 (Tyr)  IsdA-NEAT  IsdC-NEAT  IsdE.
Significantly, IsdA does not transfer heme directly to IsdE under any conditions [18, 20, 21, 24].
The heme uptake mechanisms of bacterial pathogens present an ideal path for targeted drug
delivery because these pathogens accumulate heme via active transport and are maximally
expressed in iron-limiting conditions of the host, which happens during infection [25]. It is
thought that metal-substituted protoporphyrins (PPIXs) could be inserted into enzymes by the
bacteria and render them useless for catalytic activity [25-27]. However, most studies do not
focus on how the metal-substituted PPIX can affect the heme uptake pathway. With the detailed
characterization of the Isd heme transfer system of S. aureus, we propose that a compound that
could be transferred only partially through the heme uptake system and could have a greater
efficacy in potentially serving as an actual route for potentially killing the bacteria by preventing
the bacteria from uptaking important iron resources.
IsdA-N and IsdH-N3 will bind rings with metals other than Fe. GaPPIX and MnPPIX bind
and form nearly indistinguishable three-dimensional structures when bound to IsdH-N3 and
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exhibit similar ring transfer properties to apo-IsdA as for the native heme [28]. Similar results
have been reported for CoPPIX binding to IsdA-N [11, 29] and for Zn(II)-PPIX binding to IsdCN [19]. Despite claims for an antibacterial "Trojan horse" approach in which these compounds
gain access to the interior of the cell via Isd transfers [25, 27, 28], there have been no reports of
the effects of metal substituted-PPIXs on the heme transfer with IsdA, IsdC and IsdE, the core
proteins located in the cell wall of S. aureus. A second controlling feature in the highly specific
and unidirectional nature of the Isd heme transfer mechanism may well involve the peripheral
substituents of the heme, not just the coordination properties of the ferric iron. The role of the
carboxylic acid tails of the heme in binding and transfer properties may be challenged by
changing the carboxylic acids to the relatively non-polar dimethyl ester side chain.
In this study, the effects of metal and the ring periphery substitution on the PPIX transfer in
the Isd system of S. aureus are investigated using Co(III)PPIX (CoPPIX), Mn(III)PPIX
(MnPPIX) and Fe(III)PPIX-dimethyl ester (FePPIX-DME).

Electrospray ionization mass

spectrometry (ESI-MS), UV-visible absorption and magnetic circular dichroism (MCD)
spectroscopies were used to probe ring binding and ring transfer properties of the IsdA-N, IsdCN and IsdE proteins. IsdA binds to each of the rings but the subsequent transfer properties to
IsdC-N or IsdE are not the same as found with heme. FePPIX-DME transfers from IsdA-N to
IsdC-N but neither protein transfers the ring to IsdE. IsdA-N does not transfer CoPPIX to IsdCN or IsdE. IsdA-N does transfer MnPPIX to both IsdC-N and IsdE. Significantly, it is possible
that since CoPPIX and FePPIX-DME bind to IsdA-N, the lack of transfer to IsdC-N and
subsequently to IsdE for CoPPIX could prove to be used as a potential disruption agent to the S.
aureus heme transfer system and may identify as a possible anti-microbial agent against this
bacteria.

8.2 Experimental Methods
8.2.1 Materials and Methods
Experimental procedures have previously been reported; please refer to Chapter 2 for further
protein growth, protein purification, ESI-MS and MCD spectroscopy preparatory and running
procedures.
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8.2.2 Porphyrin synthesis and addition to Isd proteins
CoPPIX and MnPPIX chloride were purchased from Frontier Scientific (Logan, UT). All
samples used for binding were dissolved in DMF. FePPIX-DME was prepared from free-base
PPIX-DME purchased from Frontier Scientific (Logan, UT) using standard metal insertion
procedures [30] and dissolved in pyridine. FePPIX-DME synthesis was confirmed from the UVvisible absorption spectrum where a blue shift in the Soret band from ~405 nm (free base PPIXDME) to ~385 nm (FePPIX-DME) was observed. The reaction purity was confirmed with ESIMS analysis. The experimental data of a mass peak of 644.2 Da (FePPIX-DME - H) matched
the theoretical mass of 645.55 Da. No free base PPIX-DME (mass 590.71 Da) was found in the
mass spectrum (Appendix Figure 8-14). All porphyrins masses were checked by ESI-MS to
ensure sample purity.
To insert the porphyrin into the heme-free proteins, concentrated (10x stoichiometric excess)
solutions of M-PPIXs were added to each of the apo-Isd proteins and subsequent holo-Isd
proteins formed were purified to separate excess free PPIX from PPIX-bound protein using G-25
size exclusion chromatography with 10 mM PBS buffer pH 7.4.

8.3 Results
8.3.1 FePPIX-DME binding to IsdA-N: absorption, MCD and ESI-mass
spectra.
Figure 8-1A shows the UV-visible absorption and MCD spectra of FePPIX-DME in pyridine.
The axial coordination of the Fe3+ by pyridine resembles axial ligation from the His in the Isd
proteins. Even in neat pyridine a mixture of species is observed in the MCD spectrum
emphasizing the much higher resolution of this technique when studying porphyrins.

The

assignment of the B or Soret absorption band to the 400 nm region (401 nm) with its
accompanying positive MCD pseudo-A term (401/416 nm) is straightforward, the assignment of
the absorption bands in the 500-700 nm region is complicated by the superposition of both the
first -* band, the Q00 and associated Qvib bands and the charge transfer bands (LMCT or
MLCT). In Figure 8-1A, the 550/559 MCD band envelope are assigned as the Q00 and the
594/629 nm envelope as LMCT. In Figure 8-1B the spectral data when excess FePPIX-DME
was added to apo-IsdA-N and the resulting complex purified by column chromatography are
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shown. In comparison to the uncomplexed PPIX-DME ring significant UV-visible absorption
and MCD spectral bands shifts when it is bound to the IsdA-N are observed. The MCD Soret
band blue shifts from a pseudo-A term centered at 412 nm to one centered on 417 nm. The
absorption and MCD spectra in Figure 8-1B arise solely from the FePPIX-DME bound to the
protein, because FePPIX-DME is not soluble in 10 mM PBS buffer pH 7.4 and the
chromatographic isolation of the protein will have separated the protein from any remaining free
FePPIX-DME, the spectra must be from the protein bound ring. It is clear that there is a mixture
of high and low spin species due to underlying charge transfer bands found in the Soret
absorption band at 405 nm, which distort the MCD spectral alignment. There are significant
changes in the Q band region. The appearance of a band at 626 nm in the absorption spectrum
associated with a 614/643 nm derivative-like envelope in the MCD spectrum is strongly
correlated with ring binding [16, 31]. The Q:B MCD band ratio is also reduced from ~3:1 for
FePPIX-DME to ~2:1 upon binding with IsdA-N. The MCD spectrum of FePPIX-DME bound
to IsdA-N in Figure 8-1B is very similar to that reported for heme-bound IsdA-N, which exhibits
a similar B:Q ratio as well as similar spectral features [16]. In view of this similarity, and the
differences from the pyridine solution, Figure-1A, it can be concluded that IsdA-N binds
FePPIX-DME through the same tyrosine ligand that binds heme [16, 29].
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Figure 8-1
Absorption and MCD spectra of A) FePPIX-DME in pyridine and B)
FePPIX-DME bound to IsdA-N purified by column chromatography. Significant UVvisible absorption and MCD spectral band shifts following binding of free PPIX-DME to IsdA-N
are observed. The MCD spectrum now shows the presence of two species as the cross-over red
shifts to 417 nm from 409 of the free heme. The appearance of the 614 nm and 643 nm MCD
bands under the more intense 626 nm absorption band indicate that the FePPIX-DME is much
more high spin than when not bound.
Figure 8-2A shows the charge states and deconvoluted mass spectra of the species in solution
following reaction of 3 µM IsdA-N with excess (30 µM) FePPIX-DME. Apo-IsdA-N (aA) has a
charge state distribution of +6 to +8, which match previously reported data [18]. Upon binding
FePPIX-DME, holo-IsdA-N forms (hA), with charge states between +7 and +9, indicating that
the protein overall volume remains similar to the apo-conformation. The deconvoluted data
show a shift in the mass associated with apo-IsdA-N (14,627 Da) to that for holo-(FePPIXDME)-IsdA-N (15,269 Da). The difference matches the theoretical mass of FePPIX-DME of
~644 Da. Approximately 40% of the apo-IsdA-N binds FePPIX-DME even though the FePPIXDME is in excess. This means that the binding constant is significantly less than that for heme.
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Typically, over 95% of apo-IsdA-N binds heme in the presence of excess heme to form holoIsdA-N [18].

Figure 8-2
ESI-Mass spectral data recorded following reaction of FePPIX-DME with
IsdA-N. A) Charge state and deconvoluted mass spectra after the reaction of 3 µM IsdA-N with
excess (30 µM) FePPIX-DME. Apo-IsdA-N and holo-IsdA-N are both observed. Apo-IsdAN(aA, 14627 Da) has a charge state distribution of +6 to +8 and following binding, holo-IsdA-N
(hA, 15269 Da) there is a shift to a +7 to +9 distribution. B) Charge state and deconvoluted mass
spectra after the reaction of 3 µM holo-IsdA-N with excess (6 µM) apo-IsdC-N. Four species
are present in solution, apo and holo-IsdA-N, with charge states +6 to +8, and apo and holoIsdC-N (14441/15058 Da), with charge states +7 to +9. The data show that IsdA-N does transfer
FePPIX-DME to IsdC-N. C) Charge state and deconvoluted mass spectra after the reaction of 6
µM holo-IsdA-N with 3 µM apo-IsdC-N and 6 µM apo-IsdE. Five species are present in
solution, apo and holo-IsdA-N (+7 and +8), apo and holo-IsdC-N (+7 to +9) and apo-IsdE
(30287 Da, +11 to +13). The data clearly show that no holo-IsdE is present. No FePPIX-DME
has transferred to IsdE. The peaks are adducted by a common 62 Da adduct found after
centrifugation sample preparation (labeled * in the deconvoluted spectra)
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8.3.2 FePPIX-DME binding and transfer determined by ESI-MS and MCD
techniques
Since IsdA-N binds FePPIX-DME the heme transfer mechanism was tested to determine the
effects of reducing the polar carboxylic acid side chains of heme to the relatively non-polar
methyl-esters using ESI-MS and UV-visible and MCD absorption spectroscopy. The mass
spectral data for the reaction of 3 µM holo-IsdA-N mixed with 6 µM (excess) apo- IsdC-N are
shown in Figure 8-2B. Charge state data indicate that four species are present in solution:
apo/holo-IsdA-N, with charge states +6 to +8 as previously reported [18], and apo/holo-IsdC-N,
with charge states +7 to +9. Deconvolution shows that there is approximately 25% holo-IsdA-N
and 25% holo-IsdC-N. indicating that indeed holo-IsdA-N does transfer the FePPIX-DME to
apo-IsdC-N. There were no further changes after one hour.
Figure 8-3A shows absorption and MCD data for the same reaction as described in Figure 81A.

30 µM FePPIX-DME was mixed with 3 µM apo-IsdC-N and purified by column

chromatography to remove excess free FePPIX-DME. When the spectral data are compared
with those for FePPIX-DME bound in holo-IsdA-N, it clear that there is a blue shift in the Soret
band from 405 nm to 400 nm. This is reflected in the MCD spectrum with slight blue shifts in the
A-like term (by 2 nm from (-)390, (+)407 and (-)426 nm to (-)388, (+)405 and (-)424 nm).
These spectroscopic changes of binding FePPIX-DME binding to IsdC-N are similar to those
reported for heme binding apo-IsdC-N [20]. Therefore, IsdC-N coordinates the FePPIX-DME
with a tyrosine amino acid ligand. This result is not unexpected as other porphryins are bound in
much the same way as the heme [19].
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Figure 8-3
Absorption and MCD spectra of A) FePPIX-DME bound to IsdC-N and B)
FePPIX-DME transferred from IsdA-N to IsdC-N. A) A solution of FePPIX-DME mixed
with apo-IsdC-N. When compared to FePPIX-DME bound holo-IsdA-N, there is a blue shift in
the Soret band from 405 to 400 nm. This is reflected in the MCD spectrum with slight blue shift
in the A term-like band centered at 405 nm. The overlapping MCD bands in the Soret region
indicates the presence of mixed species. B) A solution of 3 µM holo-IsdA-N mixed with 6 µM
apo-IsdC-N. The complicated, overlapped appearance is due to a mixture of holo-IsdA-N and
holo-IsdC-N in solution.
The ESI-MS data, Figure 8-2B, showed that FePPIX-DME was transferred from holo-IsdA-N
to IsdC-N when holo-IsdA-N was mixed with apo-IsdC-N. The optical spectral data in Figure 83B confirm this. When 3 µM holo-IsdA-N was added to 6 µM apo-IsdC-N new spectra that
resemble an average of holo-IsdA-N and holo-IsdC-N was observed. The Soret band at 402 nm
is midway between those for the two individual FePPIX-DME bound species. There is a
significant decrease in the B and Q band intensities in the MCD spectrum relative to the 294 nm
band, due to the presence of the two holo species in solution, where the decrease in signal arises
from cancelling of band intensities. Therefore these data confirm the ESI-MS results: IsdA-N is
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able to transfer FePPIX-DME to IsdC-N but not completely, unlike with heme transfer, where
heme is transferred completely from IsdA-N to IsdC-N [13, 18].
The most important reaction in the Isd system is the transfer of heme from IsdA-N via IsdC-N
to IsdE, that is through the cell wall to the membrane. The data described in Figure 8-2C show
the resultant FePPIX-DME-bound species when 6 µM holo-IsdA-N was mixed with 3 µM apoIsdC-N and 6 µM apo-IsdE. The charge state data show that there are five species present in
solution: apo/holo-IsdA-N (+7 and +8), apo/holo-IsdC-N (+7 to +9) and apo-IsdE (+11 to +13).
There are no charge states attributable to holo-IsdE present.

Deconvolution showed that

FePPIX-DME transfer had occurred from IsdA-N to IsdC-N but not to the apo-IsdE. Therefore,
clearly, neither IsdA-N nor IsdC-N can transfer FePPIX-DME to IsdE.
The same three-protein experiment was carried out monitoring the results by absorption and
MCD spectroscopy, Figure 8-4.

A spectroscopic advantage with FePPIX-DME is that the

spectroscopy closely resembles the absorption spectra to heme since only the periphery
carboxylic acid tails are changed. Therefore, the binding amino acids can be readily predicted by
comparing the spectra to that of well characterized heme binding properties in the Isd system.
The spectra measured were very similar to the set measured following mixing holo-IsdA-N with
apo-IsdC-N, Figure 8-2, which resulted in a mixture of holo/apo-IsdA-N and holo/apo-IsdC-N.
IsdE binds heme with a proximal histidine, which is different from the tyrosine that binds heme
in IsdA-N and IsdC-N [16, 17, 31, 32]. This change from a nitrogen donor to an oxygen donor
for the iron, red shifts the Soret band from 402 to 415 nm, in much the same way that these
donor atoms change the spectrum of myoglobin [33]. If IsdE bound FePPIX-DME under the
conditions of the experiment, a large change in the absorption spectrum would be expected as is
seen when IsdE binds heme [18, 31]. Since no spectral changes are seen compared with a mixed
solution of holo-IsdA-N and holo-IsdC-N, no FePPIX-DME transfer has taken place.
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Figure 8-4
Absorption and MCD spectral data recorded when apo-IsdE and apo-IsdC-N
were mixed with holo(FePPIX-DME)-IsdA-N. 3 µM holo-IsdA-N was mixed with 3 µM apoIsdC-N and 6 µM apo-IsdE. The spectra are typical of holo-IsdA-N and holo-IsdC-N not holoIsdE indicating that neither holo-IsdA-N nor holo-IsdC-N are able to transfer FePPIX-DME to
apo-IsdE.

8.3.3 Effects of central metal of heme on heme transfer
The focus of this study now shifts to looking at the effect of the central metal on PPIX
transfer between the core Isd proteins. CoPPIX and MnPPIX were chosen as ideal candidates
since these metals straddle Fe in the Periodic Table. In these experiments, the axial ligand
preferences are essentially testing the effects of hardness of the metal, where Co(III) is a harder
metal than Fe(III), which is harder than Mn(III). The importance of a +3 charge on the metal has
been demonstrated previously [25-27], where it appears that +3 metals mimic Fe(III) and have a
higher efficacy of anti-bacterial properties when compared to +2 metal substituted PPIXs.

161

8.3.4 CoPPIX binding to IsdA-N monitored by MCD spectroscopy.
It has been shown previously that IsdA-N binds CoPPIX in the same manner as IsdA-N binds
heme [11, 29]. The X-ray crystallography data show that overall protein confiormation is similar
indicating that while ring shape is an important factor in binding, perhaps the metal is not as
critical a factor for protein binding. However, if the ligand binding properties of each metal are
different then it would be expected that changes in ring transfer properties with each metal would
occur. Free CoPPIX has different spectral properties than CoPPIX bound to IsdA-N, Figure 8-5.
The Soret band at 421 nm red shifts to 426 nm upon CoPPIX binding. This is mirrored in the
MCD spectrum with a shift in the Soret peak (+)417 nm to (+)420 nm and the trough from (-)430
to (-)433 nm. In comparison to heme binding, the Q bands also shift by 2 nm upon binding [16].
Sensitive measures of the excited state modifications by the environment are found in the ratios
of the MCD B (Soret) band magnitude compared with the Q band span. The B:Q band ratio
changes from >1 to <1 upon CoPPIX binding. This change is similar to heme binding with
IsdA-N because the heme bound to IsdA-N exhibits a significantly higher spin than the free
heme [16]. These results coincide with the results from the crystal structure of IsdA-N with
CoPPIX, where the CoPPIX ring is bound by the same tyrosine ligand that would bind heme [11,
29].
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Figure 8-5
Absorption and MCD spectra of A) free Co-PPIX at pH 10 and B) CoPPIX
added in excess to apo-IsdA-N. The Soret band at 421 nm red shifts to 426 nm following
CoPPIX binding, which is mirrored in the MCD spectrum. The Q bands also shift by 2 nm with
CoPPIX binding to apo-IsdA-N. The B:Q band ratio changes from >1 to <1 upon Co-PPIX
binding.
CoPPIX binding to apo-IsdA-N was confirmed by ESI-MS, Figure 8-6A. Apo-IsdA-N (aA)
has a charge state distribution of +6 to +8. Upon binding CoPPIX (hA), the charge states remain
the same. This means that the overall volume remains similar to the apo-conformation, this result
is also seen with heme binding to IsdA-N [16, 18]. Deconvolution, shows that both apo-IsdA-N
(14624 Da) and holo-IsdA-N (15241 Da) exist in solution. An increase of ~617 Da corresponds
to an increase in mass that matches CoPPIX. Approximately 75% of IsdA-N binds CoPPIX,
meaning that the binding to IsdA-N is significantly less favourable than with heme. Typically,
when adding excess heme to IsdA-N, followed by purification steps, >95% of the protein is
holo-IsdA-N [16, 18]. However, these ESI-MS results confirm the UV-visible absorption and
MCD spectroscopic results.
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8.3.5 CoPPIX binding and transfer monitored by ESI-MS and MCD
spectroscopy
CoPPIX transfer from holo-CoPPIX-IsdA-N to apo-IsdC-N was investigated using ESI-MS.
Mass spectral data, Figure 8-6B, for a solution of 3 µM holo-IsdA-N mixed with 6 µM apo-IsdCN show no charge states attributable to holo(CoPPIX)-IsdC-N: only the +7 and +8 charge states
of apo-IsdA-N and holo-IsdA-N, and the +7 to +9 of apo-IsdC-N are observed in the spectrum.
Deconvolution shows only apo-IsdC-N (14444 Da) with a mixture of apo-IsdA-N (14623 Da)
and holo-IsdA-N (15239 Da), this means that no Co-PPIX transfer has taken place.
Transfer of CoPPIX from holo-IsdA-N directly to apo-IsdE was also investigated by ESI-MS,
Figure 8-6C. No transfer took place when 3 µM IsdA-N was mixed with excess (6 µM) apoIsdE; the ESI mass spectral data show the presence of only holo-IsdA-N

and apo-IsdE.

Deconvolution showed that apo-IsdA-N (14622 Da), holo-IsdA-N (15241 Da) and apo-IsdE
(30278 Da) were present.
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Figure 8-6
ESI-mass spectral data recorded following reaction of Co-PPIX with apoIsdA-N, apo-IsdC-N and apo-IsdE. A) Mass spectral data recorded when excess CoPPIX was
added to apo-IsdA-N. Apo-IsdA-N (aA, 14,624 Da) has a charge state distribution of +6 to +8.
Upon binding to form the holo-IsdA-N (hA, 15,241 Da), the charge state distribution remains the
same. Approximately 0.75 mol equivalents of the apo-IsdA-N binds to the CoPPIX even though
there is excess of the CoPPIX. B) Mass spectral data recorded when 6 µM apo-IsdC-N is mixed
with 3 µM holo-CoPPIX-IsdA-N. The mass spectrum only shows the +7 to +8 charge states for
apo-IsdA-N (aA) and holo-IsdA-N (hA) and the +7 to +9 charge states for apo-IsdC-N (aC,
14444 Da). Clearly, no Co-PPIX transfer has taken place. C) Mass spectral data recorded when
6 µM apo-IsdE is mixed with 3 µM holo-CoPPIX- IsdA-N. In addition to the mixture of apoIsdA-N and holo-IsdA-N, the +11 to +13 charge states of apo-IsdE (AE, 30278 Da) peaks are
observed. No CoPPIX transfer from hA to apo-IsdE has taken place.
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Figure 8-7
Absorption and MCD spectral data recorded for CoPPIX when apo-IsdC-N
(A) and apo-IsdE (B) were mixed with holo-IsdA-N. A) Spectra recorded following mixing 6
µM apo-IsdC-N with 3 µM holo-IsdA-N. The UV-visible absorption and MCD spectra did not
change when apo-IsdC-N is added indicating that no CoPPIX transfer took place. B) Spectra
recorded following mixing of 6 µM apo-IsdE with 3 µM holo-IsdA-N. The UV-visible
absorption and MCD spectra did not change when apo-IsdE was added indicating no CoPPIX
transfer took place.
The null transfer results were confirmed by UV-visible absorption and MCD spectroscopy,
Figure 8-7. The spectral data for a solution of 3 µM holo-IsdA-N mixed with 6 µM apo-IsdC-N
are the same as for the original holo-IsdA-N. Although, the actual heme binding spectrum of
IsdA-N and IsdC-N are very similar, there are slight differences in the MCD spectrum [16]. The
same spectral result is found when 3 µM holo-IsdA-N was mixed with 6 µM apo-IsdE as no
significant changes in the UV-visible absorption and MCD spectra were found. The overall
spectral envelope and Q:B band ratio remain approximately the same. Since IsdE binds heme
through a histidine ligand, a dramatic shift in the spectrum would be expected if CoPPIX was
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transfered from holo-CoPPIX-IsdA-N to apo-IsdE [18]. Although IsdA-N binds Co-PPIX, ring
transfer does not occur from IsdA-N to either IsdC-N or IsdE.

8.3.6 MnPPIX binding to IsdA-N by MCD spectroscopy and ESI-MS
Previous studies have shown that IsdH-N3 is able to bind MnPPIX and transfer the ring to
apo-IsdA-N [28]. In the study described here, the transfer of IsdA-N-bound MnPPIX across the
three core proteins: from holo-MnPPIX-IsdA-N, to apo-IsdC-N and on to apo-IsdE was
investigated. The absorption spectral data in Figure 8-8 resembles the spectra reported when
MnPPIX is transferred from IsdH-N3 to IsdA-N, with two prominent bands in the UV-visible
absorption spectrum, at 368 and 468 nm and weaker bands at 563 and 614 nm [28]. While there
are only minor shifts in the absorption spectrum when MnPPIX binds to IsdA-N, there are
significant changes in the MCD spectrum. The MCD band at centered at 387 nm shifts to 381
nm and there is significant resolution in the Q bands between 450 and 650 nm. As such, the Blike terms at 447 nm and 492 nm become more resolved while the psuedo-A-term at 589 and 605
nm is defined. Complicating some of the spectra measured was the presence of free MnPPIX
which after protein purification can only result due to the ring being labile within the protein.
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Figure 8-8
Absorption and MCD spectral data recorded for MnPPIX at pH 10 and
when added to apo-IsdA-N. (A) Free MnPPIX at pH 10 and (B) spectra recorded following
mixing of excess MnPPIX with apo-IsdA-N. The change in the UV-visible and MCD spectra
when apo-IsdA-N is added indicate that MnPPIX binding took place. Significantly increased
resolution is observed in the Q bands between 500 and 650 nm which supports a change in the
environment of the MnPPIX.
The MnPPIX binding was confirmed with ESI-MS, Figure 8-9A. Reaction of apo-IsdA-N
with excess MnPPIX results in ESI mass spectra that show masses from apo-IsdA-N and holoIsdA-N, both with a charge state distribution of +6 to +8. Observation of the same charge state
distribution is an indication that IsdA-N binds MnPPIX with little change in overall volume of
the holo protein, which is the same as for heme binding. Deconvolution shows an approximately
50% mix of apo-IsdA-N (14626 Da) and holo-IsdA-N (15298 Da). Typically, when adding
excess heme to IsdA-N, followed by purification steps, we find >95% of the protein is holoIsdA-N [18]. This means that MnPPIX binding is not as favourable as heme binding to the IsdAN.
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Figure 8-9
ESI-Mass spectral data recorded following reaction of MnPPIX with apoIsdA-N, apo-IsdC-N and apo-IsdE. A) Reaction of IsdA-N with excess MnPPIX. Apo-IsdAN(aA, 14,626 Da) has a charge state distribution of +6 to +8. Following mixing with MnPPIX,
holo-(MnPPIX)-IsdA-N (hA, 15,298 Da) is formed, which exhibits the same charge state
distribution. B) Four species are observed in solution (apo/holo-IsdA-N and apo/holo-IsdC-N
(apo-14,442 Da holo-15,056 Da) when 2.5 µM apo-IsdC-N is mixed with 3 µM holo-IsdA-N.
While holo-IsdAN transfers MnPPIX to IsdC-N, transfer is not complete. C) MnPPIX transfers
from holo-IsdAN (3 µM) to apo-IsdE(3 µM). Both IsdE (apo-30289 Da and holo-30904 Da)
species exist in solution. D) MnPPIX transfer from holo-IsdA-N (6 µM) to apo-IsdC-N (3 µM)
and then to apo-IsdE (6.5 µM). All six apo/holo species (IsdA-N: apo-14628 Da and holo-15241
Da; IsdC-N: apo-14443 Da and holo-15057 Da; and IsdE: apo-30290 Da and holo-30904 Da) are
observed.

8.3.7 MnPPIX binding and transfer monitored by absorption and MCD
spectroscopy and ESI mass spectrometry
Figure 8-9B shows the ESI mass spectrum of a solution containing 2 µM holo-IsdA-N mixed
with 3 µM apo-IsdC-N. The data show that holo-IsdAN does transfer MnPPIX to IsdC-N. Four
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species are present in the charge state spectra: apo/holo-IsdA-N (+7 and +8), apo-IsdC-N (+7 and
+8) and holo-IsdC-N (+7 to +9). A slight increase in the charge state envelope of IsdC-N upon
binding MnPPIX could indicate a slightly more open conformation. This result is expected as it
has been shown that IsdC-N contains a flexible heme pocket and was able to bind Zn(II)PPIX
[19]. Deconvolution shows that transfer is not complete, however, when compared with heme
binding [18], with all four species (apo-IsdC-N (14442 Da), holo-IsdC-N (15056 Da), apo-IsdAN (14626 Da) and holo-IsdA-N (15242 Da)) present in solution.
This same reaction was examined using absorption and MCD spectra. Excess apo-IsdC-N
was added to MnPPIX bound IsdA-N. The UV-visible absorption and MCD spectra, Figure 810A do change slightly when compared with holo-MnPPIX-IsdA-N. The Soret band centered at
369 nm becomes much more resolved in the MCD spectrum confirming a change in environment
of the MnPPIX. We should note that the heme bound spectra of IsdA-N and IsdC-N are also
very similar, due to the same ring binding ligand (tyrosine).
The ESI mass spectrum, Figure 8-9C, of a solution containing 5 µM holo-IsdAN mixed with
6.5 µM apo-IsdE showed charge states for four species: apo/holo-IsdA-N (+7 and +8) and
apo/holo-IsdE (+11 to +13). Clearly, MnPPIX does transfer from holo-IsdA-N to apo-IsdE.
Deconvolution shows that there exists approximately equal concentrations of apo-IsdA-N (14628
Da) and holo-IsdA-N (15242 Da), and also IsdE (apo-IsdE (30289 Da) and holo-IsdE (30904
Da). Therefore, although MnPPIX does transfer it does not transfer completely. Significantly,
heme does not transfer from holo-IsdA-N to IsdE [18]. In the case of MnPPIX, it is possible that
the transfer takes place via a dissociative/associative mechanism rather than the highly specific
protein-protein interactions that are required for the transfer of heme from IsdC-N to IsdE [18].
Absorption and MCD spectra confirm that a change in the MnPPIX take splace when 3 µM
holo-IsdA-N is mixed with 6 µM apo-IsdE, Figure 8-10B. MnPPIX transfer from the holo-IsdAN to apo-IsdE. The Soret band red shifts from 369 to 372 nm while the Q band shoulder blue
shifts from 606 to 600 nm. Overall, the spectrum is complicated and not as resolved as for the
IsdA-N to IsdC-N transfer. Therefore, it is probable that these spectra represent a mixture of
apo/holo-IsdA-N, apo/holo-IsdE and free MnPPIX in solution as shown in the ESI mass
spectrum, Figure 8-9C.
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Figure 8-10 UV-visible absorption and MCD spectra recorded following reaction of
MnPPIX with apo-IsdA-N, apo-IsdC-N and apo-IsdE. A) Reaction of holo-(MnPPIX)-IsdAN (3 µM) with apo-IsdC-N (6 µM). The UV-visible absorption and MCD spectra change
reflecting the formation of holo-IsdC-N. The Soret band centered at 369 nm becomes more
resolved. B) MnPPIX transfer from holo-IsdA-N (3 µM) to apo-IsdE (6 µM). The Soret band
red shifts from 369 to 372 nm while the Q band shoulder blue shifts from 592 to 587 nm.
The complete transfer of MnPPIX across all three core Isd proteins was monitored by ESIMS, Figure 8-9D. Holo-(MnPPIX)-IsdA-N (6 µM) was mixed with apo-IsdC-N (3 µM) and
apo-IsdE (5 µM). The ESI-mass spectrum shows that all six apo/holo pairs exist in solution
meaning that transfer has taken place and is almost complete, as very little apo-IsdE remains in
solution. It has been reported that IsdE has the highest heme affinity [13] and therefore, if
MnPPIX is labile within the heme pocket of the IsdA-N and IsdC-N, it might preferentially bind
to IsdE.
The absorption and MCD spectral data for this same reaction, Figure 8-11, show the results of
mixing a solution of 3 µM holo-IsdA-N with 3 µM apo- IsdC-N and 6 µM apo-IsdE. There is
further redshifting of the Soret band to 374 from 372 nm. The Q band region is less resolved
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with shoulders at 490 nm and a broad MCD band at 619 nm. This suggests the presence of each
of the holo-species in solution, IsdA-N, IsdC-N and IsdE and also the free MnPPIX. Evidence
for free MnPPIX in solution is shown by the double band at ~619 nm. The 619 nm peak was not
prominent in any other MCD spectrum except for free MnPPIX at pH 10 with a peak at 615 nm.
With size-exclusion chromatography performed on all holo-protein solutions, free Mn-PPIX in
the MCD spectrum leads us to conclude that binding is not very tight and the ring is labile.

Figure 8-11 UV-visible absorption and MCD spectra recorded for the reaction of holoIsdA-N (3 µM) with apo- IsdC-N (3 µM) and apo-IsdE (6 µM). The Soret band shifts to 374
from 372 nm. The Q band region is less resolved with shoulder peaks at 490 nm and a broad
MCD band envelope is recorded at 619 nm. These data suggest a complicated mixture of
MnPPIX species.

8.4 Discussion
8.4.1 Importance of the propionic side chains of heme in heme transfer.
The Isd heme transfer system of S. aureus is a novel target for new antibiotic compounds.
This system can potentially be abused with a "Trojan Horse" approach [25-28]. With new
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studies looking at different metal substituted porphryins in the Isd system as potential antibiotic
agents and their effects on binding [11, 28] it becomes important to study other aspects of the
system such as the importance of the heme binding ligands [29] and the critical components of
the heme ring itself. In this study, the effects of changing the propionic sidechain to the dimethyl
ester and of changing the Fe(III) to Co(III) and Mn(III) are reported.
The crystal structures of IsdA-N, IsdC-N and IsdE can be compared with that of myoglobin,
Figure 8-12. It appears that the carboxylic acid orientation is important in these proteins. From
the crystal structures of the heme bound in myoglobin, IsdA-N and IsdC-N, the propionic side
chains of the heme are facing away from the binding site out towards the bulk solvent while the
opposing vinyl side of the protoporphyrin ring is buried into the hydrophobic pocket in all of the
structures except for IsdE and myoglobin. The heme bound the IsdE protein have both propionic
side chains facing into the heme pocket [11, 17, 19, 32, 34].

Therefore, there has been

considerable speculation about the mechanism of heme transfer [29] and that it is possible that
hydrogen bonding interactions as well as ligands playing a key role in protein-protein
interactions.

Figure 8-12 Crystal structures of holo heme binding proteins A) Myoglobin (1MBN) [34],
B) IsdA-NEAT (2ITF) [17], C) IsdC-NEAT (2O6P) and D) IsdE (2Q8Q) [32]. The cartoon
ribbons of their structures are colored blue to red for the direction N to C terminal. The
calculated surfaces are shown in grey with the heme pockets oriented forward. The structure of
heme is shown as a reference. The crystal structures of the heme bound proteins myoglobin,
IsdA-N and IsdC-N show the propionic side chains facing away from the binding site out
towards bulk solvent while the opposing vinyl side of the protoporphyrin ring is buried into the
hydrophobic pocket in all of the structures except for IsdE.
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The results of the PPIX (FePPIX-DME, CoPPIX. MnPPIX) transfer experiments investigated
in this study are summarized in Figure 8-13.

Upon close inspection of these X-ray

crystallography structures, the hydrophobic pocket appears to be unable to accept porphyrin
rings much larger than protoporphyrin IX and, therefore, FePPIX-DME is an ideal candidate to
look at the effects of heme transfer with regards to heme structure. The ESI-MS, UV-visible
absorption and MCD spectral data show that IsdA-N is able to bind FePPIX-DME and transfer it
to IsdC-N. However, neither IsdA-N nor IsdC-N is able to transfer FePPIX-DME to IsdE. This
may be due to IsdE binding the heme with the propionic side chains buried inside the protein.
Therefore, important hydrogen bonding interactions that would stabilize the heme within the bilobed [32] heme pocket are not now present. Since this interaction would be stripped away from
this PPIX compound, IsdE is not able to bind or accept through transfer FePPIX-DME.

Figure 8-13 Summary of PPIX binding from this study and for heme binding from past
results [18] and this study.

8.4.2 Changing the central metal of PPIX and the effect on heme transfer
Changing the central metal allows the investigation of the effects of the relative "hardness" of
the central metals compared with the Fe(III) on proximal and distal donor atom binding. Co(III)
is harder than Fe(III) and it was found that, although it was known that CoPPIX-DME binds to
IsdA-N [11, 29], holo-IsdA-N is unable to transfer CoPPIX to IsdC-N or IsdE. The proximal
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amino acid-metal bond is an important factor with the Isd heme transfer system [29] and by
changing the metal there is an effect on the strength of the critical tyrosine metal bond. The
hydroxide of the tyrosine is a "hard" ligand and in the Isd system, IsdA and IsdC do not bind to
the "soft" ferrous heme with their ferric coordinating tyrosine ligand [16]. IsdE on the other
hand, only coordinates ferric heme through an "intermediate" histidine ligand [31, 32], and this
enables IsdE to be versatile in the oxidation state of heme [31].
conformationally is indistinguishable compared to heme [11].

CoPPIX binding

Therefore, the tightness of

binding CoPPIX may overcome the releasing factors such as the important protein-protein
interactions to the point where CoPPIX transfer cannot be facilitated.
The opposite case is seen with a "softer" metal, for example, Mn(III) in MnPPIX, where
MnPPIX is transferred from MnPPIX-IsdA-N to apo-IsdC-N and on to apo-IsdE. However,
heme is not transferred directly from holo-IsdA-N apo-IsdE [18]. MnPPIX appears to be labile
as a 619 nm peak (attributed to free MnPPIX) is found in the spectra following the reaction of
MnPPIX bound holo-IsdA-N with apo-IsdC-N and apo-IsdE, Figure 8-11. From these data, it
can be proposed that the Tyr ligands of IsdA-N and IsdC-N are not able to bind MnPPIX with
such a high affinity as with heme. Figure 8-9C shows that signifigant amount of MnPPIX
tranfers to IsdE. Therefore, since IsdE does not have a coordinating tyrosine ligand [31, 32], but
instead an "intermediate" histidine, IsdE is still able to open the gated IsdA-N and IsdC-N
proteins to facilitate MnPPIX transfer. Furthermore, the histidine ligand is probably able to bind
more tightly to the softer MnPPIX.

8.5 Conclusion
In summary, the propionic acid chains of heme play a key role in heme transfer reactions,
especially with regard to heme binding to IsdE, where the propionic acid side chains are
completely buried within the heme pocket [32]. IsdA-N is able to bind FePPIX-DME and
transfer it to IsdC-N. However, FePPIX-DME bound holo-IsdA-N and holo-IsdC-N are not able
to transfer FePPIX-DME to IsdE. The "harder" CoPPIX on the other hand binds to IsdA-N [29],
but is not transferred IsdC-N or IsdE. The "softer" MnPPIX binds to IsdA-N, which is able to
transfer the ring to IsdC-N. IsdC-N is able to transfer the ring to IsdE. In a reaction unlike that
found for heme, holo-Mn(III)PPIX-IsdA-N transfers the ring directly to IsdE. To overcome the
protein-protein interactions shown to exist with this transfer, MnPPIX must be labile. As the
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heme transfer mechanism of the Isd system in S. aureus becomes widely understood a new focus
of using this system as a "Trojan Horse" technique to potentially kill the bacteria has emerged in
recent years. This leads to the ultimate goal of potentially either utilizing metalloporphryins for
cytotoxicity [28] or using photodynamic antimicrobial therapy to kill the bacteria [27]. In
addition it can be proposed PPIX analogs can be used to shut down the iron-deficient regulated
Isd system, which may work in either starving the bacteria or sufficiently weakening the bacteria
so that other antibacterial methods can be used to kill S. aureus. Key to this study is that
FePPIX-DME is able to transfer through to the central conduit of the Isd system, IsdC-N. It is
possible that this compound would be an ideal candidate as this would affect the S. aureus
growth as a potential antibiotic. Further studies are needed to determine the effectiveness of this
compound.
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8.7 Appendix

Figure 8-14 ESI-MS charge state data for FePPIX-DME. This compound matches the
theoretical mass of 645.6 Da.

Figure 8-15
UV-visible absorption and MCD spectra of holo-Co-PPIX-IsdA-N
when mixed with substoichiometric amounts of apo-IsdC-N and excess apo-IsdE. No
transfer takes place; the spectra are the same as for the holo-IsdA-N.
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Chapter 9.

Conclusion

9.1 Staphylococcus aureus
The antibiotic resistant, Gram-positive bacterium, Staphylococcus aureus (S. aureus) is a
significant problem in hospitals and communities worldwide where it is responsible for
numerous deaths. Infections caused by this bacterium can range from superficial wound lesions
to more severe infections such as pneumonia, osteomyelitis and septicemia [1]. S. aureus is
currently the leading cause of nosocomial infections [2]. Treatment for infections is costly due
to growing resistance to most antibiotics. Resistance to the ‘last resort’ antibiotic vancomycin is
more prevalent and hence, death can still result [3]. Analysis of Canadian statistics for 2006
suggests there were over 2000 deaths in Canada attributed to S. aureus [4]. Understanding how
S. aureus thrives in the host has become a major focus of research.
Iron is an essential and yet is, generally unavailable nutrient for bacteria. In the mammalian
host, total free iron levels are kept to a minimum as the host binds the free iron into a number of
proteins and thus, invading bacteria have difficulty obtaining iron [5]. The lack of iron inhibits
the growth of invading bacteria and consequently allows the host’s immune system to destroy the
infection. Like most bacteria, S. aureus has adapted and possesses a number of iron acquisition
systems. The most abundant source of iron in the human body is found in heme, which is bound
by proteins such as hemoglobin and myoglobin. In 2003, Mazmanian et al. [6] reported that
when grown in iron-limiting media, S. aureus expresses genes that are involved in iron
acquisition [6]; this series of proteins were named Isd, for iron-regulated surface determinant,
and comprise of a series of 9 proteins: IsdH, IsdB, IsdA, IsdC, IsdE, IsdD, IsdF, IsdG and IsdI.
It was proposed that S. aureus could scavenge heme using the Isd protein pathway by lysing red
blood cells and extracting the intact heme from the hemoglobin. An overall summary of heme
flow and characterization of the Isd system is shown in Figure 9-1.
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Figure 9-1
Summary cartoon schematic of heme flow through the Isd heme scavenging
system in S. aureus. Characterization of the Isd system with the flow of heme from hemoglobin
binding IsdB though IsdA, IsdC and to IsdE where heme is passed through IsdF. IsdG or IsdI
finally deconstructs free heme and releases free iron. Modified from [7]. Copyright 2008
Portland Press Limited.
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9.2 Heme Binding in the Isd System
Essential to heme binding in the Isd system is that all of the heme binding proteins contain a
near iron transporter (NEAT) domain. These ~150 amino acid sequences are known to possess
heme binding properties [8]. To date, the ferric and ferrous heme binding properties of the Isd
proteins have been characterized. The NEAT domains, with the exception of IsdB-N1, IsdH-1
and IsdH-N2, of the Isd system bind ferric heme through a tyrosine amino acid binding ligand
[9-11]. IsdE, which does not contain a NEAT domain, binds heme within its bilobed structure
through a His ligand [12, 13].
In terms of ferrous heme binding, IsdB-N2 and IsdH-N3 bind ferrous heme through His and
Met ligands [11], IsdA binds ferrous heme though a His ligand [9, 10, 14] and IsdE binds
ferrous heme through 6-coordinate His and Met ligands [12, 13]. Interestingly, IsdC does not
bind ferrous heme [10, 15]. Since IsdC is the central conduit of the Isd system [9, 16, 17] and
can only bind ferric heme, extraction of heme from Hb must result in oxidation from biologically
relevant ferrous to ferric heme before heme is passed through the cell wall of the bacteria.
Much of the spectroscopic characterization of heme binding and transfer has been elucidated
using MCD spectroscopy. The value of the MCD spectral data is that although the observed
MCD bands lie at the same energy and exhibit approximately the same bandwidth as the
absorption bands, the MCD spectral data are sensitive to the nature of the protein axial ligands
binding the heme iron, the heme-iron oxidation and the heme-iron spin state [18, 19]. These
properties have such profound spectral effects that the key features in the observed MCD
envelope morphology (sign, relative magnitude, and band maxima) systematically change for a
range of heme proteins allowing ‘fingerprinting’ of novel heme binding proteins with those wellstudied [19]. In this manner, the identity of the two axial ligands (the proximal 5th position, and
the distal 6th position), the oxidation state of the iron, and its spin state, may be determined
directly from dilute solutions at room temperature with considerable confidence for each of the
Isd proteins. The MCD spectral data offer species identification far superior to that from the
absorption spectroscopic data alone.
The heme axial ligands play important roles in stabilizing heme binding. As a result of the
effects on the electronic structure of heme, each heme binding ligand significantly influence the
heme spectra, Figure 9-2. Identifying the ligands of the heme scavenging system of the Isd
proteins provides electronic information about how the Isd pathway is able to transfer heme from
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hemoglobin. This preliminary investigation of the heme binding site environment is based on
the protein backbone established by the crystal structures for IsdA, and IsdE. The orbital
contributions to the B and Q bands provide initial indication of the electronic contributions by
the axial ligands at the HOMO and LUMO levels, the orbitals most involved in heme binding.
Molecular orbitals for many porphyrins and predicted spectra based on INDO/S and TDDFT
calculations are widely available, for example, Mack et al. [20]. Figure 9-2 shows that for IsdA
there is considerable involvement of the tyrosine (Tyr166) in both the ground state and excited
states and that this axial ligand contributes to both the B and Q bands. IsdE with a ferrous heme
was calculated with both His229 and Met78 axial ligands. Both ligands interact at the iron
center for the B and Q bands, but clearly the Q band significantly involves the excited state of
His229 (under the heme).

Figure 9-2
Calculations of the orbital contributions to the B and Q bands in IsdA and
IsdE. IsdA binds a ferrous heme through His83 and ferric heme through Tyr166. Calculations
are shown for the native ferric heme. IsdE binds ferrous heme through His229 and Met78. The
calculations were carried out using ZINDO for the geometry optimizations and ZINDO/S for the
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orbital calculations. Reprinted with permission from [7].
Limited.

Copyright 2008 Portland Press

The spectroscopic results for the Isd heme scavenging system in S. aureus have allowed
identification of the heme binding ligands in IsdH-N3, IsdB-N2, IsdA, IsdC and IsdE. The
NEAT domains and IsdE are significant factors in heme-trafficking in S. aureus.

The

identification of the native oxidation state, spin state, and heme-binding ligands will aid in the
continued effort to understand the overall mechanism of heme-trafficking in Gram-positive
bacteria.

9.3 Mechanism of Heme Transfer in the Isd System
In summary, the flow of heme is from the externally-located IsdH and IsdB proteins through
to the membrane-associated IsdE protein. Heme transfers unidirectionally and completely from
IsdB-N2 to IsdA-N to IsdC-N then to IsdE or from IsdH-N3 to IsdA-N to IsdC-N then to IsdE.
IsdB-N2 and IsdH-N3 can transfer heme to IsdC-N. Unique protein-protein interactions exist
with apo-IsdB-N1N2 and Hb with regards to heme extraction and the mechanism of heme
removal. Interestingly, only fully intact apo-IsdB-N1N2 is able to extract heme from metHb.
Protein-protein interactions must be located in the first NEAT domain of IsdB and in the linker
region between the two NEAT domains. Upon heme extraction, IsdB-N1N2 is able to denature
and deconstruct metHb into subunit components that comprise of ah(αβ) aa(αβ) dimer, apo-α and
apo-β strands. Addition of IsdA-N, IsdC-N and IsdE completes heme transfer from IsdB-N1N2
to IsdA-N and IsdC-N with subsequent transfer to IsdE, the end of the cell wall transfer system.
Overall, when looking at heme extraction from metHb, the Isd system forms an efficient machine
that is able to "shred" metHb and extract the precious iron-containing heme resource inside.
A significant component to the mechanistic analysis is that heme does not transfer from holoIsdA-N directly to apo-IsdE; apo-IsdC-N is the required facilitator. This fact, taken together
with the demonstrated unidirectionality of the transfer reactions, suggests that specific proteinprotein interactions must be a necessary part of the mechanism required to drive the heme
transfer towards the membrane.
IsdC-N can be considered as a catalyst that facilitates heme transfer through the cell wall
anchored Isd proteins (IsdA-N, IsdC-N and IsdE). Intact IsdC-N is required to complete heme
transfer from IsdA-N to IsdE. Overall, the rate of transfer from IsdA-N to IsdC-N is faster than
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transfer from IsdC-N to IsdE. When IsdC-N acts as a heme shuttle between IsdA-N and IsdE,
the key to fitting the transfer reaction studied is to introduce a step that slowly disables IsdC-N,
by binding heme but becoming conformationally unable to transfer heme. With IsdC-N acting as
a heme shuttle between IsdA and IsdE, the differential rates of heme transfer support the
hypothesis that heme stockpiling would result in the cell wall. As a result, this facet of the Isd
heme transfer system may impart heme cytotoxicity relief on the bacterium by throttling the
heme transfer reaction into the cell interior.
When looking at the Isd protein structure, it might be thought that each Isd protein would be
significantly different from each other, as each possesses slightly different heme binding
spectroscopy and different heme transfer properties. Figure 9-3 shows a 3D protein structure
alignment of all heme binding Isd NEAT domains (IsdB-N2, IsdH-N3, IsdA-N, IsdC-N) with
secondary structure beta sheets coloured in gold and alpha helices coloured in blue. Remarkably,
the structural 3D alignment and orientation of amino acids in the Isd proteins are all very similar,
especially in the heme binding pocket, despite having different sequences. A major difference
lies within IsdC-N, which has an extra lip in the heme pocket shown on the right of Figure 9-3.
The sequence alignment is presented in Figure 9-4. The heme binding tyrosine ligands are
conserved and highlighted with a red box. The extra lip of IsdC-N is highlighted in green.
Interestingly, IsdA-N also has an extra sequence highlighted in green. However, this is located
on the periphery of the protein away from the heme pocket. Current studies of heme transfer
have found that transfer from IsdA-N to IsdC-N involves a hand clasp model, where the NEAT
domains overlap each other and essential beta sheets interact in order to facilitate heme transfer
[21]. Overall, the small differences in protein structure and amino acids sequences lead to a
finely tuned heme transfer machine that is the Isd system.
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Figure 9-3
Protein alignment of all heme binding NEAT domains found in the Isd
system. The Isd NEAT domains align together with amino acid positioning and similar
secondary structure elements. IsdC-N contains a larger lip that can be seen at the right of the
figure. The crystal structures come from the pdb with IsdC-N (2O6P), IsdA-N (2ITF), IsdH-N3
(2Z6F) and IsdB-N2 (3RTL).

Figure 9-4
Amino acid protein alignment of all heme binding NEAT domains found in
the Isd system. The heme binding Isd NEAT domains are very similar in not only residues but
also structure. The ferric heme binding residues are boxed in red. IsdA-N and IsdC-N contain
extra segments. IsdA-N has a sequence outside of the protein while IsdC-N has an extra string of
amino acids at the lip of heme binding pocket. The crystal structure sequences come from the
pdb with IsdC-N (2O6P), IsdA-N (2ITF), IsdH-N3 (2Z6F) and IsdB-N2 (3RTL).
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9.4 Exploiting Heme Transfer in the Isd System
Heme transfer down the chain of proteins in the Isd system must be governed by a gate
triggered by critical protein-protein interactions. The gate residues are in the heme crevice that
binds the heme in place and prevents loss due to dissociation. Holo-IsdC-N does not release
heme to the mutant IsdE(MH), a protein that cannot bind heme. Heme binding ligand mutations
disable important heme releasing triggers. This effectively neutralizes important protein-protein
interactions. Without the heme binding ligands the mutant IsdE now acts under affinity control
transferring heme to apo-IsdA-N, apo-IsdC-N, and apo-IsdE. These transfers are not observed
with native IsdE. Not only do the heme binding ligands play crucial roles in decreasing Kd
values, from IsdA to IsdC and IsdE, but these ligands also dictate the selectivity and
unidirectionality of the system.
The propionic acid chains of heme play a key role in heme transfer reactions, especially with
regard to heme binding to IsdE, where the propionic acid side chains are completely buried
within the heme pocket [12]. The role of the propionic side chains was tested be using FePPIXDME heme analogue.

IsdA-N was able to bind FePPIX-DME and transfer it to IsdC-N.

However, FePPIX-DME bound holo-IsdA-N and holo-IsdC-N were not able to transfer FePPIXDME to IsdE. Changing the central metal from FeIII to CoIII and MnIII tested the role of axial
ligation. The "harder" CoPPIX was bound by IsdA-N [9], but was not transferred to IsdC-N or
IsdE. The "softer" MnPPIX was bound by IsdA-N, which was able to transfer the ring to IsdCN. IsdC-N was then able to transfer the ring to IsdE. In a reaction unlike that found for heme,
holo-MnPPIX-IsdA-N transfered the ring directly to IsdE. In order to overcome the proteinprotein interactions shown to exist with this transfer, MnPPIX must be labile. As the heme
transfer mechanism of the Isd system in S. aureus became more widely understood, a new focus
of using this system as a "Trojan Horse" technique to potentially kill the bacteria emerged in
recent years. This may lead to the ultimate goal of potentially utilizing metalloporphryins for
cytotoxicity [22] or using photodynamic antimicrobial therapy to kill the bacteria [23].
Critically, is that FePPIX-DME is able to transfer through to IsdC-N, the central conduit of the
Isd system, but not to IsdE. It is possible that this compound would be an ideal candidate as a
potential antibiotic for S. aureus by shutting down the Isd system and starving the bacteria of
essential resources. Further studies are needed to determine the effectiveness and safety of this
compound.
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9.5 Final Remarks
Although utilization of Hb in S. aureus is mediated by the Isd heme transfer system [6, 24],
this motif is also found in other Gram-positive pathogens such as Bacillus anthracis,
Chlorstridium tetani and Listeria monocytogenes [2, 8, 25]. As a result of the research focus on
the Isd system of S. aureus, the system is now almost fully characterized. With the development
of techniques such as ESI-MS, MCD spectroscopy and x-ray crystal structure studies looking at
heme binding and heme transfer, it is opportunistic to look at other similar systems to the Isd
system of S. aureus. Overall, since the Isd proteins are very similar not only structurally, but
also spectroscopically, it is possible that other systems may not be unique and may contain key
features that are found in the Isd system. Therefore, characterization of new systems can be
accelerated by technique refinement from the Isd system.

Furthermore, it is possible that

blocking the heme transfer system with "Trojan Horse" porphyrins may work on other bacteria.
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